
<html lang="en"     class="pb-page"  data-request-id="323deda1-503f-47d5-b32d-85025acca205"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2013.56.issue-24;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm401075x;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)" /></meta><meta name="dc.Creator" content="Edward J.  Hennessy" /></meta><meta name="dc.Creator" content="Ammar  Adam" /></meta><meta name="dc.Creator" content="Brian M.  Aquila" /></meta><meta name="dc.Creator" content="Lillian M.  Castriotta" /></meta><meta name="dc.Creator" content="Donald  Cook" /></meta><meta name="dc.Creator" content="Maureen  Hattersley" /></meta><meta name="dc.Creator" content="Alexander W.  Hird" /></meta><meta name="dc.Creator" content="Christopher  Huntington" /></meta><meta name="dc.Creator" content="Victor M.  Kamhi" /></meta><meta name="dc.Creator" content="Naomi M.  Laing" /></meta><meta name="dc.Creator" content="Danyang  Li" /></meta><meta name="dc.Creator" content="Terry  MacIntyre" /></meta><meta name="dc.Creator" content="Charles A.  Omer" /></meta><meta name="dc.Creator" content="Vibha  Oza" /></meta><meta name="dc.Creator" content="Troy  Patterson" /></meta><meta name="dc.Creator" content="Galina  Repik" /></meta><meta name="dc.Creator" content="Michael T.  Rooney" /></meta><meta name="dc.Creator" content="Jamal C.  Saeh" /></meta><meta name="dc.Creator" content="Li  Sha" /></meta><meta name="dc.Creator" content="Melissa M.  Vasbinder" /></meta><meta name="dc.Creator" content="Haiyun  Wang" /></meta><meta name="dc.Creator" content="David  Whitston" /></meta><meta name="dc.Description" content="A series of dimeric compounds based on the AVPI motif of Smac were designed and prepared as antagonists of the inhibitor of apoptosis proteins (IAPs). Optimization of cellular potency, physical pro..." /></meta><meta name="Description" content="A series of dimeric compounds based on the AVPI motif of Smac were designed and prepared as antagonists of the inhibitor of apoptosis proteins (IAPs). Optimization of cellular potency, physical pro..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="December 13, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm401075x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm401075x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm401075x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm401075x" /></link>
        
    
    

<title>Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm401075x" /></meta><meta property="og:title" content="Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0025.jpeg" /></meta><meta property="og:description" content="A series of dimeric compounds based on the AVPI motif of Smac were designed and prepared as antagonists of the inhibitor of apoptosis proteins (IAPs). Optimization of cellular potency, physical properties, and pharmacokinetic parameters led to the identification of compound 14 (AZD5582), which binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, respectively). This compound causes cIAP1 degradation and induces apoptosis in the MDA-MB-231 breast cancer cell line at subnanomolar concentrations in vitro. When administered intravenously to MDA-MB-231 xenograft-bearing mice, 14 results in cIAP1 degradation and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0 mg/kg. Antiproliferative effects are observed with 14 in only a small subset of the over 200 cancer cell lines examined, consistent with other published IAP inhibitors. As a result of its in vitro and in vivo profile, 14 was nominated as a candidate for clinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm401075x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm401075x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm401075x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm401075x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm401075x&amp;href=/doi/10.1021/jm401075x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 9897-9919</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4010708" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm401158e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+J.++Hennessy">Edward J. Hennessy</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ammar++Adam">Ammar Adam</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+M.++Aquila">Brian M. Aquila</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lillian+M.++Castriotta">Lillian M. Castriotta</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald++Cook">Donald Cook</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maureen++Hattersley">Maureen Hattersley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexander+W.++Hird">Alexander W. Hird</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Huntington">Christopher Huntington</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Victor+M.++Kamhi">Victor M. Kamhi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Naomi+M.++Laing">Naomi M. Laing</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Danyang++Li">Danyang Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Terry++MacIntyre">Terry MacIntyre</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+A.++Omer">Charles A. Omer</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vibha++Oza">Vibha Oza</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Troy++Patterson">Troy Patterson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Galina++Repik">Galina Repik</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+T.++Rooney">Michael T. Rooney</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jamal+C.++Saeh">Jamal C. Saeh</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Li++Sha">Li Sha</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa+M.++Vasbinder">Melissa M. Vasbinder</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Haiyun++Wang">Haiyun Wang</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David++Whitston">David Whitston</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Oncology iMed, Innovative Medicines & Early Development, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, Massachusetts 02451, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (781) 839-4153. E-mail: <a href="/cdn-cgi/l/email-protection#bcd9d8cbddced892d4d9d2d2d9cfcfc5fcddcfc8ceddc6d9d2d9dfdd92dfd3d1"><span class="__cf_email__" data-cfemail="3a5f5e4d5b485e14525f54545f4949437a5b494e485b405f545f595b14595557">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm401075x&amp;href=/doi/10.1021%2Fjm401075x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 9897–9919</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">December 9, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>16 July 2013</li><li><span class="item_label"><b>Published</b> online</span>13 December 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 27 December 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm401075x" title="DOI URL">https://doi.org/10.1021/jm401075x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9897%26pageCount%3D23%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DEdward%2BJ.%2BHennessy%252C%2BAmmar%2BAdam%252C%2BBrian%2BM.%2BAquila%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D24%26contentID%3Djm401075x%26title%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BDimeric%2BSmac%2BMimetics%2Bas%2BPotent%2BIAP%2BAntagonists%2BResulting%2Bin%2Ba%2BClinical%2BCandidate%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%2B%2528AZD5582%2529%26numPages%3D23%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9919%26publicationDate%3DDecember%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm401075x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3621</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">52</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm401075x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Novel Class of Dimeric Smac Mimetics as Potent IAP Antagonists Resulting in a Clinical Candidate for the Treatment of Cancer (AZD5582)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;J. Hennessy&quot;},{&quot;first_name&quot;:&quot;Ammar&quot;,&quot;last_name&quot;:&quot;Adam&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;M. Aquila&quot;},{&quot;first_name&quot;:&quot;Lillian&quot;,&quot;last_name&quot;:&quot;M. Castriotta&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;Cook&quot;},{&quot;first_name&quot;:&quot;Maureen&quot;,&quot;last_name&quot;:&quot;Hattersley&quot;},{&quot;first_name&quot;:&quot;Alexander&quot;,&quot;last_name&quot;:&quot;W. Hird&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Huntington&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;M. Kamhi&quot;},{&quot;first_name&quot;:&quot;Naomi&quot;,&quot;last_name&quot;:&quot;M. Laing&quot;},{&quot;first_name&quot;:&quot;Danyang&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Terry&quot;,&quot;last_name&quot;:&quot;MacIntyre&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;A. Omer&quot;},{&quot;first_name&quot;:&quot;Vibha&quot;,&quot;last_name&quot;:&quot;Oza&quot;},{&quot;first_name&quot;:&quot;Troy&quot;,&quot;last_name&quot;:&quot;Patterson&quot;},{&quot;first_name&quot;:&quot;Galina&quot;,&quot;last_name&quot;:&quot;Repik&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;T. Rooney&quot;},{&quot;first_name&quot;:&quot;Jamal&quot;,&quot;last_name&quot;:&quot;C. Saeh&quot;},{&quot;first_name&quot;:&quot;Li&quot;,&quot;last_name&quot;:&quot;Sha&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;M. Vasbinder&quot;},{&quot;first_name&quot;:&quot;Haiyun&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;Whitston&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;12&quot;,&quot;day&quot;:&quot;13&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;9897-9919&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm401075x&quot;},&quot;abstract&quot;:&quot;A series of dimeric compounds based on the AVPI motif of Smac were designed and prepared as antagonists of the inhibitor of apoptosis proteins (IAPs). Optimization of cellular potency, physical properties, and pharmacokinetic parameters led to the identification of compound 14 (AZD5582), which binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC50 = 15, 21, and 15 nM, respectively). This compound causes cIAP1 degradation and induces apoptosis in the MDA-MB-231 breast cancer cell line at subnanomolar concentrations in vitro. When administered intravenously to MDA-MB-231 xenograft-bearing mice, 14 results in cIAP1 degradation and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0 mg/kg. Antiproliferative effects are observed with 14 in only a small subset of the over 200 cancer cell lines examined, consistent with other published IAP inhibitors. As a result of its in vitro and in vivo profile, 14 was nominated as a candidate for clinical &quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401075x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401075x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401075x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401075x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm401075x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401075x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm401075x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm401075x&amp;href=/doi/10.1021/jm401075x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm401075x" /></input><a href="/doi/pdf/10.1021/jm401075x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm401075x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm401075x%26sid%3Dliteratum%253Aachs%26pmid%3D24320998%26genre%3Darticle%26aulast%3DHennessy%26date%3D2013%26atitle%3DDiscovery%2Bof%2Ba%2BNovel%2BClass%2Bof%2BDimeric%2BSmac%2BMimetics%2Bas%2BPotent%2BIAP%2BAntagonists%2BResulting%2Bin%2Ba%2BClinical%2BCandidate%2Bfor%2Bthe%2BTreatment%2Bof%2BCancer%2B%2528AZD5582%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D24%26spage%3D9897%26epage%3D9919%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=292200" title="Layers">Layers</a>,</li><li><a href="/action/doSearch?ConceptID=292506" title="Materials">Materials</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jmcmar.2013.56.issue-24/production/jmcmar.2013.56.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of dimeric compounds based on the AVPI motif of Smac were designed and prepared as antagonists of the inhibitor of apoptosis proteins (IAPs). Optimization of cellular potency, physical properties, and pharmacokinetic parameters led to the identification of compound <b>14</b> (AZD5582), which binds potently to the BIR3 domains of cIAP1, cIAP2, and XIAP (IC<sub>50</sub> = 15, 21, and 15 nM, respectively). This compound causes cIAP1 degradation and induces apoptosis in the MDA-MB-231 breast cancer cell line at subnanomolar concentrations in vitro. When administered intravenously to MDA-MB-231 xenograft-bearing mice, <b>14</b> results in cIAP1 degradation and caspase-3 cleavage within tumor cells and causes substantial tumor regressions following two weekly doses of 3.0 mg/kg. Antiproliferative effects are observed with <b>14</b> in only a small subset of the over 200 cancer cell lines examined, consistent with other published IAP inhibitors. As a result of its in vitro and in vivo profile, <b>14</b> was nominated as a candidate for clinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80118" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80118" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The process of programmed cell death, known as apoptosis, plays a critical role in the maintenance of homeostasis and in regulating the amount of cells in higher organisms.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Apoptosis plays key roles during development and aging and is the means by which damaged or unwanted cells are removed. Aberrations in the apoptotic process would thus be expected to disrupt this homeostasis, and, indeed, abnormal apoptosis is implicated in a variety of diseases, including autoimmune disorders, viral infections, degenerative diseases of the central nervous system, and cancer.<a onclick="showRef(event, 'ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref2 ref3">(2, 3)</a></div><div class="NLM_p">The development of resistance to standard-of-care therapies in the treatment of cancer is a major cause of disease progression and represents a critical challenge in the development of novel cancer therapeutics. Although there can be many causes behind this acquired drug resistance, a major mechanism of resistance lies in the dysfunctional survival signaling in cancer cells and the reluctance of these cells to undergo apoptosis. Indeed, the propensity of cancerous cells to avoid undergoing apoptosis has long been recognized as one of the hallmarks of cancer.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Thus, agents that can restore sensitivity of these cells to various proapoptotic cues might conceivably be employed as cancer therapies, either alone or in combination with other drugs.</div><div class="NLM_p">Cells can undergo apoptosis in response to a variety of stimuli, such as chemotherapy or radiation-induced cellular stresses. On receiving a proapoptotic signal, a variety of intracellular signaling process occur, eventually culminating in the activation of cysteine-dependent aspartyl specific proteases (caspases) that are responsible for effecting cell death. In recent years, it has become evident that particular members of a family of structurally related proteins known as the inhibitor of apoptosis proteins (IAPs) play a role in the suppression of such proapoptotic signaling in mammalian cells.<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5, 6)</a> The IAPs are characterized by the presence of one to three repeating domains of ∼70–80 amino acids, known as baculovirus IAP repeat (BIR) domains. Certain members of the IAP family, such as X chromosome-linked IAP (XIAP), function by directly binding to and sequestering proapoptotic caspases (such as caspase-3, caspase-7, and caspase-9) that are critical to the apoptotic process. In particular, the BIR3 domain of XIAP has been shown to directly bind caspase-9, preventing the self-dimerization necessary for caspase-9 catalytic activity.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Caspase-3 and caspase-7 bind to the XIAP BIR2 domain and to a linker region between the BIR1 and BIR2 domains that blocks the caspase-3 and caspase-7 catalytic sites.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8-10)</a> Other IAP family members, such as cellular IAP1 (cIAP1) and cellular IAP2 (cIAP2), have been shown to play a complementary role in apoptotic signaling owing to the E3 ubiquitin ligase activity of a region of these proteins called the RING domain.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Specifically, cIAP1 and cIAP2 can inhibit apoptosis through ubiquitination of key proteins involved in canonical and noncanonical NF-κB signaling<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> and TNF receptor-mediated activation of caspase-8,<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> resulting in their proteasomal degradation. XIAP, cIAP1, and cIAP2 are frequently overexpressed in certain types of cancer and are associated with high-grade disease and poor prognosis.<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> Moreover, downregulation of these IAPs has been shown to restore sensitivity to apoptotic stimuli.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Taken together, these features provide a compelling argument for targeting the IAP family of proteins as a potential strategy for developing an anticancer agent.</div><div class="NLM_p">One of the proteins released from mitochondria in response to apoptotic stimuli, known as Smac (second mitochondrial activator of caspases), is the endogenous inhibitor of a number of members of the IAP family. Upon its release into the cytoplasm, the N-terminal portion of Smac is cleaved, revealing a region of the peptide that can bind to a groove on the BIR domains of XIAP. This interaction interferes with the ability of caspases to bind effectively to XIAP and thus the caspases are displaced and freed to execute the apoptotic process. Smac also binds with high affinity toward cIAP1 and cIAP2. The interaction between Smac and the IAPs has been well-characterized, and it has been established that the bulk of this binding interaction involves the four N-terminal amino acid residues of activated Smac (alanine–valine–proline–isoleucine, AVPI).<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> In fact, the tetrapeptide AVPI itself (<b>1</b>; Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is a moderately potent inhibitor of the interaction between a biotinylated Smac 7-mer peptide and the BIR3 domain of XIAP (IC<sub>50</sub> = 0.58 μM).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Given the promise of antagonists of the IAP family of proteins as potential anticancer agents, a significant amount of work has been invested in the design of nonpeptide Smac mimetics that can be dosed in vivo to effect antitumor activity. These efforts have been extensively reviewed,<a onclick="showRef(event, 'ref21 ref22 ref23 ref24 ref25'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24 ref25">(21-25)</a> and a number of compounds have advanced to human clinical trials. Furthermore, because Smac protein is known to exist in a dimeric state in solution and interacts with the IAPs as a dimer,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> a number of examples of bivalent compounds (in which two monomeric Smac mimetics are covalently linked) have been described in the literature. These dimers have been shown to interact concurrently with both the BIR2 and BIR3 domains of XIAP<a onclick="showRef(event, 'ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29">(27-29)</a> and as a result are typically much more effective inhibitors than the corresponding monomers in cellular assays measuring IAP inhibition. Indeed, several dimeric Smac mimetics are also being evaluated as anticancer agents in clinical trials.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><div class="NLM_p last">As part of our drug-discovery program aimed at identifying novel cancer therapies, we too became interested in the IAP family of proteins as molecular targets for small-molecule inhibitors. In this article, we describe our efforts at identifying novel dimeric Smac mimetics as potential anticancer agents, culminating in the nomination of a compound as a candidate for clinical evaluation.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85411" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85411" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">At the outset of our studies, we wanted to identify appropriate positions from which monomeric Smac mimetics could be effectively dimerized. In a seminal paper surveying the effects of varying each residue (P1–P4) of the AVPI motif,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Fesik and co-workers identified compounds in which the (<i>R</i>)-tetrahydronaphthyl and (<i>R</i>)-indanyl groups served as effective replacements for the isoleucine residue at P4 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>; <b>2</b> and <b>3</b>). Our analysis of the published structure of (<i>R</i>)-tetrahydronaphthyl compound <b>2</b> bound to the BIR3 domain of XIAP<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> suggested that there is room for further substitution at the solvent-exposed 2-position of the tetrahydronaphthyl ring and that this might be a suitable position to introduce a linkage for dimerization (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of AVPI (<b>1</b>) and monomeric Smac mimetics containing tetrahydronaphthyl or indanyl groups at the P4 position (<b>2</b> and <b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dimerization strategy based on incorporating a linker at the 2-position of the tetrahydronaphthyl ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the location of the linker between two monomeric units, we wanted to choose a linker that would have minimal steric requirements to prevent disruption of critical binding interactions between the remainder of the molecule with the target protein. Given that a 1,3-bisacetylene linkage has been employed in several previously described effective dimeric Smac mimetics<a onclick="showRef(event, 'ref27 ref31'); return false;" href="javascript:void(0);" class="ref ref27 ref31">(27, 31)</a> and that this linear type of linkage was anticipated to contribute minimal steric bulk, our initial explorations were focused on installation of a propargylic ether at the tetrahydronaphthyl 2-position and subsequent homocoupling to afford the diyne-containing bivalent compounds.</div><div class="NLM_p">To test our initial hypothesis, we first assessed the effects of incorporating a substituent at the 2-position of the tetrahydronaphthyl ring on binding to the IAP proteins of interest. The four possible diastereomeric matched pairs of <b>2</b> were thus prepared, and the binding affinities of these compounds to the BIR3 domains of both cIAP1 and XIAP were determined. Specifically, the assays used measured the ability of the compounds to competitively displace a 5-carboxyfluorescein-tagged synthetic peptide from the AVPI binding groove using fluorescence polarization (see the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> for full experimental details). In accord with the previously published findings,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> we found that the absolute stereochemistry of the amino-substituted carbon of the tetrahydronaphthyl group was critical to effective binding to the BIR3 domains of both cIAP1 and XIAP (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), with the (1S)-amino analogues (<b>4</b> and <b>6</b>) being more potent than the (1R) isomers (<b>5</b> and <b>7</b>). Interestingly, the stereochemistry at the ether-substituted carbon appears to affect the magnitude of the dropoff in potency between the (1S) and (1R) isomers. For example, (1R,2R) analogue <b>7</b> is nearly 30-fold less potent in the cIAP1 BIR3 binding assay and is over 60-fold less potent in the XIAP BIR3 assay than (1S,2R) compound <b>4</b>. However, (1R,2S) isomer <b>5</b> is only 3–6-fold less potent than (1S,2S) isomer <b>6</b> in these assays.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. cIAP1 BIR3 and XIAP BIR3 Binding Data for the Four Diastereomeric Monomers That Contain a Propargylic Ether at the Tetrahydronaphthyl 2-Position</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0017.gif" alt="" id="fx1" /></img><div></div></div><div class="NLM_p">The impact of stereochemistry is even more pronounced in assays that assessed the effects of compounds in cells. For example, it has been demonstrated that the binding of Smac mimetics to cIAP1 in MDA-MB-231 cells can lead to cIAP1 autoubiquitination followed by proteasomal degradation of the protein.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> We found that monomeric (1S) isomers <b>4</b> and <b>6</b> induce cIAP1 degradation in MDA-MB-231 cells at lower concentrations than (1R) isomers <b>5</b> and <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Moreover, certain cancer cell lines that produce autocrine TNFα (e.g., MDA-MB-231 and HCC461) have been shown to be particularly sensitive to IAP antagonists as single agents,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> and, indeed, (1S) isomers <b>4</b> and <b>6</b> are more potent inhibitors of MDA-MB-231 cell proliferation than are (1R) isomers <b>5</b> and <b>7</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). These observed differences in cellular potency between diastereomers are consistent with the differences in their ability to bind to the BIR3 domains of cIAP1 and XIAP, as discussed earlier. Because we and others have previously shown that inhibition of both cIAP1 and XIAP is necessary to inhibit proliferation in such cell lines (including MDA-MB-231),<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> the antiproliferative activity observed for compounds <b>4</b> and <b>6</b> therefore suggests effective binding of these compounds to both proteins in cells. Thus, inclusion of the propargylic ether moiety did not seem to have a detrimental effect on either binding affinity or cellular potency of monomeric Smac mimetics relative to <b>2</b>, with the (1S,2R) configuration of the tetrahydronaphthyl amino alcohol giving the most potent analogue (<b>4</b>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Cellular Potency Data for the Diastereomeric Monomers and Dimers Containing a 2-Substituted Tetrahydronaphthyl P4 Moiety</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">tetrahydronaphthyl stereochemistry</th><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">MDA-MB-231 cIAP1 degradation EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">MDA-MB-231 antiproliferative GI<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(1S,2R)</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">monomer</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">16</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">dimer</td><td class="colsep0 rowsep0" align="left">0.2</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(1R,2S)</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">monomer</td><td class="colsep0 rowsep0" align="left">126</td><td class="colsep0 rowsep0" align="left">192</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">dimer</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">97</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(1S,2S)</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">monomer</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">dimer</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">(1R,2R)</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">monomer</td><td class="colsep0 rowsep0" align="left">>370</td><td class="colsep0 rowsep0" align="left">2190</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">dimer</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">61</td></tr></tbody></table></div></div><div class="NLM_p">Because the above data suggested that dimerization of these monomers through the alkyne should be tolerated with minimal effect on binding affinity, we next prepared the bivalent analogues of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. A marked increase in antiproliferative activity was observed with the dimers (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>; compounds <b>8</b>–<b>11</b>), consistent with the postulate that the dimeric compounds can bind to both the BIR2 and BIR3 domains of XIAP simultaneously. This binding is expected to disrupt the interactions between XIAP and caspases-3, -7, and -9, eventually culminating in apoptosis.</div><div class="NLM_p">A significant increase in potency in the cIAP1 degradation cell assay was also observed for all of the dimers relative to the respective monomers (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). In contrast to the binding of dimeric compounds to both the BIR2 and BIR3 domains of XIAP, previously described bivalent Smac mimetics have been demonstrated to bind only to the BIR3 domain of cIAP1 (and not the BIR2 domain).<a onclick="showRef(event, 'ref12 ref35'); return false;" href="javascript:void(0);" class="ref ref12 ref35">(12, 35)</a> As a result, dimers can concurrently bind to the BIR3 domains of two cIAP1 molecules. The E3 ligase activity of cIAP1 that results in autoubiquitination and protein degradation has been shown to be dependent on dimerization of the RING domain of the protein;<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> therefore, it is likely that by binding to the BIR3 domains of two cIAP1 molecules simultaneously, these bivalent compounds can facilitate RING domain dimerization at lower concentrations than the monomeric compounds.</div><div class="NLM_p">Having demonstrated that functionalization of the tetrahydronaphthyl moiety at the 2-position is tolerated and that dimerization from this position affords cell-potent inhibitors of cIAP1 and XIAP, we next prepared the corresponding compounds containing an indanyl group in the P4 position. Our interest in these analogues was not only the expectation that binding to the target proteins would not be drastically affected but also that the requisite chiral aminoindanol starting material is readily available from commercial sources, facilitating the preparation of multigram quantities of intermediates for further SAR development. Thus, synthesis of matched pair of <b>8</b> (compound <b>12</b>; Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) confirmed that dimerization through the indanyl 2-position is tolerated with no apparent loss in cellular potency relative to the tetrahydronaphthyl analogue.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Effects of Variation of the P2 Residue on Cellular Potency, Lipophilicity, and Polar Surface Area<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0018.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0019.gif" alt="" id="fx3" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Values for cLogP and Log D calculated using ACD LogD software (v. 12.01). PSA, polar surface area; NPSA, nonpolar surface area.</p></div></div><div></div></div><div class="NLM_p">A key goal of our chemistry strategy was to identify compounds with physical properties that would be compatible with intravenous administration. Given the very high molecular weight (typically greater than 1000) of these dimeric Smac mimetics and the well-established paradigm that the likelihood of a compound being orally bioavailable drops off significantly above a molecular weight of 500,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> it was anticipated that these compounds would have limited oral exposure. Indeed, the other dimeric Smac mimetics under evaluation in human clinical trials are dosed intravenously<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and thus we surmised that a compound based on the scaffold described herein would require sufficient aqueous solubility to be a viable candidate drug. Although cell-potent dimers <b>8</b> and <b>12</b> did not appear to have limitations in this respect (measured solubility of >1000 μM at pH 7.4), we wanted to generate additional compounds with favorable properties as candidates for in vivo testing.</div><div class="NLM_p">As a result, we next set out to study the effects of modifications at the P2 position of the AVPI motif. The side chain of this residue is directed away from the AVPI binding groove and as a result does not contribute to specific binding interactions with the protein. Therefore, the P2 residue is tolerant of a range of different substituents of varying polarity,<a onclick="showRef(event, 'ref20 ref30 ref38'); return false;" href="javascript:void(0);" class="ref ref20 ref30 ref38">(20, 30, 38)</a> and, in fact, this position has been utilized as a site of dimerization previously.<a onclick="showRef(event, 'ref27 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref27 ref39 ref40">(27, 39, 40)</a> Our expectation was that variation of this residue would provide an opportunity to modulate the physical properties (and possibly the pharmacokinetic profiles) of the resulting dimers. However, we found that the cellular potency was greatly affected by the nature of this side chain, with compounds containing only more lipophilic groups demonstrating effects on cIAP1 degradation or cell proliferation at the concentrations evaluated (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><div class="NLM_p">The impact of lipophilicity on cellular potency has been discussed previously within the context of Smac mimetics,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> as compounds containing less lipophilic groups are often less potent in cells. This phenomenon is likely the result of poor membrane permeability, a well-documented characteristic of peptides and peptidic compounds attributable to a combination of low lipophilicity and high polar surface area (PSA).<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> The differences between the cellular potencies of the compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> can thus be rationalized by comparing parameters for lipophilicity<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and polar surface area (corrected for the positive contribution to membrane permeability from nonpolar surface area, according to the method of Stenberg et al.).<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Although cell-potent compounds <b>12</b> and <b>14</b> have low measured Caco-2 permeability (apparent apical-to-basolateral permeability <0.1 × 10<sup>–6</sup> cm/sec), the compounds containing more polar side chains at P2 are even more poorly permeable (below the level of detection), effectively preventing intracellular exposure.</div><div class="NLM_p">Having demonstrated the necessity for relatively lipophilic groups to attain cell-potent compounds, we were mindful of the impact on physical properties that this restriction imposed. To assess the room for improving upon these compounds, we next considered modifications to the proline ring of the AVPI motif (P3) to see what impact these changes would have. Dimeric compounds containing a variety of proline mimetics were prepared and assessed for their IAP antagonistic activity (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). By and large, the changes made to the proline ring were well-tolerated in terms of cell potency. However, many of the compounds resulting from these changes had poor aqueous solubility coupled with high plasma protein binding, limiting the attractiveness of this approach to identify an agent suitable for intravenous dosing.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Modifications to the P3 Residue and Effects on Cellular Potency and Physical Properties</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0020.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0021.gif" alt="" id="fx5" /></img><div></div></div><div class="NLM_p">In addition to the compounds described above, we also investigated alternative means of connecting two monomeric Smac mimetics through the same region of the scaffold (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). In line with our observations on the binding affinities for the different diastereomers of the tetrahydronaphthyl ring system, <i>trans-</i>aminoindanol dimer <b>24</b> demonstrated comparable levels of cellular potency to <i>cis</i>-aminoindanol analogue <b>14</b>. Similarly, we found that saturation of the diyne moiety of the linker (example <b>25</b>) does not result in any appreciable change in the cellular potencies relative to the unsaturated matched pair. Replacing this <i>n</i>-alkyl chain with a polyether linker (<b>26</b>) likewise afforded a cell-potent Smac mimetic. Dimerization through a tetrahydroquinoline P4 group (compound <b>27</b>) also resulted in potent cell activity. In an attempt to remove the additional chiral centers imparted by the substituted tetrahydronaphthyl or indanyl systems described above, we designed and prepared spiro-aminoamide analogue <b>28</b>, although we found that this compound proved to be somewhat less effective at inducing cIAP1 degradation and inhibiting cell proliferation than the corresponding 1,2-disubstituted compounds.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Modifications to the Linker Region of Dimeric Smac Mimetics</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0022.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">In addition to the dimerization linkage through an oxygen atom at the 2-position of the tetrahydronaphthyl or indanyl ring system, we also investigated the feasibility of linking two monomeric Smac mimetics through nitrogen atoms on the indane ring (as a bisamide); the results of these efforts are detailed in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>. The bisamide linker was expected to be more conformationally rigid than the corresponding bisether linker, and, indeed, there does appear to be a dependence on the linker length with respect to the cellular potencies of these amide analogues. For example, terephthalamide analogue <b>29</b> is less potent in the MDA-MB-231 proliferation assay than biphenyl compound <b>30</b> or the more conformationally flexible <b>31</b>, suggesting that the shorter linker is suboptimal for simultaneous binding to both the BIR2 and BIR3 domains of XIAP. However, the length or flexibility of the linker would not be expected to affect binding to cIAP1 BIR3 drastically, and, indeed, compounds <b>29</b>–<b>31</b> have roughly equivalent binding affinities to cIAP1 BIR3 (data not shown) despite the marked differences in cellular cIAP1 degradation. Therefore, a more plausible explanation for the differences in cellular potency is that the shorter, less hydrophobic linker of <b>29</b> renders this compound less cell-permeable and thus apparently less potent in cell-based assays. This effect has been observed previously in bivalent Smac mimetics with linkers of different lengths<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> and would explain the differences in cIAP1 degradation observed despite the similar binding affinities.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Dimeric Smac Mimetics Containing Bisamide Linkers</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0023.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0024.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">To investigate the cellular mechanism of action of this series further, studies were conducted to elucidate the biochemical effects of compound binding to the different IAP proteins in MDA-MB-231 cells. Consistent with the data presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, compound <b>14</b> induces the degradation of cIAP1 in a dose-dependent manner following 1 h of treatment; the degradation of cIAP2 protein is likewise observed at similar concentrations (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, <a class="ref internalNav" href="#notes-1" aria-label="Figure S2">Figure S2</a>). No changes in XIAP levels are observed, however, even after 4 h of exposure to considerably higher concentrations of <b>14</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>, <a class="ref internalNav" href="#notes-1" aria-label="Figure S3">Figure S3</a>). These observations are consistent with the effects of previously described Smac mimetics in this cell line following similar compound exposure times.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">In addition to studying the effects of these Smac mimetics on the IAP proteins themselves, we wanted to assess the ability of this series to disrupt the binding of caspases by XIAP. In particular, the binding of a Smac mimetic such as <b>14</b> to the BIR3 domain of XIAP would be expected to interfere with the interaction between XIAP and caspase-9.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Thus, treatment of MDA-MB-231 cells with <b>14</b> for 4 h followed by immunoprecipitation of caspase-9 from the cell lysates showed that the interaction between XIAP and caspase-9 is indeed disrupted, whereas untreated cells show intact caspase-9–XIAP complexes (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>).</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>14</b> on caspase-9–XIAP interaction. MDA-MB-231 cells were either untreated or exposed to 1 μM <b>14</b> for 4 h, and then caspase-9 was immunoprecipitated from the protein lysates. The levels of caspase-9–XIAP complexes were determined by blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While working to establish what effects structural modifications to these compounds had on cellular potency and physical properties, we also examined the effects of these changes on the rat pharmacokinetic profiles of the compounds. Being that a variety of substitution patterns afford cell-potent IAP antagonists, our aim was to prioritize compounds for further study on the basis of these pharmacokinetic data (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>). In general, compounds from this class of dimeric Smac mimetic are quickly cleared in rat, with many compounds having rates of clearance approaching or exceeding hepatic blood flow (<i>Q</i><sub>H</sub> for rat = 72 mL/min/kg). These values imply an extrahepatic mechanism of elimination from the plasma. Indeed, for each of the examples shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, the parent compound was detected unchanged in the urine of the test animals, suggesting renal clearance as a contributing secondary mechanism of elimination; the extent of renal clearance varied from compound to compound (<1–14% of total clearance). In addition, a bile duct-cannulated rat pharmacokinetic study with <b>14</b> demonstrated that biliary clearance contributed significantly (∼30%) to the total clearance of the compound. Although the other examples in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> were not subjected to the same experiment, it is feasible that biliary secretion could play some role in the systemic elimination of these compounds as well.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Pharmacokinetic Parameters for Representative Compounds Following Intravenous Dosing in Rat<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">example</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center" char="±">CL (mL/min/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char="±"><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="±">AUC (ng h/mL)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="center">0.2</td><td class="colsep0 rowsep0" align="char" char="±">111 ± 9</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">30 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="center">0.2</td><td class="colsep0 rowsep0" align="char" char="±">44 ± 3</td><td class="colsep0 rowsep0" align="char" char="±">2.3 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">1.6 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">76 ± 5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="char" char="±">50 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="±">0.8 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">0.5 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">166 ± 3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="center">0.8</td><td class="colsep0 rowsep0" align="char" char="±">45 ± 5</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">3.6 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="±">262 ± 35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="center">1.0</td><td class="colsep0 rowsep0" align="char" char="±">80 ± 1</td><td class="colsep0 rowsep0" align="char" char="±">1.9 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">206 ± 1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="center">0.2</td><td class="colsep0 rowsep0" align="char" char="±">68 ± 15</td><td class="colsep0 rowsep0" align="char" char="±">1.2 ± 0.4</td><td class="colsep0 rowsep0" align="char" char="±">0.6 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="±">40 ± 9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="center">0.5</td><td class="colsep0 rowsep0" align="char" char="±">37 ± 8</td><td class="colsep0 rowsep0" align="char" char="±">1.4 ± 0.5</td><td class="colsep0 rowsep0" align="char" char="±">6.6 ± 2.3</td><td class="colsep0 rowsep0" align="char" char="±">230 ± 46</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">CL, total plasma clearance; <i>V</i><sub>ss</sub>, volume of distribution at steady state; <i>t</i><sub>1/2</sub>, elimination half-life; and AUC, area under the curve.</p></div></div></div><div class="NLM_p">In spite of the apparent suboptimal pharmacokinetic profiles for this class of dimers, we were optimistic about the ability of these compounds to demonstrate in vivo antitumor activity because of our observation of apoptosis induction (measured by the extent of caspase-3 cleavage) and cell death in the MDA-MB-231 cell line following short exposure times. In particular, cultured MDA-MB-231 cells were treated with increasing concentrations of compound for brief periods of time (1 and 3 h), at which point the cells were rinsed and exposed to fresh media to remove the compound. The level of caspase-3 cleavage was assessed after 24 h, whereas the amount of surviving cells remaining was determined after a total of 72 h. In the case of compound <b>14</b>, substantial apoptosis induction was observed at subnanomolar concentrations (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A) despite the cells being exposed to compound for only the first 1 or 3 h of the experiment. The extent of caspase-3 cleavage correlated well with the fraction of cells surviving after 72 h (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B). In contrast, various monomeric Smac mimetics failed to show any antiproliferative effects under similar conditions (data not shown). Although we have not firmly established the cause of this prolonged activity, it is possibly a function of the mode of inhibition of the dimers and the resulting effects on the rate of dissociation from the protein (<i>k</i><sub>off</sub>). For instance, dimeric Smac protein has been demonstrated to bind with higher affinity to an XIAP construct containing both the BIR2 and BIR3 domains relative to one containing the BIR3 domain alone, with a resulting 100-fold decrease in <i>k</i><sub>off</sub>.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Dimeric Smac mimetics are similarly known to be much more potent IAP antagonists than the corresponding monomers, likewise owing to avidity resulting from simultaneous binding to the BIR2 and BIR3 domains of XIAP.<a onclick="showRef(event, 'ref12 ref28'); return false;" href="javascript:void(0);" class="ref ref12 ref28">(12, 28)</a> This would be expected to result in a much smaller net <i>k</i><sub>off</sub> that is a function of the dissociation rates from both the BIR2 and BIR3 domains. In fact, the binding of bivalent Smac mimetics to XIAP protein constructs containing both the BIR2 and BIR3 domains has been shown to result in conformational changes in the protein,<a onclick="showRef(event, 'ref28 ref29 ref40'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref40">(28, 29, 40)</a> a phenomenon typically associated with slow off kinetics.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Therefore, it is feasible that dimeric Smac mimetics such as <b>14</b> will also have a much smaller <i>k</i><sub>off</sub> than the respective monomers and will remain bound to the target protein even after the cells are washed. Thus, these data suggest that apoptosis induction and cell death should be observed in vivo despite the relatively short plasma half-lives of this series of compounds.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment of cells with compound <b>14</b> promotes caspase-3 cleavage and results in cell death. MDA-MB-231 cells were exposed to <b>14</b> for 1 or 3 h, and then the culture media was removed and replaced with drug-free media. (A) Apoptosis was assessed by determining the level of active caspase-3 in each well after 24 h total. (B) Cell survival was determined by MTS assay after 72 h total. A reading of 0% survival represents complete death of the cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To explore the potential of compound <b>14</b> to demonstrate antitumor activity in vivo, we examined the pharmacokinetics of the compound in mice to verify that sufficient plasma concentrations could be achieved. Following a modest 0.5 mg/kg intravenous bolus dose of <b>14</b>, unbound plasma levels remained above the concentrations at which apoptosis induction and cell death were observed in MDA-MB-231 cells over the course of several hours. Given the data presented in Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>, we believed this would be a sufficient duration of exposure to show effects using in vivo models.</div><div class="NLM_p">Compound <b>14</b> was administered intravenously to mice bearing MDA-MB-231 xenografts, and measures of pharmacodynamic activity (intratumoral levels of cIAP1 degradation and cleaved caspase-3) were measured at 4, 6, and 18 h postdose (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Considerable degradation of cIAP1 was observed at all doses examined, with no restoration in protein levels observed over the course of 18 h. Because cIAP1 degradation is known to occur rapidly following the binding of a Smac mimetic (2–5 min in vitro),<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> this effect in vivo would likely be dependent upon the higher initial plasma concentrations following a bolus intravenous dose. This explains the significant activity seen even at very low doses of <b>14</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A). The cIAP1 levels would only recover after protein resynthesis, thus resulting in the prolonged duration of action we observe, similar to what has been seen with previous Smac mimetics.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Although cIAP1 degradation happens very quickly upon exposure to <b>14</b> in vivo, apoptosis induction (as measured by the amount of cleaved caspase-3) takes longer to reach a maximal effect.<a onclick="showRef(event, 'ref27 ref46'); return false;" href="javascript:void(0);" class="ref ref27 ref46">(27, 46)</a> Therefore, the extent of caspase-3 cleavage in vivo is expected to be more dependent on the duration of compound exposure above a threshold concentration, and, as a result, we observe increased levels of this activity at higher doses (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B). The levels of cleaved caspase-3 then diminish over time, returning to near-baseline levels at 18 h.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacodynamic data following a single intravenous dose of compound <b>14</b> to mice bearing MDA-MB-231 xenografts. (A) Measured tumor levels of cIAP1 protein degradation. (B) Levels of intratumoral cleaved caspase-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having demonstrated effects of IAP inhibition in vivo, the ability of compound <b>14</b> to exert antitumor activity in the MDA-MB-231 xenograft model was assessed (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). Orthotopically implanted tumors were allowed to grow to ∼120 mm<sup>3</sup> before administering a single intravenous dose of <b>14</b>. After 1 week, an additional dose of <b>14</b> was given to the mice, and the tumors were monitored for regrowth. At the lowest dose tested (0.1 mg/kg), very modest antitumor activity was observed. However, at the higher doses (0.5 and 3.0 mg/kg) tumor regressions occurred, with nearly complete disappearance of the tumors at the 3.0 mg/kg dose. Regrowth occurred slowly and was dependent on the initial dosage amount. For example, although the tumors in the 0.5 mg/kg group returned to their original size after approximately 10 days following the second dose, the tumors in the 3.0 mg/kg group took roughly 6 weeks to return to the size they were before the first dose and even then they grew at a slower rate until the end of the study.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor activity of <b>14</b> in the MDA-MB-231 xenograft efficacy model. Tumors were allowed to grow to an average size of 120 mm<sup>3</sup>, and the mice were then treated with either vehicle or <b>14</b> intravenously once a week for 2 weeks (as indicated by the two black arrows). Tumor volumes were monitored twice a week for 78 days and are plotted as the geometric mean volumes ± standard error (SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>14</b> was profiled for its antiproliferative activity across a number of cancer cell lines representing a variety of tumor types (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Of the 200 cell lines examined, only a small subset of these are sensitive to <b>14</b> alone (for example, GI<sub>50</sub> ≤ 1 μM in only 34 of the 200 cell lines, comparable to the activity of other Smac mimetics<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> in large cell panels). The most sensitive cell lines span a variety of tumor types, such as 97-7 (bladder), 647V (bladder), BT-549 (breast), and MiaPaCa2 (pancreatic). Previous work has shown that several factors can affect the underlying senstivity of cancer cell lines to Smac mimetic treatment, including expression levels of cIAP2<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47, 48)</a> or the cell surface protein LRIG1.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Although the reasons for the sensitivity profile we observe have not been determined for all cell lines in this panel, the data in Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a> indicate that as a single agent compound <b>14</b> does not exhibit broad-based cytotoxicity but instead should be employed in selected tumor settings expected to be sensitive to IAP inhibitors or in rational combinations with other targeted therapies.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Antiproliferative activity of <b>14</b> across a panel of 200 cancer cell lines. The cell lines are ranked in order of decreasing sensitivity to <b>14</b>. The horizontal line at pGI<sub>50</sub> = 6 reflects an antiproliferative GI<sub>50</sub> of 1 μM; those cell lines in which <b>14</b> is more potent (i.e., sensitive cell lines) are colored green, whereas those in which <b>14</b> is less potent (i.e., resistant cell lines) are colored red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consistent with the in vitro and in vivo data presented above, fluoresence polarization assays confirmed that compound <b>14</b> binds with high affinity to the BIR3 domains of both cIAP1 and cIAP2 as well as both the isolated BIR2 and BIR3 domains of XIAP, with measured IC<sub>50</sub> values effectively at the lower limit of detection under the assay conditions used (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). In spite of its relatively high lipophilicity, the dihydrochloride salt of compound <b>14</b> has sufficient aqueous solubility (>7 mg/mL at pH 4–6) to enable formulation for intravenous administration at the projected efficacious doses. With respect to chemical stability, <b>14</b> was found to be photostable and hydrolytically stable between pH 4–6, although some amide hydrolysis was observed under strongly acidic (pH 1) and basic (pH > 8) conditions. In addition, the compound is stable in the plasma of multiple species, with no compound degradation observed after several hours under physiological conditions. In light of the overall in vitro profile of compound <b>14</b> as well as its promising in vivo activity at readily achievable and tolerable plasma concentrations, this compound was nominated for clinical development as an anticancer agent (AZD5582).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Summary of Measured IC<sub>50</sub> Values for Compound <b>14</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">IAP Protein BIR Domain</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cIAP1 BIR3</td><td class="colsep0 rowsep0" align="left">15 ± 10<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cIAP2 BIR3</td><td class="colsep0 rowsep0" align="left">21<a class="ref internalNav" href="#t8fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR2</td><td class="colsep0 rowsep0" align="left">21 ± 13<a class="ref internalNav" href="#t8fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">XIAP BIR3</td><td class="colsep0 rowsep0" align="left">15 ± 12<a class="ref internalNav" href="#t8fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup>a</sup><p class="last">Average of 12 measurements.</p></div><div class="footnote" id="t8fn2"><sup>b</sup><p class="last">Average of 2 measurements.</p></div><div class="footnote" id="t8fn3"><sup>c</sup><p class="last">Average of 12 measurements.</p></div><div class="footnote" id="t8fn4"><sup>d</sup><p class="last">Average of 10 measurements.</p></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i11">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Smac mimetics described herein were prepared by utilizing standard peptide coupling reagents and reaction conditions, with commercially available or readily accessible amino acids. The preparation of the requisite tetrahydronaphthyl-based amino alcohols followed a modification of published procedures<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and is outlined in Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>. Treatment of 1,2-dihydronapthalene with <i>N</i>-bromosuccinimide in aqueous THF afforded racemic bromohydrin <b>32</b>, which, when exposed to ammonium hydroxide, was transformed to the racemic <i>trans</i>-1,2-aminoalcohol <b>33</b> (via the intermediate epoxide). Benzoylation of the amino group afforded racemic benzamide <b>34</b>, which could be separated into the individual enantiomers by chiral chromatography. The <i>cis</i>-aminoalcohols were prepared from benzamides <b>34</b> by activation of the hydroxyl group with thionyl chloride, resulting in intramolecular S<sub>N</sub>2 displacement of the intermediate chlorosulfite esters to afford <i>cis</i>-oxazolines <b>35</b>.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Acidic hydrolysis revealed <i>cis</i>-aminoalcohols <b>33</b>; comparison of the specific rotations to literature values established the absolute stereochemical configuration of each enantiomer.<a onclick="showRef(event, 'ref50 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref50 ref52 ref53">(50, 52, 53)</a> Attempted hydrolysis of <b>34</b> under acidic conditions (6 N HCl, 100 °C) to recover the enantiopure <i>trans</i>-aminoalcohols instead resulted in a mixture of the <i>trans</i>- and <i>cis</i>-isomers of <b>33</b>, presumably through the intermediacy of oxazoline <b>35</b>. We instead found that hydrolysis of the amide group under basic conditions (NaOH, EtOH/H<sub>2</sub>O) gave cleanly the pure enantiomers of <i>trans</i>-1,2-aminoalcohol <b>33</b>, with the assignment of absolute stereochemistry of each made by correlation of the assignments for the <i>cis</i>-aminoalcohols to the common precursor, <b>34</b>. Comparison of the specific rotations of each <i>trans</i>-<b>33</b> to the previously published value for the (1S,2S) enantiomer confirmed these assignments.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Chiral Tetrahydronaphthyl Aminoalcohols<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-bromosuccinimide, THF/H<sub>2</sub>O, rt; (b) NH<sub>4</sub>OH, MeOH/H<sub>2</sub>O, rt; (c) benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) NaOH, EtOH/H<sub>2</sub>O, 80 °C; (e) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) HCl, dioxane/H<sub>2</sub>O, 100 °C.</p></p></figure><div class="NLM_p">A general preparation of the Smac mimetics described in this article is shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, which details the synthesis of compounds <b>4</b> and <b>8</b>. Coupling of (1<i>S</i>,2<i>R</i>)-<i>cis</i>-<b>33</b> to Boc-proline under standard peptide-bond-formation conditions (EDCI, HOBt, DMF) gave amide <b>36</b>, which could be selectively propargylated on the free hydroxyl group using KOH in DMF to give <b>37</b>. This was then transformed to Boc-protected monomeric Smac mimetic <b>39</b> by an iterative sequence of deprotection followed by amide bond formation (first with Boc-<i>tert</i>-leucine and then with Boc-<i>N</i>-methylalanine). Final deprotection gave monomer <b>4</b>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Preparation of Monomeric and Dimeric Smac Mimetics<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc-Pro-OH, EDCI, HOBt hydrate, DMF, 0 °C to rt; (b) propargyl bromide, KOH, DMF, 0 °C; (c) 4 N HCl/dioxane, rt; (d) Boc-Tle-OH, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (e) Boc-<i>N</i>-Me-Ala-OH, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (f) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><div class="NLM_p">Monomeric Boc-protected terminal alkyne-containing Smac mimetic <b>39</b> was homocoupled to afford the diyne by heating in the presence of copper(II) acetate and a stoichiometric base (such as pyridine or triethylamine). The reaction progress was monitored carefully, as prolonged reaction times were found to result in unidentified side products that were inseparable from the desired diyne. Removal of the Boc groups under standard conditions yielded desired dimer <b>8</b>. The synthetic sequence outlined in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> was also applicable to the preparation of monomers <b>5</b>–<b>7</b> and dimers <b>9</b>–<b>11</b>.</div><div class="NLM_p">Smac mimetics containing an indanyl moiety were prepared analogously to the procedures described above for the tetrahydronaphthyl-based compounds, only commencing with commercially available (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-amino-2-indanol instead (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Coupling to Boc-proline followed by O-propargylation yielded cleanly intermediate <b>42</b>. Alternatively, we found that the propargyl group could be introduced first (via the alkoxide) to give intermediate <b>44</b>, which could then be coupled to Boc-proline. Deprotection of the Boc group from <b>42</b> then gave intermediate <b>43</b>. Building off of compound <b>43</b> with one protected amino acid at a time as for the tetrahydronaphthyl-containing compounds described above (Method A) afforded the Boc-protected monomeric compounds, which could be subjected under the aforementioned dimerization conditions followed by deprotection. In some cases, particularly when the side chain of the P2 residue contained a heteroatom that required a protecting group, it was advantageous to treat intermediate <b>43</b> directly with a dipeptide acid containing the P1 and P2 residues of the AVPI motif preassembled (Method B); this avoided the need for orthogonal protecting groups and enabled global deprotection of the compound following the dimerization event. The reagent DMTMM (4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl-morpholinium chloride), previously demonstrated to be superior to other amide bond-forming reagents for couplings of sterically hindered peptidomimetics,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> was employed in these reactions to minimize epimerization and side-product formation.</div><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Aminoindanol-Containing Dimeric Smac Mimetics<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc-Pro-OH, ethyl chloroformate, 4-methylmorpholine, EtOAc, 0 °C to rt; (b) propargyl bromide, KOH, DMF, 0 °C; (c) 4 N HCl/dioxane, rt, or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) NaH, propargyl bromide, THF, 0 °C to reflux; (e) EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (f) isobutyl chloroformate, 4-methylmorpholine, THF, 0 °C; (g) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O, rt; (h) DMTMM, 4-methylmorpholine, EtOAc, 0 °C to rt; (i) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><div class="NLM_p">The chemistry outlined in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> is likewise applicable to the preparation of compounds in which the proline residue of AVPI has been replaced with a proline mimetic (<b>19</b>–<b>23</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Thus, intermediate <b>44</b> was coupled to the requisite proline-mimetic building blocks, which were either commercially available or were readily prepared following previously published procedures (e.g., cyclopropyl-fused proline for compound <b>23</b><a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a>). Elaboration of the resulting products as described above afforded the target dimers. In the case of spiro-cyclopropylthiaproline intermediate <b>46</b> utilized in the preparation of compound <b>21</b>, the reagent was prepared from known <b>45</b><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> as a racemate (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). As a result, a mixture of diastereomers was formed in the coupling of <b>46</b> with <b>44</b>. These diastereomers were separated chromatographically, and each was carried on through the subsequent sequence of steps to afford diastereomeric Smac mimetics. The assignment of the absolute stereochemistry at P3 was then made by comparing the binding affinity and cellular potency measured for each diastereomer (data not shown), with only one diastereomer demonstrating measurable binding, cIAP1 degradation, or antiproliferative effects.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Spiro-Cyclopropylthiaproline Used in the Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 37% aqueous formaldehyde, water, rt; (b) di-<i>tert</i>-butyldicarbonate, NaHCO<sub>3</sub>, water, rt</p></p></figure><div class="NLM_p">Several compounds presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> can likewise be readily prepared following the general protocols described above. For example, the <i>trans</i>-isomer of <b>14</b> (compound <b>24</b>) was prepared utilizing the chemistry shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, only starting instead with commercially available (1<i>S</i>,2<i>S</i>)-<i>trans</i>-1-amino-2-indanol. Compound <b>25</b>, in which the diyne linker in <b>14</b> has been fully saturated, was prepared from di-Boc-protected <b>14</b> by hydrogenation over Pd/C followed by removal of the protecting groups under standard conditions.</div><div class="NLM_p">The synthesis of polyether linker compound <b>26</b> commenced by preparation of N-protected tripeptide <b>48</b> (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>) using chemistry similar to that described earlier. Treatment of this intermediate with diamine <b>50</b> (obtained by O-alkylation of (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-amino-2-indanol with the ditosylate <b>49</b>) afforded the target compound. Intermediate <b>48</b> was also employed in the synthesis of compound <b>27</b>, which utilized the tetrahydroquinoline-derived amine <b>53</b> prepared in four steps from commercially available quinoline 4-carboxylic acid (Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). The individual enantiomers of Boc-protected intermediate <b>52</b> were obtained by chiral chromatography, and these were carried forward independently to give both diastereomers of the dimeric Smac mimetic. As in the case of compound <b>21</b>, the absolute stereochemistry at the chiral center on the tetrahydroquinoline ring was made on the basis of the comparison of the binding affinities and cellular potencies for each diastereomer.</div><figure id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isobutyl chloroformate, 4-methylmorpholine, Chg-OMe·HCl, THF/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (b) LiOH·H<sub>2</sub>O, acetone/H<sub>2</sub>O, 0 °C; (c) DMTMM, 4-methylmorpholine, Pro-OMe·HCl; (d) <i>p</i>-TsCl, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (e) NaH, (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-amino-2-indanol, THF, 0 °C to reflux; (f) DMTMM, 4-methylmorpholine, THF/DMF, rt; (g) HCl, dioxane, rt.</p></p></figure><figure id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Raney Ni, HCl, MeOH, rt; (b) propargyl bromide, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN/MeOH, rt; (c) DPPA, triethylamine, <i>tert</i>-BuOH, 80 °C; (d) chiral chromatography; (e) HCl, dioxane, rt; (f) <b>48</b>, EDCI, HOBt hydrate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (g) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><div class="NLM_p">Compound <b>28</b> was also prepared using intermediate <b>48</b> by incorporating the commerically available methyl 2-amino-2,3-dihydro-1<i>H</i>-indene-2-carboxylate group at the P4 position. Ester hydrolysis followed by amide bond formation using propargylamine gave Boc-protected monomer <b>56</b>. Copper-promoted dimerization followed by removal of the Boc groups yielded the target compound (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).</div><figure id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>48</b>, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (b) NaOH, MeOH/water, rt; (c) EDCI, HOBt hydrate, 4-methylmorpholine, propargylamine, DMF, 0 °C to rt; (d) Cu(OAc)<sub>2</sub>, triethylamine, CH<sub>3</sub>CN, 70 °C; (e) HCl, MeOH, rt.</p></p></figure><div class="NLM_p">The synthesis of compounds <b>29</b>–<b>31</b> in which a bisamide linker connects the two monomeric Smac mimetics required the preparation of protected <i>cis</i>-diaminoindane intermediate <b>60</b> (Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>). Regiospecific radical addition of <i>tert</i>-butyl dichlorocarbamate (<b>57</b>) across the double bond of indene<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> followed by reduction of the N-chloro intermediate gave racemic <i>trans-</i><b>58</b>, which could be converted to <i>cis-</i><b>60</b> by azide displacement of the benzylic chloride followed by reduction to the primary amine. Coupling of this racemic material to Fmoc-Pro-OH afforded the expected mixture of diastereomers, which were separated chromatographically following removal of the Fmoc protecting group (<b>61</b>). Both diastereomers were carried forward independently through the sequence of steps depicted in Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>, and the assignment of absolute stereochemistry at the indane ring was made on the basis of the data obtained with the final dimeric compounds as descibed previously. Thus, addition of the P2 and P1 amino acid residues to <b>61</b> followed by Boc-deprotection of the indane amino group gave intermediate <b>63</b>. The linker group between the two monomeric units was installed by means of a diacid dichloride, and final Fmoc-deprotection revealed target dimers <b>29</b>–<b>31</b>.</div><figure id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Dimeric Smac Mimetics Containing a 1,2-Diaminoindane Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ca(OCl)<sub>2</sub>, HCl, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C; (b) indene, toluene, 35–40 °C, then NaHSO<sub>3</sub>, water, 5–10 °C; (c) NaN<sub>3</sub>, DMF, rt; (d) Pd/C, H<sub>2</sub>, EtOH, rt; (e) Fmoc-Pro-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) EtNH<sub>2</sub>, THF, rt; (g) Fmoc-Chg-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (h) Fmoc-<i>N</i>-Me-Ala-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (i) 4 N HCl/dioxane, rt; (j) diacid dichloride (for <b>29</b>, terephthaloyl chloride; for <b>30</b>, biphenyl-4,4′-dicarbonyl dichloride; for <b>31</b>, decanedioyl dichloride), DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Given the well-documented role of the IAP family of proteins in the suppression of apoptosis in cancer cells as well as the potential for a Smac mimetic to be an effective treatment for human cancers, we conducted extensive studies to discover and develop novel inhibitors of the IAPs. As a result, we have discovered a series of dimeric Smac mimetics based on the AVPI motif by identifying a site of effective dimerization in monomers containing a tetrahydronaphthyl P4 substituent. Initial work to establish the preferred stereochemistry at this residue led to alkyne-containing monomers <b>4</b> and <b>6</b> that, when dimerized, gave very potent inhibitors <b>8</b> and <b>10</b>, respectively, validating our initial design hypothesis. Further SAR development established the feasibility of replacing the tetrahydronaphthyl ring with an indanyl ring and led to an understanding of the drivers for cellular potency and physical properties. This class of dimers exhibits very high levels of cellular potency (cIAP1 degradation and inhibition of cell proliferation) in the MDA-MB-231 cancer cell line. Importantly, apoptosis induction and cell death are observed even following transient treatment of these cells with compound, suggesting that sustained exposure in vivo would not be necessary to exert pharmacodynamic effects. Thus, upon intravenous administration of compound <b>14</b> to tumor-bearing mice, reductions in cIAP1 protein levels and increases in cleaved caspase-3 were observed, consistent with inhibition of both cIAP1 and XIAP in vivo. In an MDA-MB-231 xenograft efficacy study, measurable tumor growth inhibition was observed at lower doses (0.1 and 0.5 mg/kg) of <b>14</b> as a single agent, whereas nearly complete tumor regression was observed at a higher dose (3.0 mg/kg). Consistent with previously described Smac mimetics, compound <b>14</b> inhibits proliferation in a relatively small subset of cancer cell lines. Given the high binding affinity to IAP family members and the cellular potency of <b>14</b> coupled with the physical properties and pharmacokinetics to allow for the in vivo activity observed following intravenous dosing, this compound was nominated for further development in human clinical trials. Further details of the clinical development of this compound will be reported in the future.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86256" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86256" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All reagents and solvents used were purchased from commercial sources and used without further purification. <sup>1</sup>H NMR spectra were obtained using a Bruker 300 or 400 MHz spectrometer at temperatures ranging from 23 to 100 °C; chemical shifts are expressed in parts per million (ppm, δ units) and are referenced to the residual protons in the deuterated solvent used. Most compounds described in this article appear as mixtures of amide rotamers by NMR at room temperature, and the resonances reported in this section are given as ranges of chemical shifts, reflective of these rotameric mixtures. Alternatively, heating the NMR sample (dissolved in DMSO-<i>d</i><sub>6</sub>) at 100 °C often causes the resonances to coalesce; spectral data obtained at 100 °C are denoted as such. Coupling constants are given in units of hertz (Hz). Splitting patterns describe apparent multiplicities and are designated as s (singlet), d (doublet), t (triplet), q (quartet), m (multiplet), and br s (broad singlet). Optical rotations were measured using a PerkinElmer Model 341 polarimeter. Mass spectrometry analyses were performed with an Agilent 1100 equipped with Waters columns (Atlantis T3, 2.1 × 50 mm, 3 μm or Atlantis dC18, 2.1 × 50 mm, 5 μm) eluted with a gradient mixture of water and acetonitrile with either formic acid or ammonium acetate added as a modifier. Reverse-phase chromatography was performed on a Gilson system using an Atlantis Prep T3 OBD reverse-phase HPLC column (19 mm × 100 mm) in water/MeCN with 0.1% TFA as mobile phase. Thin-layer chromatography was performed using EMD silica gel 60 F<sub>254</sub> plates, which were visualized using either UV light or a stain prepared by dissolving 2 g of KMnO<sub>4</sub> and 12 g of Na<sub>2</sub>CO<sub>3</sub> in 200 mL of H<sub>2</sub>O. Column chromatography was performed using SiliCycle SiliaSep preloaded silica gel cartridges on Teledyne ISCO CombiFlash Companion automated purification systems. Unless otherwise indicated, all final compounds were purified to ≥95% purity, as assessed by analytical HPLC using an Agilent 1100 equipped with Waters columns (Atlantis T3, 2.1 × 50 mm, 3 μm or Atlantis dC18, 2.1 × 50 mm, 5 μm) eluted for >10 min with a gradient mixture of water and acetonitrile with either formic acid or ammonium acetate added as a modifier, monitored at wavelengths of 220, 254, and 280 nm.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>trans</i>-2-Bromo-1,2,3,4-tetrahydronaphthalen-1-ol (racemic, <b>32</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask was charged with 1,2-dihydronaphthalene (7.03 g, 54.0 mmol), THF (50 mL), and water (25 mL). The resulting biphasic mixture was placed in a room temperature water bath, and then <i>N</i>-bromosuccinimide (10.66 g, 59.9 mmol) was added. The mixture was allowed to stir at room temperature overnight and was then partitioned between EtOAc and water. The aqueous layer was further extracted with EtOAc, and the combined organics were washed with brine, dried (MgSO<sub>4</sub>), filtered, and concentrated to give a magenta colored solid. This was recrystallized from EtOAc/hexanes to give the title compound as a colorless, crystalline solid (9.59 g, 78%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.06–2.18 (m, 1H), 2.40–2.51 (m, 1H), 2.78–2.91 (m, 2H), 4.43–4.50 (m, 1H), 4.63–4.71 (m, 1H), 5.90 (br s, 1H), 7.07–7.14 (m, 1H), 7.16–7.24 (m, 2H), 7.34–7.40 (m, 1H). LC–MS (M + H) 227, 229.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>trans</i>-1-Amino-1,2,3,4-tetrahydronaphthalen-2-ol (racemic, <b>33</b>)</h3><div class="NLM_p last">A 500 mL round-bottomed flask was charged with <b>32</b> (9.47 g, 41.7 mmol) and MeOH (10 mL). Aqueous ammonium hydroxide (28% ammonia; 50 mL, 359 mmol) was added, and the mixture was allowed to stir at room temperature for 1 week (reaction time unoptimized). The bulk of the unreacted NH<sub>3</sub> was evaporated under reduced pressure, and the resulting mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL). The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give the product as a colorless to pale yellow solid (5.98 g, 88%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.57–1.70 (m, 1H), 1.79–2.08 (m, 3H), 2.66–2.85 (m, 2H), 3.42–3.58 (m, 2H), 4.83 (br s, 1H), 6.97–7.05 (m, 1H), 7.05–7.18 (m, 2H), 7.47–7.54 (m, 1H). LC–MS (M + H) 164.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>trans</i>-<i>N</i>-(2-Hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)benzamide (<b>34</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing racemic <i>trans</i>-<b>33</b> (3.11 g, 19.1 mmol) was treated with CH<sub>2</sub>Cl<sub>2</sub> (60 mL) and triethylamine (3.50 mL, 25.1 mmol). The resulting solution was cooled to 0 °C, and then benzoyl chloride (2.40 mL, 20.7 mmol) was added dropwise. After 1 h, the reaction was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub>, and the combined organics were washed with water and concentrated under reduced pressure to give a solid residue. This was recrystallized from EtOAc/hexanes to give the product as a tan colored solid (4.18 g, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.72–1.84 (m, 1H), 2.03–2.15 (m, 1H), 2.72–2.94 (m, 2H), 3.85–3.95 (m, 1H), 4.96–5.00 (m, 1H), 5.01–5.08 (m, 1H), 7.07–7.19 (m, 4H), 7.42–7.49 (m, 2H), 7.49–7.56 (m, 1H), 7.88–7.97 (m, 2H), 8.58–8.67 (m, 1H). LC–MS (M + H) 268. The racemic material was subjected to supercritical fluid chromatography with a chiral column (Chiralpak AS column, mobile phase =80:20 CO<sub>2</sub>/EtOH, flow rate = 60 mL/min, temperature = 40 °C) to afford the separate enantiomers each in >98% ee. The absolute stereochemistry of each was determined by converting to <i>cis</i>- and <i>trans</i>-aminoalcohols <b>33</b> as described below. (1<i>S</i>,2<i>S</i>)-<b>34</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> +98 (<i>c</i> 0.25, MeOH), (1<i>R</i>,2<i>R</i>)-<b>34</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> −99 (<i>c</i> 0.21, MeOH).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3a<i>R</i>,9b<i>S</i>)-2-Phenyl-3a,4,5,9b-tetrahydronaphtho[1,2-<i>d</i>][1,3]oxazole ((−)-<b>35</b>)</h3><div class="NLM_p last">A 100 mL round-bottomed flask was charged with (1<i>S</i>,2<i>S</i>)-<b>34</b> (803 mg, 3.00 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (12 mL). The heterogeneous mixture was cooled to 0 °C, and then thionyl chloride (0.44 mL, 6.0 mmol) was added dropwise, resulting in a homogeneous solution. This was allowed to stir at 0 °C with slow warming to room temperature. After stirring at room temperature overnight, the solution was concentrated under reduced pressure. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and saturated NaHCO<sub>3</sub>, and the aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organics were washed with water and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (gradient elution; <i>R</i><sub><i>f</i></sub> in 80:20 hexanes/EtOAc = 0.42) to give the product as a colorless solid (717 mg, 96%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.16–1.24 (m, 2H), 1.93–2.05 (m, 1H), 2.29–2.39 (m, 1H), 2.64–2.76 (m, 2H), 3.00–3.09 (m, 1H), 5.66–5.81 (m, 2H), 7.18–7.25 (m, 1H), 7.26–7.35 (m, 2H), 7.57–7.65 (m, 3H), 7.72–7.79 (m, 1H), 8.11–8.19 (m, 2H). LC–MS (M + H) 250. (3a<i>R</i>,9b<i>S</i>)-<b>35</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> −309 (<i>c</i> 0.25, MeOH). The same procedure was followed using (1<i>R</i>,2<i>R</i>)-<b>34</b> to afford the opposite enantiomer, (3a<i>S</i>,9b<i>R</i>)-<b>35</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> +298 (<i>c</i> 0.19, MeOH).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-Amino-1,2,3,4-tetrahydronaphthalen-2-ol (<i>cis</i>-(+)-<b>33</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing (3a<i>R</i>,9b<i>S</i>)-<b>35</b> (648 mg, 2.60 mmol) was treated with dioxane (2 mL) and 6 N HCl (4 mL). The resulting solution was heated at 100 °C. After heating overnight, the reaction was allowed to cool and partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water. The aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub> and was then treated with NaOH until pH ∼13. The aqueous layer was then extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×), and the combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the product as a colorless solid (404 mg, 95%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.54–1.79 (m, 3H), 1.82–1.96 (m, 1H), 2.58–2.75 (m, 1H), 2.77–2.90 (m, 1H), 3.61–3.88 (m, 2H), 4.68 (br s, 1H), 6.97–7.06 (m, 1H), 7.06–7.17 (m, 2H), 7.34–7.44 (m, 1H). LC–MS (M + H) 164. [α]<sub class="stack">D</sub><sup class="stack">20</sup> +72 (<i>c</i> 0.1, MeOH). This is in agreement with the literature value of [α]<sub class="stack">D</sub><sup class="stack">20</sup> +68 (<i>c</i> 0.92, MeOH).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> The above procedure was also used to generate the opposite enantiomer starting from (3a<i>S</i>,9b<i>R</i>)-<b>35</b>. (1<i>R</i>,2<i>S</i>)-<i>cis</i>-<b>33</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> −64 (<i>c</i> 0.2, MeOH). This is in line with the literature values of [α]<sub class="stack">D</sub><sup class="stack">20</sup> −68 (<i>c</i> 0.88, MeOH),<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> [α]<sub class="stack">D</sub><sup class="stack">20</sup> −75.0 (<i>c</i> 1.0, 0.1 M HCl in MeOH),<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> and [α]<sub class="stack">D</sub><sup class="stack">20</sup> −64.2 (<i>c</i> 8.7, MeOH).<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (1<i>S</i>,2<i>S</i>)-<i>trans</i>-1-Amino-1,2,3,4-tetrahydronaphthalen-2-ol (<i>trans</i>-(−)-<b>33</b>)</h3><div class="NLM_p last">A 50 mL round-bottomed flask was charged with (1<i>S</i>,2<i>S</i>)-<b>34</b> (270 mg, 1.01 mmol) and NaOH (418 mg, 10.45 mmol). EtOH (2.5 mL) and water (2.5 mL) were added, and the resulting mixture was heated in an 80 °C oil bath. After 5 days of heating, the reaction was allowed to cool and was concentrated under reduced pressure. The residue was partitioned between CH<sub>2</sub>Cl<sub>2</sub> and water, and the aqueous layer was further extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were then extracted with aqueous 1 N HCl (2×), and the combined acidic aqueous extracts were washed with CH<sub>2</sub>Cl<sub>2</sub> before being carefully neutralized with solid NaOH to pH ∼13. Finally, this mixture was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organics were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the product as a tan colored solid (93 mg, 56%). [α]<sub class="stack">D</sub><sup class="stack">20</sup> −72 (<i>c</i> 0.1, CHCl<sub>3</sub>). This is in accord with the literature value of [α]<sub class="stack">D</sub><sup class="stack">20</sup> −85.4 (<i>c</i> 0.634, CHCl<sub>3</sub>).<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> The above procedure was also used to generate the opposite enantiomer starting from (1<i>R</i>,2<i>R</i>)-<b>36</b>. (1<i>R</i>,2<i>R</i>)-<i>trans</i>-<b>33</b> [α]<sub class="stack">D</sub><sup class="stack">20</sup> +72 (<i>c</i> 0.1, CHCl<sub>3</sub>).</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (<i>S</i>)-<i>tert</i>-Butyl 2-(((1<i>S</i>,2<i>R</i>)-2-Hydroxy-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)pyrrolidine-1-carboxylate (<b>36</b>)</h3><div class="NLM_p last">A 50 mL round-bottomed flask was charged with (1<i>S</i>,2<i>R</i>)-<i>cis</i>-<b>33</b> (283 mg, 1.73 mmol), Boc-Pro-OH (408 mg, 1.90 mmol), and HOBt hydrate (325 mg, 2.12 mmol). Anhydrous DMF (6 mL) was added, and the solution was cooled to 0 °C. To this was added EDCI (393 mg, 2.05 mmol), and the resulting mixture was allowed to stir at 0 °C with slow warming to room temperature. After stirring overnight, the reaction was partitioned between EtOAc and aqueous 1 N HCl. The aqueous layer was extracted with EtOAc, and the combined organics were washed with saturated NaHCO<sub>3</sub> and then twice with water before being concentrated under reduced pressure to give the product as a colorless foam (635 mg, quantitative). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.27–1.45 (m, 9H), 1.71–2.00 (m, 6H), 2.02–2.20 (m, 1H), 2.59–2.70 (m, 1H), 2.89–3.00 (m, 1H), 3.23–3.35 (m, 1H), 3.35–3.42 (m, 1H), 3.91–3.99 (m, 1H), 4.24–4.30 (m, 1H), 4.71–4.88 (m, 1H), 4.92–5.04 (m, 1H), 7.01–7.15 (m, 3H), 7.17–7.24 (m, 1H), 7.70–7.87 (m, 1H). LC–MS (M + H) 361.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (<i>S</i>)-<i>tert</i>-Butyl 2-(((1<i>S</i>,2<i>R</i>)-2-(Prop-2-yn-1-yloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)pyrrolidine-1-carboxylate (<b>37</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing <b>36</b> (624 mg, 1.73 mmol) was treated with anhydrous DMF (6 mL). The solution was cooled to 0 °C, and then propargyl bromide (80% solution in toluene; 300 μL, 2.70 mmol) was added. Powdered potassium hydroxide (287 mg, 5.12 mmol) was added to the solution, and the resulting mixture was allowed to stir at 0 °C. After 2 h, additional powdered KOH (99 mg) and propargyl bromide (100 μL) were added, and the mixture was allowed to stir at 0 °C for 1 h further. The mixture was then partitioned between EtOAc and water, and the aqueous layer was further extracted with EtOAc. The combined organics were washed with water and were concentrated under reduced pressure. The crude material was purified by silica gel chromatography (graduent elution; <i>R</i><sub><i>f</i></sub> in 60:40 hexanes/EtOAc = 0.30) to give the product as a colorless to pale yellow solid (475 mg, 69%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.25–1.47 (m, 9H), 1.67–1.78 (m, 1H), 1.78–1.96 (m, 3H), 2.00–2.18 (m, 2H), 2.65–2.79 (m, 1H), 2.81–2.91 (m, 1H), 3.21–3.35 (m, 1H), 3.35–3.43 (m, 2H), 3.84–3.94 (m, 1H), 4.15–4.31 (m, 3H), 5.11–5.26 (m, 1H), 7.06–7.24 (m, 4H), 7.93–8.05 (m, 1H). LC–MS (M + H) 399.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>tert</i>-Butyl ((<i>S</i>)-3,3-Dimethyl-1-oxo-1-((<i>S</i>)-2-(((1<i>S</i>,2<i>R</i>)-2-(prop-2-yn-1-yloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)pyrrolidin-1-yl)butan-2-yl)carbamate (<b>38</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing <b>37</b> (469 mg, 1.18 mmol) was treated with 4 N HCl in dioxane (5.0 mL, 20 mmol), and the resulting solution was allowed to stir at room temperature. After 1 h, the reaction was concentrated under reduced pressure. The residue was dissolved in MeOH and was reconcentrated to give the intermediate hydrochloride as a solid. The flask was then charged with Boc-Tle-OH (297 mg, 1.28 mmol) and HOBt hydrate (226 mg, 1.48 mmol). Anhydrous DMF (5 mL) was added followed by 4-methylmorpholine (155 μL, 1.41 mmol), and the resulting solution was cooled to 0 °C. EDCI (268 mg, 1.40 mmol) was added, and the resulting mixture was allowed to stir at 0 °C with slow warming to room temperature. After stirring overnight, the reaction was partitioned between EtOAc and 1 N HCl. The aqueous layer was extracted with EtOAc, and the combined organics were washed with saturated NaHCO<sub>3</sub> and then water and were concentrated under reduced pressure. The crude material was purified by silica gel chromatography (gradient elution; <i>R</i><sub><i>f</i></sub> in 60:40 hexanes/EtOAc = 0.23) to give the product as a colorless, viscous oil (516, 85%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.85–1.03 (m, 9H), 1.33–1.41 (m, 9H), 1.77–1.93 (m, 3H), 1.93–2.16 (m, 3H), 2.66–2.77 (m, 1H), 2.80–2.91 (m, 1H), 3.37–3.42 (m, 1H), 3.57–3.66 (m, 1H), 3.67–3.76 (m, 1H), 3.84–3.92 (m, 1H), 4.13–4.19 (m, 1H), 4.20–4.27 (m, 2H), 4.45–4.52 (m, 1H), 5.14–5.21 (m, 1H), 6.46–6.54 (m, 1H), 7.05–7.11 (m, 2H), 7.11–7.18 (m, 1H), 7.25–7.31 (m, 1H), 8.08–8.15 (m, 1H). LC–MS (M + H) 512.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>tert</i>-Butyl ((<i>S</i>)-1-(((<i>S</i>)-3,3-Dimethyl-1-oxo-1-((<i>S</i>)-2-(((1<i>S</i>,2<i>R</i>)-2-(prop-2-yn-1-yloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)carbamoyl)pyrrolidin-1-yl)butan-2-yl)amino)-1-oxopropan-2-yl)(methyl)carbamate (<b>39</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing <b>38</b> (510 mg, 1.00 mmol) was treated with 4 N HCl in dioxane (5.0 mL, 20 mmol), and the resulting solution was allowed to stir at room temperature. After 1 h, the solution was concentrated under reduced pressure. The residue was dissolved in MeOH and was reconcentrated to give the intermediate hydrochloride salt as a solid residue. The flask was charged with Boc-<i>N</i>-Me-Ala-OH (232 mg, 1.14 mmol) and HOBt hydrate (199 mg, 1.30 mmol). Anhydrous DMF (6 mL) was added, and the solution was cooled to 0 °C. 4-Methylmorpholine (125 μL, 1.14 mmol) was added followed by EDCI (233 mg, 1.22 mmol), and the resulting mixture was allowed to stir at 0 °C with slow warming to room temperature. After stirring at room temperature overnight, the reaction was partitioned between EtOAc and aqueous 1 N HCl. The aqueous layer was extracted with EtOAc, and the combined organics were washed sequentially with saturated NaHCO<sub>3</sub> and then water and were concentrated under reduced pressure. The crude material was purified by silica gel chromatography (gradient elution; <i>R</i><sub><i>f</i></sub> in 20:80 hexanes/EtOAc = 0.41) to give the title compound as a colorless, viscous oil (544 mg, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.83–1.04 (m, 9H), 1.14–1.26 (m, 3H), 1.32–1.47 (m, 9H), 1.76–1.92 (m, 3H), 1.93–2.18 (m, 3H), 2.66–2.80 (m, 4H), 2.80–2.93 (m, 1H), 3.37–3.42 (m, 1H), 3.59–3.74 (m, 2H), 3.84–3.92 (m, 1H), 4.16–4.29 (m, 2H), 4.44–4.55 (m, 2H), 4.55–4.65 (m, 1H), 5.14–5.22 (m, 1H), 7.05–7.12 (m, 2H), 7.12–7.19 (m, 1H), 7.25–7.32 (m, 1H), 7.38–7.64 (m, 1H), 8.09–8.17 (m, 1H). LC–MS (M + H) 597.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (<i>S</i>)-1-((<i>S</i>)-3,3-Dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)-<i>N</i>-((1<i>S</i>,2<i>R</i>)-2-(prop-2-ynyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide hydrochloride (<b>4</b>)</h3><div class="NLM_p last">A 100 mL round-bottomed flask containing <b>39</b> (161 mg, 0.27 mmol) was treated with 4 N HCl in dioxane (4.0 mL, 16 mmol), and the resulting solution was allowed to stir at room temperature for 1 h. The volatile components were then evaporated under reduced pressure, and the residue was dissolved in MeOH and was reconcentrated to give the title compound as a solid film (138 mg, 96%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.92–1.08 (m, 9H), 1.28–1.35 (m, 3H), 1.74–1.93 (m, 3H), 1.95–2.17 (m, 3H), 2.43–2.49 (m, 3H), 2.65–2.77 (m, 1H), 2.80–2.91 (m, 1H), 3.37–3.43 (m, 1H), 3.63–3.75 (m, 2H), 3.86–3.99 (m, 2H), 4.16–4.28 (m, 2H), 4.44–4.50 (m, 1H), 4.52–4.58 (m, 1H), 5.15–5.22 (m, 1H), 7.04–7.22 (m, 3H), 7.25–7.30 (m, 1H), 8.11–8.18 (m, 1H), 8.57–8.66 (m, 1H), 8.75–8.88 (m, 1H), 9.09–9.22 (m, 1H). LC–MS (M + H) 497.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>tert</i>-Butyl (2<i>S</i>,2′<i>S</i>)-1,1′-(2<i>S</i>,2′<i>S</i>)-1,1′-((2<i>S</i>,2′<i>S</i>)-2,2′-(1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,1-diyl)bis(azanediyl)bis(oxomethylene)bis(pyrrolidine-2,1-diyl))bis(3,3-dimethyl-1-oxobutane-2,1-diyl)bis(azanediyl)bis(1-oxopropane-2,1-diyl)bis(methylcarbamate) (<b>40</b>)</h3><div class="NLM_p last">A 250 mL round-bottomed flask containing <b>39</b> (382 mg, 0.64 mmol) was charged with copper(II) acetate (134 mg, 0.74 mmol). Acetonitrile (6 mL) and pyridine (0.31 mL, 3.8 mmol) were added, and the resulting heterogeneous mixture was placed in an oil bath preheated to 80 °C. After 1 h, the reaction was allowed to cool to room temperature and was concentrated under reduced pressure. The residue was partitioned between EtOAc and dilute aqueous NH<sub>4</sub>OH, and the aqueous layer was further extracted with EtOAc. The combined organics were washed with water and were concentrated under reduced pressure. The crude material was purified by silica gel chromatography (gradient elution; <i>R</i><sub><i>f</i></sub> in EtOAc = 0.36) to give the product as a colorless solid (312 mg, 82%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.84–1.05 (m, 18H), 1.13–1.28 (m, 6H), 1.33–1.49 (m, 18H), 1.73–1.92 (m, 6H), 1.92–2.18 (m, 6H), 2.65–2.79 (m, 8H), 2.79–2.90 (m, 2H), 3.57–3.71 (m, 4H), 3.80–3.89 (m, 2H), 4.30–4.43 (m, 4H), 4.43–4.49 (m, 2H), 4.49–4.54 (m, 2H), 4.54–4.66 (m, 2H), 5.13–5.22 (m, 2H), 7.04–7.12 (m, 4H), 7.12–7.18 (m, 2H), 7.19–7.64 (m, 4H), 8.11–8.20 (m, 2H). LC–MS (M + H) 1192.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,1-diyl))bis(1-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) (<b>8</b>)</h3><div class="NLM_p">A 250 mL round-bottomed flask containing <b>40</b> (210 mg, 0.18 mmol) was treated with 4 N HCl in dioxane (4.0 mL, 16 mmol), and the resulting mixture was allowed to stir at room temperature for 1 h. The volatile components were then evaporated under reduced pressure, and the residue was partitioned between EtOAc and saturated NaHCO<sub>3</sub>. The aqueous layer was further extracted with EtOAc, and the combined organics were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a viscous oil. This material was lyophilized from a MeCN/H<sub>2</sub>O solution to give the title compound as a colorless, amorphous solid (172 mg, 99%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.98 (br s, 18H), 1.17 (d, 6H), 1.81–1.94 (m, 4H), 1.97–2.18 (m, 8H), 2.25 (s, 6H), 2.67–2.77 (m, 2H), 2.84–2.95 (m, 2H), 2.98–3.06 (m, 2H), 3.60–3.70 (m, 2H), 3.71–3.80 (m, 2H), 3.87–3.93 (m, 2H), 4.33–4.43 (m, 4H), 4.48–4.56 (m, 4H), 5.16–5.23 (m, 2H), 7.02–7.17 (m, 6H), 7.25–7.31 (m, 2H), 7.57–7.68 (m, 4H). LC–MS (M + H) 992.</div><div class="NLM_p last">The following compounds were prepared in an analogous manner to compounds <b>4</b> and <b>8</b> using the appropriate diastereomer of aminoalcohol <b>33</b>:</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>S</i>)-1-((<i>S</i>)-3,3-Dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-2-(prop-2-ynyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide hydrochloride (<b>5</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.02 (s, 9H), 1.38 (d, 3H), 1.87–1.95 (m, 2H), 2.00–2.19 (m, 4H), 2.52 (s, 3H), 2.68–2.75 (m, 1H), 2.87–2.97 (m, 1H), 3.10–3.23 (m, 3H), 3.73–3.80 (m, 1H), 3.93–4.01 (m, 2H), 4.27 (br s, 2H), 4.46–4.52 (m, 1H), 4.53–4.57 (m, 1H), 5.15–5.19 (m, 1H), 7.06–7.10 (m, 2H), 7.12–7.20 (m, 2H), 7.34–7.42 (m, 1H), 8.19–8.27 (m, 1H), 8.85 (br s, 2H). LC–MS (M + H) 497.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>R</i>,1′<i>R</i>,2<i>S</i>,2′<i>S</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,1-diyl))bis(1-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) (<b>9</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.96 (s, 18H), 1.16 (d, 6H), 1.84–1.95 (m, 4H), 1.97–2.15 (m, 8H), 2.25 (s, 6H), 2.63–2.80 (m, 2H), 2.86–2.95 (m, 2H), 2.98–3.05 (m, 2H), 3.63–3.72 (m, 2H), 3.75–3.83 (m, 2H), 3.90–3.95 (m, 2H), 4.39–4.44 (m, 4H), 4.46–4.55 (m, 4H), 5.13–5.20 (m, 2H), 7.04–7.10 (m, 2H), 7.11–7.20 (m, 6H), 7.36–7.42 (m, 2H), 7.58–7.67 (m, 2H). LC–MS (M + H) 992.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>S</i>)-1-((<i>S</i>)-3,3-Dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)-<i>N</i>-((1<i>S</i>,2<i>S</i>)-2-(prop-2-ynyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide Hydrochloride (<b>6</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.05 (s, 9H), 1.38 (d, 3H), 1.83–1.97 (m, 3H), 2.04–2.11 (m, 3H), 2.52 (s, 3H), 2.72–2.77 (m., 1H), 2.79–2.93 (m, 1H), 3.12–3.13 (m, 1H), 3.58–3.72 (m, 2H), 3.72–3.81 (m, 2H), 3.96–4.03 (m, 1H), 4.18–4.31 (m, 2H), 4.38–4.44 (m, 1H), 4.49–4.59 (m, 1H), 4.86–4.90 (m, 1H), 7.03–7.11 (m, 2H), 7.13–7.16 (m, 1H), 7.26–7.28 (m, 1H), 7.86 (br s, 1H), 8.23 (br s, 1H), 8.97 (br s, 2H). LC–MS (M + H) 497.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>S</i>,2′<i>S</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,1-diyl))bis(1-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) (<b>10</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.00 (s, 18H), 1.17 (d, 6H), 1.82–1.90 (m, 4H), 1.91–2.00 (m, 2H), 2.00–2.11 (m, 6H), 2.25 (s, 6H), 2.66–2.79 (m, 2H), 2.81–2.88 (m, 2H), 3.00–3.06 (m, 2H), 3.57–3.69 (m, 2H), 3.69–3.82 (m, 4H), 4.39 (s, 6H), 4.50–4.54 (m, 2H), 4.85–4.90 (m, 2H), 7.05–7.18 (m, 6H), 7.25–7.31 (m, 2H), 7.62 (br s, 2H), 7.90 (br s, 2H). LC–MS (M + H) 992.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>S</i>)-1-((<i>S</i>)-3,3-Dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-2-(prop-2-ynyloxy)-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine-2-carboxamide Hydrochloride (<b>7</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.03 (s, 9H), 1.38 (d, 3H), 1.83–1.99 (m, 3H), 2.00–2.14 (m, 3H), 2.50 (s, 3H), 2.62–2.77 (m, 1H), 2.77–2.92 (m, 1H), 3.08–3.10 (m, 1H), 3.60–3.79 (m, 2H), 3.83–3.88 (m, 1H), 3.97–4.02 (m, 1H), 4.26 (d, 2H), 4.36–4.42 (m, 1H), 4.51–4.56 (m, 1H), 4.84–4.87 (m, 1H), 7.06–7.12 (m, 1H), 7.12–7.19 (m, 3H), 7.74 (br s, 1H), 8.23 (br s, 1H), 9.03 (br s, 2H). LC–MS (M + H) 497.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>R</i>,1′<i>R</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(1,2,3,4-tetrahydronaphthalene-2,1-diyl))bis(1-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) (<b>11</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.97 (s, 18H), 1.16 (d, 6H), 1.80–2.00 (m, 6H), 2.25 (s, 6H), 2.64–2.76 (m, 2H), 2.79–2.87 (m, 2H), 2.98–3.06 (m, 2H), 3.63–3.70 (m, 2H), 3.73–3.77 (m, 2H), 3.81–3.86 (m, 2H), 4.35–4.41 (m, 6H), 4.48–4.53 (m, 2H), 4.83–4.86 (m, 2H), 7.05–7.11 (m, 2H), 7.11–7.18 (m, 6H), 7.62 (br s, 2H), 7.74 (br s, 2H). LC–MS (M + H) 992.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>S</i>)-<i>tert</i>-Butyl 2-((1<i>S</i>,2<i>R</i>)-2-Hydroxy-2,3-dihydro-1<i>H</i>-inden-1-ylcarbamoyl)pyrrolidine-1-carboxylate (<b>41</b>)</h3><div class="NLM_p last">A 1000 mL round-bottomed flask was charged with Boc-Pro-OH (38.85 g, 180.5 mmol) and EtOAc (400 mL). The mixture was cooled to 0 °C, and then 4-methylmorpholine (20.0 mL, 182 mmol) was added, resulting in a colorless solution. Ethyl chloroformate (17.2 mL, 180 mmol) was added dropwise, resulting in a heterogeneous, colorless suspension. This was allowed to stir at 0 °C for 30 min, and then (1<i>S</i>,2<i>R</i>)-1-amino-2,3-dihydro-1<i>H</i>-inden-2-ol (26.50 g, 177.6 mmol) was added. The resulting mixture was allowed to stir at 0 °C with slow warming to room temperature. After stirring at room temperature overnight, the reaction was transferred to a 1000 mL separatory funnel and was washed with water (300 mL). The aqueous layer was extracted with EtOAc (150 mL), and the combined organics were washed sequentially with 1 N HCl (225 mL), half-saturated NaHCO<sub>3</sub> (250 mL), and brine (100 mL) and were then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a solid residue. This was recrystallized from EtOAc/hexanes to give the title compound as a colorless solid (55.76 g, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.41 (s, 9H), 1.75–1.96 (m, 2H), 2.00–2.09 (m, 1H), 2.09–2.19 (m, 1H), 2.81–2.95 (m, 1H), 3.04–3.13 (m, 1H), 3.36–3.41 (m, 2H), 4.25–4.31 (m, 1H), 4.43–4.49 (m, 1H), 4.59–4.64 (m, 1H), 5.15–5.21 (m, 1H), 7.11–7.27 (m, 4H), 7.29–7.39 (m, 1H). LC–MS (M + H) 346.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (<i>S</i>)-<i>tert</i>-Butyl 2-((1<i>S</i>,2<i>R</i>)-2-(Prop-2-ynyloxy)-2,3-dihydro-1<i>H</i>-inden-1-ylcarbamoyl)pyrrolidine-1-carboxylate (<b>42</b>)</h3><div class="NLM_p last">A 1000 mL round-bottomed flask was charged with <b>41</b> (48.38 g, 139.7 mmol). Anhydrous DMF (300 mL) was added, and the resulting solution was cooled to 0 °C. Propargyl bromide (80 wt % in toluene; 18.0 mL, 167 mmol) was added, and the cold solution was then treated in portions with powdered KOH (16.13 g, 287.5 mmol) over 5 min. The resulting heterogeneous mixture was allowed to stir at 0 °C for 60 min and was then diluted with EtOAc (300 mL) and water (300 mL). The mixture was transferred to a separatory funnel, and the layers were separated. The aqueous layer was diluted with additional water (200 mL) and was extracted with EtOAc (3 × 100 mL). The combined organics were washed with water (3 × 100 mL) and then brine (∼100 mL) and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give a tan/brown oil. The product was crystallized from EtOAc/hexanes to give a tan colored solid (49.59 g, 92%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.40 (s, 9H), 1.73–1.85 (m, 1H), 1.85–1.94 (m, 1H), 1.94–2.06 (m, 1H), 2.06–2.20 (m, 1H), 3.03–3.08 (m, 2H), 3.14–3.20 (m, 1H), 3.30–3.46 (m, 2H), 4.12–4.25 (m, 2H), 4.27–4.30 (m, 1H), 4.35–4.45 (m, 1H), 5.30–5.38 (m, 1H), 7.16–7.29 (m, 4H), 7.46–7.48 (m, 1H). LC–MS (M + H) 385.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (<i>S</i>)-<i>N</i>-((1<i>S</i>,2<i>R</i>)-2-(Prop-2-ynyloxy)-2,3-dihydro-1<i>H</i>-inden-1-yl)pyrrolidine-2-carboxamide Trifluoroacetate (<b>43</b>)</h3><div class="NLM_p last">A 1000 mL round-bottomed flask was charged with <b>42</b> (30.09 g, 78.26 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (100 mL). The resulting solution was placed in a room temperature water bath, and then trifluoroacetic acid (50 mL, 673 mmol) was added. The resulting solution was allowed to stir at room temperature for 3 h and was then concentrated under reduced pressure. The residue was dissolved in diethyl ether (300 mL), and a solid material soon crystallized from the solution. The solid was isolated by suction filtration and was washed with ether and dried in air to give the title compound (28.15 g, 90%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.85–1.94 (m, 2H), 1.94–2.03 (m, 1H), 2.23–2.36 (m, 1H), 2.95–3.13 (m, 2H), 3.17–3.27 (m, 1H), 3.27–3.36 (m, 1H), 3.41–3.47 (m, 1H), 4.15–4.21 (m, 2H), 4.26–4.29 (m, 1H), 4.36–4.40 (m, 1H), 5.34–5.41 (m, 1H), 7.21–7.29 (m, 4H), 8.61 (br s, 1H), 8.71–8.78 (m, 1H), 9.30 (br s, 1H). LC–MS (M + H) 285.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (1<i>S</i>,2<i>R</i>)-2-(Prop-2-ynyloxy)-2,3-dihydro-1<i>H</i>-inden-1-amine (<b>44</b>)</h3><div class="NLM_p last">NaH (60% dispersion in mineral oil; 0.89 g, 22 mmol) was added slowly to a solution of (1<i>S</i>,2<i>R</i>)-1-amino-2,3-dihydro-1<i>H</i>-inden-2-ol (3.00 g, 20.1 mmol) in anhydrous THF (50 mL) at 0 °C with stirring. The resulting mixture was allowed to warm to room temperature over 30 min before being heated to reflux. A solution of propargyl bromide (80% in toluene; 3.30 g, 22.2 mmol) in anhydrous THF (10 mL) was added dropwise to this suspension. The resulting mixture was heated at reflux for 1 h and was then allowed to cool to room temperature. EtOAc (200 mL) and water (200 mL) were added. The layers were separated, and the aqueous phase was extracted with EtOAc (100 mL × 3). The combined organic phases were washed with water (300 mL) and then brine (300 mL) and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1 →10:1) to give the title compound as an oil (1.90 g, 50%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 1.70 (s, 2H), 2.43 (t, <i>J</i> = 1.8 Hz, 1H), 3.02 (s, 2H), 4.32–4.25 (m, 4H), 7.20–7.25 (m, 3H), 7.38 (m, 1H). LC–MS (M + H) 188.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Method A for the Preparation of Boc-Protected Indanyl-Based Monomers</h3><div class="NLM_p last">The general procedures described for the preparation of the tetrahydronaphthyl-based compound <b>4</b> were followed utilizing compound <b>43</b> as a reagent.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Method B for the Preparation of Boc-Protected Indanyl-Based Monomers</h3><div class="NLM_p last">Amide bond formation between Boc-<i>N</i>-Me-Ala-OH and a suitably protected amino acid methyl ester followed by ester hydrolysis gave a dipeptide acid fragment, which could then be coupled to compound <b>43</b>. A representative procedure is described here for the Boc-protected monomer used in the preparation of compound <b>13</b>.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>tert</i>-Butyl Methyl((<i>S</i>)-1-((<i>S</i>)-3-methyl-1-oxo-1-((<i>S</i>)-2-((1<i>S</i>,2<i>R</i>)-2-(prop-2-ynyloxy)-2,3-dihydro-1<i>H</i>-inden-1-ylcarbamoyl)pyrrolidin-1-yl)butan-2-ylamino)-1-oxopropan-2-yl)carbamate</h3><div class="NLM_p last">Isobutyl chloroformate (0.74 g, 5.4 mmol) was added dropwise to a solution of Boc-<i>N</i>-Me-Ala-OH (1.00 g, 4.92 mmol) and 4-methylmorpholine (0.80 g, 7.9 mmol) in anhydrous THF (20 mL) at 0 °C. After stirring at this temperature for 20 min, a solution prepared from valine methyl ester hydrochloride (820 mg, 4.89 mmol) and 4-methylmorpholine (1.0 g, 9.9 mmol) in anhydrous THF (10 mL) was added to this suspension. The mixture was allowed to stir at 0 °C for 1 h and was then partitioned between EtOAc and water. The aqueous phase was extracted with EtOAc, and the combined organic extracts were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated aqueous NaHCO<sub>3</sub>, and brine before being dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (EtOAc/hexane = 10:1 → 5:1) to afford the dipeptide ester as a colorless solid (1.30 g, 84%). A solution of this compound (380 mg, 1.20 mmol) in acetone (10 mL) was cooled to 0 °C and was treated with a solution of LiOH monohydrate (0.10 g, 2.4 mmol) in water (5 mL). After stirring at 0 °C for 3 h, the reaction was acidified with 2 N aqueous HCl to pH ∼3 and was then concentrated under reduced pressure. The residue was partitioned between EtOAc and water, and the aqueous layer was further extracted with EtOAc. The combined organic phases were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated aqueous NaHCO<sub>3</sub>, and brine before being dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the dipeptide acid as a solid (360 mg, 99%). DMTMM (4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl-morpholinium chloride, 0.58 g, 2.1 mmol) was added to a cold (0 °C) solution of this dipeptide acid (320 mg, 1.06 mmol) and compound <b>43</b> (500 mg, 1.26 mmol) in THF (20 mL) and DMF (10 mL) followed by 4-methylmorpholine (0.60 g, 5.9 mmol). The resulting suspension was allowed to stir overnight at room temperature and was then partitioned between EtOAc and water. The aqueous layer was further extracted with EtOAc, and the combined organic extracts were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated aqueous NaHCO<sub>3</sub>, and brine before being dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 100:1→ 50:1) to give the Boc-protected monomer as a colorless solid (450 mg, 75%). LC–MS (M + H) 569.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> Preparation of Indanyl-Based Dimeric Smac Mimetics</h3><div class="NLM_p last">The Boc-protected monomers (prepared by either Method A or B) could be dimerized by the procedure described above for compound <b>40</b>. Removal of the Boc groups was then carried out at room temperature under standard conditions (4 N HCl in dioxane, or 1:1 CH<sub>2</sub>Cl<sub>2</sub>/trifluoroacetic acid) to reveal the target Smac mimetic as its hydrochloride or trifluoroacetate salt. Select examples were then converted to their unprotonated form through an aqueous workup with saturated NaHCO<sub>3</sub>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) (<b>12</b>)</h3><div class="NLM_p last">Prepared following Method A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.88–1.04 (m, 18H), 1.07–1.16 (m, 6H), 1.76–1.94 (m, 4H), 1.94–2.13 (m, 6H), 2.13–2.21 (m, 6H), 2.90–3.09 (m, 6H), 3.58–3.79 (m, 4H), 4.24–4.39 (m, 6H), 4.45–4.57 (m, 4H), 5.27–5.36 (m, 2H), 7.13–7.29 (m, 8H), 7.78–7.88 (m, 2H), 8.04–8.11 (m, 2H). LC–MS (M + H) 964.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-3-methyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)pyrrolidine-2-carboxamide) Bistrifluoroacetate (<b>13</b>)</h3><div class="NLM_p last">Prepared following Method B. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.85–1.00 (m, 12H), 1.25–1.41 (m, 6H), 1.80–2.10 (m, 10H), 2.91–3.10 (m, 4H), 3.50–3.80 (m, 4H), 3.1–4.02 (m, 2H), 4.22–4.35 (m, 6H), 4.35–4.52 (m, 4H), 5.25–5.32 (m, 2H), 7.15–7.30 (m, 14H), 8.06–8.21 (m, 2H), 8.70–8.92 (m, 4H), 8.92–9.13 (m, 2H). LC–MS (M + H) 936.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) (<b>14</b>)</h3><div class="NLM_p last">Prepared following Method A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.00–1.30 (m, 10H), 1.35–1.44 (m, 6H), 1.54–1.94 (m, 14H), 1.97–2.12 (m, 6H), 2.48–2.52 (m, 6H), 2.96–3.11 (m, 4H), 3.57–3.68 (m, 2H), 3.71–3.81 (m, 2H), 3.85–3.98 (m, 2H), 4.30–4.42 (m, 6H), 4.42–4.50 (m, 2H), 4.52–4.61 (m, 2H), 5.28–5.39 (m, 2H), 7.13–7.30 (m, 8H), 7.57–7.70 (m, 2H), 8.31–8.48 (m, 2H), 8.90–9.33 (m, 4H). LC–MS (M + H) 1015.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-((<i>S</i>)-2-(methylamino)propanamido)-2-(piperidin-4-yl)acetyl)pyrrolidine-2-carboxamide) Tetratrifluoroacetate (<b>15</b>)</h3><div class="NLM_p last">Prepared following Method B. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.20–1.60 (m, 12H), 1.60–2.10 (m, 12H), 2.68–2.95 (m, 4H), 2.95–3.12 (m, 4H), 3.20–3.43 (m, 4H), 3.60–3.90 (m, 6H), 4.20–4.43 (m, 6H), 4.44–4.58 (m, 2H), 4.60–4.80 (m, 2H), 5.19–5.39 (m, 2H), 5.57 (br s, 4H), 7.08–7.39 (m, 8H), 8.12–8.30 (m, 2H), 8.52–8.80 (m, 2H), 8.80–9.07 (m, 6H), 9.07–9.30 (m, 2H). LC–MS (M + H) 1018.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-(1-acetylpiperidin-4-yl)-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) Bistrifluoroacetate (<b>16</b>)</h3><div class="NLM_p last">Prepared following Method B. <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 1.05–1.21 (m, 4H), 1.25–1.34 (m, 8H), 1.60–1.72 (m, 4H), 1.80–2.10 (m, 16H), 2.10–2.33 (m, 2H), 2.35–2.47 (m, 10H), 2.70–2.88 (m, 2H), 2.98–3.15 (m, 6H), 3.60–3.75 (m, 2H), 3.75–3.95 (m, 2H), 4.31–4.89 (m, 4H), 4.80–4.73 (m, 8H), 5.39–5.52 (m, 2H), 7.08–7.33 (m, 10H), 7.65–7.82 (m, 2H). LC–MS (M + H) 1102.</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-(1-(2-hydroxyethyl)piperidin-4-yl)-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) Tetratrifluoroacetate (<b>17</b>)</h3><div class="NLM_p last">Prepared following Method B. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.02–1.48 (m, 10H), 1.50–2.30 (m, 20H), 2.75–3.25 (m, 12H), 3.42–3.65 (m, 6H), 3.65–3.83 (m, 6H), 3.85–4.00 (m, 2H), 4.19–4.41 (m, 6H), 4.43–4.60 (m, 2H), 4.60–4.80 (m, 2H), 5.21–5.43 (m, 2H), 7.05–7.36 (m, 10H), 8.21–8.25 (m, 2H), 8.78–9.23 (m, 4H), 9.29 (br s, 2H), 9.73 (br s, 2H). LC–MS (M + H) 1106.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,<i>2</i>′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-6-amino-2-((<i>S</i>)-2-(methylamino)propanamido)hexanoyl)pyrrolidine-2-carboxamide) Tetratrifluoroacetate (<b>18</b>)</h3><div class="NLM_p">Prepared following Method B. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 1.15–1.80 (m, 20H), 1.80–2.15 (m, 8H), 2.65–2.88 (m, 4H), 2.90–3.10 (m, 4H), 3.47–3.73 (m, 4H), 3.75–3.92 (m, 2H), 4.20–4.41 (m, 6H), 4.41–4.66 (m, 4H), 4.95–5.70 (m, 10H), 7.02–7.51 (m, 10H), 8.08–8.25 (m, 2H), 8.75–9.03 (m, 4H), 9.05–9.28 (m, 2H). LC–MS (M + H) 994.</div><div class="NLM_p last">For the compounds presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, the chemistry described for the above compounds was used along with the requisite Boc-protected proline mimetic (either commercially available or prepared by known routes).</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>S</i>,<i>S</i>,4<i>R</i>,4′<i>R</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(3-((<i>S</i>)-3,3-dimethyl-2-((<i>S</i>)-2-(methylamino)propanamido)butanoyl)thiazolidine-4-carboxamide) Bistrifluoroacetate (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 0.90–1.15 (m, 18H), 1.20–1.45 (m, 8H), 2.92–3.16 (m, 6H), 3.26–3.40 (m, 2H), 3.89–4.07 (m, 2H), 4.23–4.44 (m, 6H), 4.54–4.99 (m, 6H), 5.00–5.19 (m, 2H), 5.28–5.43 (m, 2H), 7.11–7.38 (m, 8H), 8.21–8.37 (m, 2H), 8.66–8.80 (m, 2H), 8.81–9.02 (m, 2H), 9.02–9.22 (m, 2H). LC–MS (M + H) 1000.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>S</i>,<i>S</i>,4<i>R</i>,4′<i>R</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(3-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)thiazolidine-4-carboxamide) Bistrifluoroacetate (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 0.92- 1.25 (m, 12H), 1.30–1.40 (m, 6H), 1.55–1.95 (m, 12H), 2.91–3.12 (m, 6H), 3.23–3.40 (m, 2H), 3.80–3.96 (m, 2H), 4.23–4.40 (m, 6H), 4.45–4.68 (m, 4H), 4.81–4.96 (m, 2H), 5.02–5.16 (m, 2H), 5.15–5.40 (m, 2H), 7.15–7.34 (m, 8H), 8.21–8.36 (m, 2H), 8.74–8.99 (m, 4H), 9.00–9.20 (m, 2H). LC–MS (M + H) 1052.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 6-(<i>tert</i>-Butoxycarbonyl)-4-thia-6-azaspiro[2.4]heptane-7-carboxylic Acid (<b>46</b>)</h3><div class="NLM_p last">Compound <b>45</b><a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (12.9 g, 70.3 mmol) was dissolved in water (100 mL), and 37% aqueous formaldehyde (20 mL, 270 mmol) was added. The reaction mixture was allowed to stir overnight at room temperature and was then cooled in an ice bath. Absolute EtOH (100 mL) was added followed by pyridine (14.0 mL, 173 mmol), bringing the mixture to pH ∼6. The mixture was cooled to 0 °C and was allowed to stir at this temperature for 1 h. The precipitated solid was isolated by suction filtration and was washed with cold EtOH to afford 4-thia-6-aza-spiro[2.4]heptane-7-carboxylic acid as a colorless solid (4.31 g, 27.1 mmol). This material was suspended in water (20 mL), and NaHCO<sub>3</sub> (6.80 g, 81.0 mmol) was added, resulting in a homogeneous solution. Di-<i>tert</i>-butyldicarbonate (8.76 g, 40.7 mmol) was then added, and the mixture was allowed to stir overnight at room temperature. CHCl<sub>3</sub> (100 mL) was added, and the mixture was cooled to 0 °C before being acidified with 6 N aqueous HCl to pH ∼3. The layers were separated, and the organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give to a colorless foam. Trituration with hexanes provided the target compound as a colorless solid (6.18 g, 34% over two steps). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 0.80–1.01 (m, 2H), 1.15–1.31 (m, 2H), 1.41 (s, 9H), 3.98 (s, 1H), 4.61 (m, 2H). LC–MS (M – H) 258.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (7<i>R</i>,7′<i>R</i>)-<i>N</i>,<i>N</i>′-{Hexa-2,4-diyne-1,6-diylbis[oxy(1<i>S</i>,2<i>R</i>)-2,3-dihydro-1<i>H</i>-indene-2,1-diyl]}bis{6-[(2<i>S</i>)-2-cyclohexyl-2-{[(2<i>S</i>)-2-(methylamino)propanoyl]amino}acetyl]-4-thia-6-azaspiro[2.4]heptane-7-carboxamide} (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.80–0.90 (m, 4H), 0.90–1.30 (m, 22H), 1.51–1.91 (m, 12H), 2.10–2.29 (m, 6H), 2.94–3.15 (m, 6H), 4.24–4.41 (m, 6H), 4.49–4.64 (m, 4H), 4.76–4.94 (m, 2H), 5.05–5.16 (m, 2H), 5.29–5.41 (m, 2H), 7.12–7.32 (m, 8H), 7.95–8.14 (m, 4H). LC–MS (M + H) 1104.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)-2,5-dihydro-1<i>H</i>-pyrrole-2-carboxamide) Bishydrochloride (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.92–1.26 (m, 10H), 1.26–1.41 (m, 6H), 1.55–1.79 (m, 8H), 1.80–1.89 (m, 2H), 1.93–2.04 (m, 2H), 2.45–2.48 (m, 6H), 2.97–3.07 (m, 4H), 3.78–3.90 (m, 2H), 4.22–4.37 (m, 8H), 4.39–4.48 (m, 2H), 4.49–4.61 (m, 2H), 5.18–5.24 (m, 2H), 5.25–5.40 (m, 2H), 5.72–5.85 (m, 2H), 5.97–6.09 (m, 2H), 7.16–7.30 (m, 8H), 8.27–8.35 (m, 2H), 8.71–8.94 (m, 4H), 9.11–9.36 (m, 2H). LC–MS (M + H) 1012.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (<i>S</i>,<i>S</i>,1<i>S</i>,1′<i>S</i>,<i>3S</i>,3′<i>S</i>,5<i>S</i>,5′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(2-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)-2-azabicyclo[3.1.0]hexane-3-carboxamide) Bishydrochloride (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.76–0.85 (m, 2H), 0.94–1.25 (m, 12H), 1.29–1.41 (m, 6H), 1.55–1.74 (m, 8H), 1.74–1.83 (m, 2H), 1.84–1.99 (m, 6H), 2.37–2.45 (m, 2H), 2.40–2.62 (m, 6H), 2.95–3.07 (m, 4H), 3.70–3.79 (m, 2H), 3.81–3.92 (m, 2H), 4.26–4.38 (m, 6H), 4.67–4.75 (m, 2H), 4.76–4.86 (m, 2H), 5.24–5.32 (m, 2H), 7.15–7.27 (m, 8H), 8.06–8.14 (m, 2H), 8.71–8.90 (m, 4H), 9.09 (br s, 2H). LC–MS (M + H) 1040.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>S</i>,2′<i>S</i>)-2,2′-(Hexa-2,4-diyne-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.98–1.30 (m, 16H), 1.58–1.81 (m, 12H), 1.84–2.15 (m, 8H), 2.25 (s, 6H), 2.78–2.87 (m, 2H), 2.97–3.05 (m, 2H), 3.25–3.35 (m, 2H), 3.59–3.65 (m, 2H), 3.66–3.74 (m, 2H), 3.74–3.81 (m, 2H), 4.23–4.33 (m, 2H), 4.38–4.50 (m, 8H), 5.12–5.20 (m, 2H), 7.13–7.25 (m, 8H), 7.60 (br s, 2H), 7.96 (br s, 2H). LC–MS (M + H) 1016.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (<i>S</i>,<i>S</i>,<i>2S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-(Hexane-1,6-diylbis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) Bishydrochloride (<b>25</b>)</h3><div class="NLM_p last">Prepared by hydrogenation (10% Pd/C, 1 atm H<sub>2</sub>, MeOH, rt) of di-Boc-protected <b>14</b> followed by Boc deprotection (4 N HCl/dioxane, rt). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 1.04–1.23 (m, 10H), 1.28–1.33 (m, 4H), 1.38–1.40 (m, 6H), 1.47–1.55 (m, 4H), 1.58–1.83 (m, 12H), 1.84–1.93 (m, 2H), 1.96–2.09 (m, 6H), 2.50–2.54 (m, 6H), 2.90–3.07 (m, 4H), 3.43–3.47 (m, 4H), 3.59–3.64 (m, 2H), 3.70–3.79 (m, 2H), 3.85–3.94 (m, 2H), 4.17–4.21 (m, 2H), 4.45–4.49 (m, 2H), 4.54–4.60 (m, 2H), 5.28–5.32 (m, 2H), 7.14–7.26 (m, 8H), 7.50–7.55 (m, 2H), 8.33–8.38 (m, 2H), 8.82–9.15 (m, 4H). LC–MS (M + H) 1024.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (<i>S</i>)-2-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)(methyl)amino)propanamido)-2-cyclohexylacetic Acid (<b>47</b>)</h3><div class="NLM_p last">Isobutyl chloroformate (4.04 g, 29.6 mmol) was added dropwise to a solution of Boc-<i>N</i>-Me-Ala-OH (5.00 g, 24.6 mmol) and 4-methylmorpholine (5.10 g, 50.4 mmol) in anhydrous THF (100 mL) at 0 °C. The mixture was allowed to stir at this temperature for 20 min and was then treated with a suspension of cyclohexylglycine methyl ester hydrochloride (5.11 g, 24.6 mmol) and 4-methylmorpholine (5.10 g, 50.4 mmol) in THF (50 mL) and CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The mixture was allowed to stir at 0 °C for 1 h and was then partitioned between EtOAc and water. The layers were separated, and the aqueous phase was extracted twice more with EtOAc. The combined organic layers were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated aqueous NaHCO<sub>3</sub>, and then brine and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (EtOAc/hexane = 10:1→ 5:1) to afford Boc-<i>N</i>-Me-Ala-Chg-OMe as a colorless solid (8.10 g, 22.7 mmol). This material was dissolved in acetone (50 mL), and the solution was cooled to 0 °C. A solution of LiOH·H<sub>2</sub>O (5.16 g, 123 mmol) in water (50 mL) was added, and the reaction mixture was allowed to stir at this temperature for 3 h. The mixture was then acidified with 2 N HCl to pH ∼3, and the volatile components were evaporated under reduced pressure. The residual material was partitioned between EtOAc and water, and the aqueous layer was further extracted with EtOAc (2×). The combined organic layers were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, and then brine and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the title compound as a solid (7.80 g, 93% over 2 steps). LC–MS (M + H) 343.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (<i>S</i>)-1-((<i>S</i>)-2-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)(methyl)amino)propanamido)-2-cyclohexylacetyl)pyrrolidine-2-carboxylic Acid (<b>48</b>)</h3><div class="NLM_p last">To a suspension of proline methyl ester hydrochloride (2.40 g, 14.6 mmol) and compound <b>47</b> (5.00 g, 14.6 mmol) in THF (100 mL) and DMF (10 mL) at 0 °C, DMTMM (8.08 g, 29.2 mmol) was added followed by 4-methylmorpholine (6.1 g, 60 mmol). The suspension was allowed to stir at room temperature overnight. The reaction mixture was then partitioned between EtOAc and water, and the aqueous layer was further extracted with EtOAc (2×). The combined organic layers were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated aqueous NaHCO<sub>3</sub>, and then brine and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by silica gel chromatography (EtOAc/hexane = 4:1 → 1:1) to afford Boc-<i>N</i>-Me-Ala-Chg-Pro-OMe as an oil (3.80 g, 8.38 mmol). A portion of this material (0.59 g, 1.30 mmol) was dissolved in acetone (20 mL), and the solution was cooled to 0 °C. A solution of LiOH·H<sub>2</sub>O (220 mg, 5.24 mmol) in water (20 mL) was added, and the reaction mixture was allowed to stir at 0 °C. After 3 h, the mixture was acidified with 2 N HCl to pH ∼3, and the volatile components were evaporated under reduced pressure. The residue was partitioned between EtOAc and water, and the aqueous layer was further extracted with EtOAc (2×). The combined organic layers were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, and then brine and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the title compound as a solid (0.40 g, 70%). LC–MS (M + H) 440.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Oxybis(ethane-2,1-diyl) Bis(4-methylbenzenesulfonate) (<b>49</b>)</h3><div class="NLM_p last">A solution of diethylene glycol (10.0 g, 94.2 mmol) and triethylamine (39.0 mL, 280 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (200 mL) was cooled to 0 °C. A solution of <i>p</i>-toluenesulfonyl chloride (36.0 g, 189 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (100 mL) was added dropwise over 20 min, and the resulting suspension was allowed to stir at room temperature overnight. Water (200 mL) was added to quench the reaction, and the organic layer was separated and was washed with 5% aqueous KHSO<sub>4</sub> and then brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to dryness. The residue was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH = 20:1) to afford the title compound as a colorless solid (25.3 g, 65%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 2.47 (s, 6H), 3.61–3.65 (m, 4H), 4.09–4.18 (m, 4H), 7.36 (d, <i>J</i> = 8.4 Hz, 4H), 7.80 (d, <i>J</i> = 8.4 Hz, 4H).</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-2,2′-((Oxybis(ethane-2,1-diyl))bis(oxy))bis(2,3-dihydro-1<i>H</i>-inden-1-amine) (<b>50</b>)</h3><div class="NLM_p last">A solution of (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-amino-2-indanol (1.49 g, 10.0 mmol) in anhydrous THF (50 mL) was added slowly to a suspension of NaH (60% dispersion in mineral oil; 0.40 g, 10 mmol) in THF (20 mL) at 0 °C. The reaction mixture was allowed to warm to room temperature over 30 min and was then heated to reflux. A solution of compound <b>49</b> (1.88 g, 4.54 mmol) in anhydrous THF (20 mL) was added dropwise to this suspension. The mixture was heated for 5 h before being allowed to cool. The mixture was carefully quenched with water (∼300 mL) and was extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic extracts were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (CH<sub>2</sub>Cl<sub>2</sub>/MeOH/NH<sub>4</sub>OH = 50:1:0.1 → 20:1:0.1) to afford the product as an oil (1.10 g, 66%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ ppm 2.99–3.06 (m, 4H), 3.70–3.90 (m, 8H), 4.17 (m, 2H), 4.33 (m, 2H), 7.11–7.26 (m, 6H), 7.47 (m, 2H). LC–MS (M + H) 369.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-((1<i>S</i>,1′<i>S</i>,2<i>R</i>,2′<i>R</i>)-((Oxybis(ethane-2,1-diyl))bis(oxy))bis(2,3-dihydro-1<i>H</i>-indene-2,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) Dihydrochloride (<b>26</b>)</h3><div class="NLM_p last">A suspension of <b>48</b> (0.77 g, 1.75 mmol) and <b>50</b> (0.29 g, 0.79 mmol) in THF (30 mL) and DMF (50 mL) was cooled to 0 °C and was then treated with DMTMM (0.97 g, 3.5 mmol). 4-Methylmorpholine (0.70 g, 6.9 mmol) was added, and the mixture was allowed to stir at room temperature overnight before being partitioned between EtOAc and water. The aqueous layer was further extracted with EtOAc, and the combined organic layers were washed sequentially with water, 5% aqueous KHSO<sub>4</sub>, saturated NaHCO<sub>3</sub>, and then brine and were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The residue was purified by preparative HPLC to afford the di-Boc-protected intermediate as a solid (360 mg). This was treated with a 4 N solution of HCl in dioxane (10 mL) at 0 °C. The mixture was allowed to stir at this temperature for 4 h and was then concentrated under reduced pressure. The residue was dissolved in MeOH and was reconcentrated (3×) to give the title compound a a colorless solid (312 mg, 36% over two steps). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ ppm 0.75–1.45 (m, 16H), 1.50–2.12 (m, 14H), 2.32–2.57 (m, 6H), 2.83–3.11 (m, 4H), 3.26–3.68 (m, 8H), 3.68–4.32 (m, 14H), 4.32–4.70 (m, 4H), 5.16–5.39 (m, 2H), 7.03–7.32 (m, 8H), 7.88–8.10 (m, 2H), 8.67–9.09 (m, 4H), 9.52–9.84 (m, 2H). LC–MS (M + H) 1012.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> 1-(Prop-2-yn-1-yl)-1,2,3,4-tetrahydroquinoline-4-carboxylic Acid (<b>51</b>)</h3><div class="NLM_p last">A Parr shaker bottle was charged with quinoline-4-carboxylic acid (5.00 g, 28.9 mmol), MeOH (120 mL), and concentrated HCl (4.0 mL). Raney Nickel (purchased as a slurry in water; approximately 10 g) was added, and the vessel was sealed on a Parr shaker. The bottle was degassed and flushed with H<sub>2</sub> and was then pressurized with H<sub>2</sub> to 60 psi. The mixture was shaken at room temperature overnight. Additional Raney Nickel (∼10 g) was added, and the reaction was continued for an additional 24 h. The vessel was put under an N<sub>2</sub> atmosphere, and the mixture was then suction filtered through a pad of Celite. The filtrate was concentrated under reduced pressure to give crude 1,2,3,4-tetrahydroquinoline-4-carboxylic acid. A portion of this material (2.56 g, 14.4 mmol) was dissolved in acetonitrile (100 mL) and MeOH (40 mL). Potassium carbonate (5.99 g, 43.3 mmol) was added followed by propargyl bromide (80% solution in toluene; 2.1 mL, 19.0 mmol). The reaction mixture was allowed to stir at room temperature for 3 days and was then concentrated under reduced pressure. The residue was diluted with water and was acidified with 1 N HCl until pH 4 to 5. The mixture was extracted with EtOAc (3×). The combined organic extracts were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (0–100% EtOAc in hexanes) to give the product as a yellow solid (1.87 g, 60% over two steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.91–2.02 (m, 1H), 2.10–2.21 (m, 1H), 3.02–3.05 (m, 1H), 3.13–3.20 (m, 1H), 3.26–3.36 (m, 1H), 3.64–3.69 (m, 1H), 3.96–4.04 (m, 1H), 4.12–4.20 (m, 1H), 6.59–6.66 (m, 1H), 6.74–6.79 (m, 1H), 7.03–7.11 (m, 2H), 12.39 (br s, 1H). LC–MS (M + H) 216.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>tert</i>-Butyl (1-(Prop-2-yn-1-yl)-1,2,3,4-tetrahydroquinolin-4-yl)carbamate (<b>52</b>)</h3><div class="NLM_p last">A mixture of <b>51</b> (1.43 g, 6.66 mmol), diphenyl phosphorazidate (2.88 mL, 13.3 mmol), and triethylamine (2.32 mL, 16.6 mmol) in anhydrous <i>tert</i>-butanol (32 mL) was heated at reflux overnight. The reaction was allowed to cool and was concentrated under reduced pressure. The residue was purified by silica gel chromatography (0–25% EtOAc in hexanes) to give the racemic product (1.16 g, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.42 (s, 9H), 1.82–1.93 (m, 1H), 1.93–2.01 (m, 1H), 3.05–3.08 (m, 1H), 3.20–3.26 (m, 2H), 3.95–4.03 (m, 1H), 4.08–4.16 (m, 1H), 4.56–4.66 (m, 1H), 6.60–6.67 (m, 1H), 6.69–6.74 (m, 1H), 7.00–7.09 (m, 2H), 7.13–7.21 (m, 1H). LC–MS (M + H) 287. This racemic material was subjected to supercritical fluid chromatography with a chiral column to give the separate enantiomers (0.52 g each, >98% ee) that were carried on separately to the respective final products.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 1-(Prop-2-yn-1-yl)-1,2,3,4-tetrahydroquinolin-4-amine Dihydrochloride (<b>53</b>)</h3><div class="NLM_p last">Hydrochloric acid (4 N in dioxane; 20 mL, 80 mmol) was added to <b>52</b> (0.52 g, 1.80 mmol). The resulting solution was allowed to stir at room temperature for 2 h and was then concentrated under reduced pressure to afford the title compound as colorless solid (0.40 g, 86%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 2.04–2.22 (m, 2H), 3.11–3.15 (m, 1H), 3.22–3.36 (m, 2H), 4.10–4.16 (m, 2H), 4.35–4.44 (m, 1H), 6.64 (br s, 1H), 6.69–6.76 (m, 1H) 6.81–6.87 (m, 1H) 7.17–7.24 (m, 1H), 7.33–7.39 (m 1H), 8.45 (br s, 3H). LC–MS (M + H) 187.</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-(1,1′-(Hexa-2,4-diyne-1,6-diyl)bis(1,2,3,4-tetrahydroquinoline-4,1-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) (<b>27</b>)</h3><div class="NLM_p last">HOBt hydrate (165 mg, 1.08 mmol) and DIPEA (0.47 mL, 2.70 mmol) were added to a mixture of compounds <b>48</b> (396 mg, 0.90 mmol) and <b>53</b> (200 mg, 0.90 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (8.5 mL), and the mixture was cooled to 0 °C. EDCI (207 mg, 1.08 mmol) was added, and the reaction mixture was then allowed to warm to room temperature and was allowed to stir overnight. The mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> and was washed sequentially with 10% aqueous citric acid, saturated NaHCO<sub>3</sub>, and then brine and was dried (MgSO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (0–100% EtOAc/hexane) to give the intermediate Boc-protected monomer as a colorless solid (341 mg, 0.56 mmol). To this material were added copper(II) acetate (153 mg, 0.84 mmol), pyridine (0.18 mL, 2.24 mmol), and acetonitrile (5 mL), and the mixture was heated at 80 °C for 3 h. On cooling, the mixture was partitioned between EtOAc and water. The aqueous layer was extracted with EtOAc, and the combined organic layers were concentrated under reduced pressure. The crude Boc-protected dimer was thus obtained as a yellow solid, which was directly treated with hydrochloric acid (4 N in dioxane; 6.0 mL, 24 mmol). The solution was allowed to stir at room temperature for 2 h and was then concentrated under reduced pressure. The crude product was purified by reverse-phase HPLC to afford the title compound a colorless solid (110 mg). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>, 100 °C) δ ppm 0.96–1.26 (m, 16H), 1.52–1.82 (m, 14H), 1.82–2.12 (m, 12H), 2.25 (s, 6H), 2.94–3.04 (m, 2H), 3.16–3.34 (m, 4H), 3.52–3.66 (m, 2H), 3.68–3.83 (m, 2H), 4.11–4.28 (m, 4H), 4.34–4.56 (m, 4H), 4.82–4.97 (m, 2H), 6.59–6.68 (m, 2H), 6.68–6.75 (m, 2H), 7.03–7.22 (m, 4H), 7.49–7.64 (m, 2H), 7.64–7.78 (m, 2H). LC–MS (M + H) 1014.</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> Methyl 2-((<i>S</i>)-1-((<i>S</i>)-2-((<i>S</i>)-2-(<i>tert</i>-Butoxycarbonyl(methyl)amino)propanamido)-2-cyclohexylacetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-indene-2-carboxylate (<b>54</b>)</h3><div class="NLM_p last">Compound <b>48</b> (310 mg, 0.71 mmol) was dissolved in DMF (4 mL), and the solution was cooled to 0 °C. EDCI (203 mg, 1.06 mmol), HOBt hydrate (162 mg, 1.06 mmol), and 4-methylmorpholine (233 μL, 2.12 mmol) were added. The mixture was allowed to stir at 0 °C for 10 min, and then methyl 2-amino-2,3-dihydro-1<i>H</i>-indene-2-carboxylate (135 mg, 0.71 mmol) was added. The reaction was allowed to stir at 0 °C with slow warming to room temperature overnight. The mixture was then partitioned between EtOAc and water. The organic layer was washed with water and was then dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (EtOAc in hexanes gradient) to afford the title compound as a colorless solid (298 mg, 69%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 0.92–1.43 (m, 10H), 1.48–1.58 (m, 9H), 1.66–1.96 (m, 6H), 1.96–2.24 (m, 4H), 2.87–2.94 (m, 3H), 3.24–3.43 (m, 2H), 3.51–3.62 (m, 1H), 3.69–3.81 (m, 5H), 3.87–3.96 (m, 1H), 4.41–4.47 (m, 1H), 4.49–4.56 (m, 1H), 4.58–4.70 (m, 1H), 7.18–7.32 (m, 4H). LC–MS (M + H) 613.</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> 2-((<i>S</i>)-1-((<i>S</i>)-2-((<i>S</i>)-2-((<i>tert</i>-Butoxycarbonyl)(methyl)amino)propanamido)-2-cyclohexylacetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-indene-2-carboxylic acid (<b>55</b>)</h3><div class="NLM_p last">Compound <b>54</b> (298 mg, 0.49 mmol) was dissolved in methanol (2.5 mL) and water (2.5 mL), and the solution was treated with NaOH (80 mg, 2.00 mmol). The mixture was allowed to stir at room temperature for 2 h and was then concentrated under reduced pressure. The residue was partitioned between EtOAc and 1 N aqueous HCl, and the organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated to give the product as a solid (290 mg, 98%). LC–MS (M +H) 599. This material was used without further purification.</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>tert</i>-Butyl ((<i>S</i>)-1-(((<i>S</i>)-1-Cyclohexyl-2-oxo-2-((<i>S</i>)-2-((2-(prop-2-yn-1-ylcarbamoyl)-2,3-dihydro-1<i>H</i>-inden-2-yl)carbamoyl)pyrrolidin-1-yl)ethyl)amino)-1-oxopropan-2-yl)(methyl)carbamate (<b>56</b>)</h3><div class="NLM_p last">Compound <b>55</b> (290 mg, 0.48 mmol) was dissolved in DMF (5 mL), and the solution was cooled to 0 °C. EDCI (139 mg, 0.73 mmol), HOBt hydrate (111 mg, 0.73 mmol), and 4-methylmorpholine (213 μL, 1.94 mmol) were added, and the mixture was allowed to stir at 0 °C for 15 min before propargylamine (32 mg, 0.58 mmol) was added. The mixture was allowed to warm to room temperature overnight and was then partitioned between EtOAc and water. The organic layer was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (EtOAc in hexanes gradient) to give the title compound as a colorless solid (100 mg, 33%). LC–MS (M + H) 636. This material was used without further purification.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (<i>S</i>,<i>S</i>,2<i>S</i>,2′<i>S</i>)-<i>N</i>,<i>N</i>′-(2,2′-(Hexa-2,4-diyne-1,6-diylbis(azanediyl))bis(oxomethylene)bis(2,3-dihydro-1<i>H</i>-indene-2,2-diyl))bis(1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamide) Bistrifluoroacetate (<b>28</b>)</h3><div class="NLM_p last">Boc-protected monomer <b>56</b> (90 mg, 0.14 mmol) was dissolved in acetonitrile (4 mL), and the solution was heated at 70 °C. To this were added copper(II) acetate (129 mg, 0.71 mmol) and triethylamine (200 μL, 1.43 mmol). The mixture was heated for 1 h and was then allowed to cool. The mixture was filtered through a short plug of silica gel, eluting with EtOAc. Concentration under reduced pressure afforded the di-Boc-protected dimer (75 mg). This material was dissolved in methanol (5 mL), and the solution was treated with gaseous HCl and was allowed to stir at room temperature overnight. The mixture was concentrated under reduced pressure, and the crude material was purified by reverse-phase HPLC (gradient of acetonitrile in H<sub>2</sub>O containing 0.1% trifluoroacetic acid) to give the title compound (bistrifluoroacetate salt) as a colorless solid (19 mg). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 0.94–1.39 (m, 10H), 1.39–1.58 (m, 6H), 1.64–1.94 (m, 16H), 1.96–2.26 (m, 6H), 2.52–2.79 (m, 6H), 3.12–3.54 (m, 6H), 3.56–4.05 (m, 10H), 4.08–4.35 (m, 4H), 4.38–4.61 (m, 2H), 5.41–5.57 (m, 2H), 7.05–7.35 (m, 8H) 8.22–8.40 (m, 2H), 8.71–8.89 (m, 2H). LC–MS (M + H) 1070. Purity: 90%.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>tert</i>-Butyl Dichlorocarbamate (<b>57</b>)</h3><div class="NLM_p last">To a mixture of <i>tert</i>-butyl carbamate (2.00 g, 17.1 mmol) and calcium hypochlorite (4.89 g, 34.2 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (40 mL) cooled to 0 °C was added 4 M aqueous HCl (22.5 mL) over 45 min. The biphasic mixture was allowed to stir at 0 °C for 1 h, and then the layers were separated. The organic layer was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, and filtered. Evaporation of the solvent under reduced pressure provided the product as a liquid (2.67 g, 84%) that was used without further purification.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>trans</i>-<i>tert</i>-Butyl (1-Chloro-2,3-dihydro-1<i>H</i>-inden-2-yl)carbamate (<b>58</b>)</h3><div class="NLM_p last">Under a N<sub>2</sub> atmosphere, indene (1.23 g, 10.6 mmol) was added dropwise to a solution of <b>57</b> (2.00 g, 10.8 mmol) in anhydrous toluene (20 mL) at a rate such that the reaction temperature was maintained at 35–40 °C. The resulting solution was heated at 40 °C for an additional 2 h before being cooled to 5–10 °C. The reaction was quenched with a 20% aqueous solution of NaHSO<sub>3</sub> (11 mL) and was allowed to stir for 1.5 h. The mixture was partitioned between EtOAc and water, and the organic layer was washed with brine and dried over Na<sub>2</sub>SO<sub>4</sub>. The mixture was filtered and concentrated under reduced pressure to give the product as a solid (2.5 g, 88%). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.57 (s, 9H), 3.22–3.25 (m, 2H), 5.28–5.35 (m, 1H), 5.55–5.59 (m, 1H), 7.20–7.37 (m, 4H), 7.40–7.45 (m, 1H). LC–MS (M + H) 255.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> <i>cis</i>-<i>tert</i>-Butyl (1-Azido-2,3-dihydro-1<i>H</i>-inden-2-yl)carbamate (<b>59</b>)</h3><div class="NLM_p last">Compound <b>58</b> (18.0 g, 67.4 mmol) was dissolved in anhydrous DMF (130 mL), and the solution was treated with NaN<sub>3</sub> (21.9 g, 337 mmol). The suspension was allowed to stir at room temperature under a N<sub>2</sub> atmosphere overnight. The mixture was then partitioned between ethyl acetate and water, and the organic layer was washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (petroleum ether/ethyl acetate = 20:1) to give the title compound as a solid (14.8 g, 80%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.41 (s, 9H), 2.85–3.03 (m, 2H), 4.16–4.25 (m, 1H), 4.92–5.02 (m, 1H), 7.20–7.35 (m, 4H), 7.38–7.47 (m, 1H). LC–MS (M + H) 275.</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> <i>cis</i>-<i>tert</i>-Butyl (1-Amino-2,3-dihydro-1<i>H</i>-inden-2-yl)carbamate (<b>60</b>)</h3><div class="NLM_p last">To a solution of <b>59</b> (15.9 g, 57.8 mmol) in ethanol (1.0 L) was added 5% Pd/C (4.0 g), and the mixture was allowed to stir under 1 atm H<sub>2</sub> at room temperature for 22 h. The catalyst was removed by filtration, and the filtrate was concentrated under reduced pressure to give the title compound as a solid (11.0 g, 77%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.37 (s, 9H), 2.70–2.82 (m, 1H), 2.86–3.00 (m, 1H), 3.96–4.09 (m, 1H), 4.10–4.17 (m, 1H), 7.20–7.63 (m, 5H), −NH<sub>2</sub> resonances were not observed. LC–MS (M + H) 249.</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>tert</i>-Butyl (1<i>S</i>,2<i>R</i>)-1-((<i>S</i>)-Pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-ylcarbamate (<b>61</b>)</h3><div class="NLM_p last">A round-bottomed flask was charged with Fmoc-Pro-OH (4.12 g, 12.2 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (15 mL), and then HATU (5.50 g, 14.5 mmol) was added followed by DIPEA (6.33 mL, 36.2 mmol). The solution was allowed to stir at room temperature for 15 min, and then a solution of <b>60</b> (3.00 g, 12.1 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (15 mL) was added dropwise. The mixture was allowed to stir at room temperature overnight and was then partitioned between EtOAc and water. The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. The crude material was purified by silica gel chromatography (30% THF in hexanes) to give the Fmoc-protected intermediate (mixture of diastereomers) as a colorless solid (6.12 g, 10.8 mmol). This material was treated with ethylamine (2 M solution in THF; 160 mL, 320 mmol), and the solution was allowed to stir at room temperature. After 3 h, the mixture was concentrated under reduced pressure, the residue was treated with CH<sub>2</sub>Cl<sub>2</sub>, and the insoluble portion was removed by filtration. The filtrate was concentrated, and the crude material was purified by silica gel chromatography (0 to 100% THF in hexanes gradient) to give the separated diastereomers: 1.17 g of the undesired diastereomer with the (1R,2S) configuration at the indane ring was obtained along with 1.31 g of the diastereomer with the desired (1S,2R) configuration at the indane ring (<b>61</b>). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 1.37 (s, 9H), 1.53–1.65 (m, 2H), 1.72–1.84 (m, 1H), 1.89–2.03 (m, 1H), 2.65–2.90 (m, 4H), 3.05–3.16 (m, 1H), 3.52–3.60 (m, 1H), 4.31 (br s, 1H), 5.25–5.35 (m, 1H), 6.85–6.94 (m, 1H), 7.06–7.14 (m, 1H), 7.14–7.26 (m, 3H), 8.03–8.12 (m, 1H). LC–MS (M + H) 346.</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>tert</i>-Butyl (1<i>S</i>,2<i>R</i>)-1-((<i>S</i>)-1-((<i>S</i>)-2-Amino-2-cyclohexylacetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-ylcarbamate (<b>62</b>)</h3><div class="NLM_p last">A round-bottomed flask was charged with Fmoc-Chg–OH (1.29 g, 3.41 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (4 mL). HATU (1.29 g, 3.41 mmol) was added followed by DIPEA (1.6 mL, 9.3 mmol), and the resulting mixture was allowed to stir at room temperature for 15 min. A solution of <b>61</b> (1.07 g, 3.10 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (10 mL) was then added, and the reaction was allowed to stir at room temperature. After 90 min, the reaction mixture was concentrated under reduced pressure, and the crude material was purified by silica gel chromatography (0 to 100% THF in hexanes gradient) to give the Fmoc-protected product as a solid (2.0 g). A portion of this material (1.40 g, 1.98 mmol) was dissolved in ethylamine (2 M solution in THF; 15 mL, 30 mmol), and the solution was allowed to stir at room temperature. After 1 h, the mixture was concentrated under reduced pressure, the residue was treated with CH<sub>2</sub>Cl<sub>2</sub>, and the insoluble portion was removed by filtration. The filtrate was concentrated, and the crude material was purified by silica gel chromatography (0 to 100% THF in hexanes gradient) to give the title compound as a colorless solid (966 mg). LC–MS (M + H) 485.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (<i>S</i>)-((<i>S</i>)-2-((<i>S</i>)-2-((1<i>S</i>,2<i>R</i>)-2-Amino-2,3-dihydro-1<i>H</i>-inden-1-ylcarbamoyl)pyrrolidin-1-yl)-1-cyclohexyl-2-oxoethyl) 2-((((9<i>H</i>-fluoren-9-yl)methoxy)carbonyl)(methyl)amino)propanoate Hydrochloride (<b>63</b>)</h3><div class="NLM_p last">A round-bottomed flask was charged with Fmoc-<i>N</i>-Me-Ala-OH (470 mg, 1.44 mmol) and HATU (603 mg, 1.59 mmol). CH<sub>2</sub>Cl<sub>2</sub> (4 mL) and DIPEA (0.76 mL, 4.3 mmol) were added, and the resulting solution was allowed to stir at room temperature for 15 min. A solution of <b>62</b> (0.70 g, 1.44 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (4 mL) was then added dropwise, and the reaction was allowed to stir at room temperature. After 1 h, the reaction mixture was concentrated under reduced pressure, and the crude material was purified by silica gel chromatography (0 to 100% THF in hexanes gradient) to give the fully protected monomer as a solid (1.1 g). This material was dissolved in 4 N HCl/dioxane (5 mL, 20 mmol), and the solution was allowed to stir at room temperature for 1 h. The mixture was then concentrated under reduced pressure to give the title compound as a colorless solid (1.0 g, 99% over two steps). <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 0.98–1.36 (m, 9H), 1.63–1.93 (m, 7H), 1.94–2.08 (m, 1H), 2.09–2.32 (m, 3H), 2.79–2.94 (m, 4H), 3.12–3.24 (m, 1H), 3.36–3.47 (m, 1H), 3.61–3.74 (m, 1H), 3.90–4.04 (m, 1H), 4.15–4.26 (m, 1H), 4.27–4.36 (m, 1H), 4.36–4.44 (m, 1H), 4.44–4.53 (m, 3H), 4.55–4.70 (m, 1H), 5.47–5.56 (m, 1H), 7.28–7.40 (m, 5H), 7.41–7.49 (m, 4H), 7.60–7.70 (m, 2H), 7.81–7.91 (m, 3H). LC–MS (M + H) 693.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>1,<i>N</i>4-Bis((1<i>S</i>,2<i>R</i>)-1-((<i>S</i>)-1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-yl)terephthalamide (<b>29</b>)</h3><div class="NLM_p last">A round-bottomed flask was charged with <b>63</b> (615 mg, 0.84 mmol) and anhydrous THF (10 mL), and the mixture was cooled to 0 °C. To this was added DIPEA (0.29 mL, 1.68 mmol) and finally a solution of terephthaloyl dichloride (85 mg, 0.42 mmol) in anhydrous THF (1 mL). The mixture was allowed to stir at 0 °C for 1 h and was then partitioned between EtOAc and water. The organic layer was washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure to give the crude di-Fmoc-protected dimer as a solid (611 mg). This was treated directly with ethylamine (2 M in THF, 15 mL, 30 mmol), and the resulting solution was allowed to stir at room temperature. After 1 h, the reaction was concentrated under reduced pressure, and the crude material was purified by reverse-phase HPLC. Lyophilization from a CH<sub>3</sub>CN/H<sub>2</sub>O solution afforded the title compound as a colorless solid (80 mg, 18% over two steps). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 0.84–1.02 (m, 4H), 1.02–1.24 (m, 12H), 1.45–1.87 (m, 20H), 2.10–2.21 (m, 6H), 2.86–2.97 (m, 2H), 2.98–3.10 (m, 2H), 3.12–3.26 (m, 4H), 3.45–3.58 (m, 2H), 3.59–3.71 (m, 2H), 4.25–4.33 (m, 2H), 4.34–4.42 (m, 2H), 4.77–4.88 (m, 2H), 5.37–5.50 (m, 2H), 7.19–7.35 (m, 8H), 7.79–7.86 (m, 2H), 7.87–7.92 (m, 4H), 7.97–8.05 (m, 2H), 8.12–8.21 (m, 2H). LC–MS (M + H) 1070.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>N</i>4,<i>N</i>4′-Bis((1<i>S</i>,2<i>R</i>)-1-((<i>S</i>)-1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-yl)biphenyl-4,4′-dicarboxamide (<b>30</b>)</h3><div class="NLM_p last">Prepared from <b>63</b> as described for compound <b>29</b> using biphenyl-4,4′-dicarbonyl dichloride. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 0.98–1.22 (m, 6H), 1.22–1.41 (m, 10H), 1.62–1.94 (m, 14H), 1.94–2.15 (m, 6H), 2.35–2.50 (m, 6H), 3.11–3.24 (m, 2H), 3.24–3.33 (m, 2H), 3.37–3.47 (m, 2H), 3.63–3.75 (m, 2H), 3.83–3.96 (m, 2H), 4.36–4.60 (m, 4H), 4.98–5.12 (m, 2H), 5.54–5.68 (m, 2H), 7.25–7.40 (m, 6H), 7.42–7.50 (m, 2H), 7.74–7.86 (m, 4H), 7.94–8.03 (m, 4H), −NH resonances were not observed. LC–MS (M + H) 1146. Purity: 93%.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>N</i>1,<i>N</i>10-Bis((1<i>S</i>,2<i>R</i>)-1-((<i>S</i>)-1-((<i>S</i>)-2-cyclohexyl-2-((<i>S</i>)-2-(methylamino)propanamido)acetyl)pyrrolidine-2-carboxamido)-2,3-dihydro-1<i>H</i>-inden-2-yl)decanediamide (<b>31</b>)</h3><div class="NLM_p last">Prepared from <b>63</b> as described for compound <b>29</b> using decanedioyl dichloride. <sup>1</sup>H NMR (300 MHz, CD<sub>3</sub>OD) δ ppm 0.96–1.15 (m, 4H), 1.15–1.38 (m, 20H), 1.52–1.89 (m, 16H), 1.90–2.24 (m, 12H), 2.26–2.33 (m, 6H), 2.85–2.96 (m, 2H), 3.06–3.16 (m, 2H), 3.16–3.27 (m, 2H), 3.63–3.74 (m, 2H), 3.85–3.96 (m, 2H), 4.39–4.53 (m, 4H), 4.74–4.81 (m, 2H), 5.37–5.46 (m, 2H), 7.18–7.30 (m, 6H), 7.32–7.40 (m, 2H), −NH resonances were not observed. LC–MS (M + H) 1106.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i87"><a href="/doi/suppl/10.1021/jm401075x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07106" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07106" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Procedures for cIAP1, cIAP2, and XIAP binding assays, MDA-MB-231 cell assays, in vivo experiments, and pharmacokinetic experiments; representative fluorescence polarization titration curves for compound <b>14</b>; western blots of MDA-MB-231 cells treated with different concentrations of <b>14</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401075x/suppl_file/jm401075x_si_001.pdf">jm401075x_si_001.pdf (664.94 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm401075x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54604" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54604" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward J. Hennessy</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#640100130516004a0c010a0a0117171d2405171016051e010a0107054a070b09"><span class="__cf_email__" data-cfemail="c2a7a6b5a3b0a6ecaaa7acaca7b1b1bb82a3b1b6b0a3b8a7aca7a1a3eca1adaf">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ammar Adam</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian M. Aquila</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lillian M. Castriotta</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald Cook</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maureen Hattersley</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexander W. Hird</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Huntington</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor M. Kamhi</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Naomi M. Laing</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Danyang Li</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Terry MacIntyre</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles A. Omer</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vibha Oza</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Troy Patterson</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Galina Repik</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael T. Rooney</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jamal C. Saeh</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Li Sha</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa M. Vasbinder</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiyun Wang</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David Whitston</span> - <span class="hlFld-Affiliation affiliation">Oncology iMed, Innovative
Medicines & Early Development, AstraZeneca
R&D Boston, 35 Gatehouse
Drive, Waltham, Massachusetts 02451, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3698e5541-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i88">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07874" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07874" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are grateful to Kanayo Azogu, Natascha Bezdenejnih-Snyder, Nancy DeGrace, Ziling Lu, and Bridget Reaney for analytical and purification support.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i89" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i89"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i90" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i90"> Abbreviations Used</h2><tr><td class="NLM_term">IAP</td><td class="NLM_def"><p class="first last">inhibitor of apoptosis proteins</p></td></tr><tr><td class="NLM_term">BIR</td><td class="NLM_def"><p class="first last">baculovirus IAP repeat</p></td></tr><tr><td class="NLM_term">XIAP</td><td class="NLM_def"><p class="first last">X chromosome-linked inhibitor of apoptosis protein</p></td></tr><tr><td class="NLM_term">cIAP1</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein 1</p></td></tr><tr><td class="NLM_term">cIAP2</td><td class="NLM_def"><p class="first last">cellular inhibitor of apoptosis protein 2</p></td></tr><tr><td class="NLM_term">AVPI</td><td class="NLM_def"><p class="first last">alanine–valine–proline–isoleucine</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">NPSA</td><td class="NLM_def"><p class="first last">nonpolar surface area</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term"><i>Q</i><sub>H</sub></td><td class="NLM_def"><p class="first last">hepatic blood flow rate</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>ss</sub></td><td class="NLM_def"><p class="first last">volume of distribution at steady state</p></td></tr><tr><td class="NLM_term"><i>t</i><sub>1/2</sub></td><td class="NLM_def"><p class="first last">plasma half-life</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term"><i>k</i><sub>off</sub></td><td class="NLM_def"><p class="first last">off rate</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">MTS</td><td class="NLM_def"><p class="first last">[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl-2<i>H</i>-tetrazolium]</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immunodeficiency</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>0</sub></td><td class="NLM_def"><p class="first last">initial plasma concentration</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">1-hydroxybenzotriazole hydrate</p></td></tr><tr><td class="NLM_term">Boc-Pro-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-1-(<i>tert</i>-butoxycarbonyl)pyrrolidine-2-carboxylic acid</p></td></tr><tr><td class="NLM_term">Boc-Tle-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-2-[(<i>tert</i>-butoxycarbonyl)amino]-3,3-dimethylbutanoic acid</p></td></tr><tr><td class="NLM_term">Boc-<i>N</i>-Me-Ala-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-2-[(<i>tert</i>-butoxycarbonyl)(methyl)amino]propanoic acid</p></td></tr><tr><td class="NLM_term">DMTMM</td><td class="NLM_def"><p class="first last">4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl-morpolinium chloride</p></td></tr><tr><td class="NLM_term">Chg-OMe·HCl</td><td class="NLM_def"><p class="first last">methyl (2<i>S</i>)-amino(cyclohexyl)ethanoate hydrochloride</p></td></tr><tr><td class="NLM_term">Pro-OMe·HCl</td><td class="NLM_def"><p class="first last">methyl (2<i>S</i>)-pyrrolidine-2-carboxylate hydrochloride</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphophoryl azide</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">Fmoc-Pro-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-1-[(9<i>H</i>-fluoren-9-ylmethoxy)carbonyl]pyrrolidine-2-carboxylic acid</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last">(dimethylamino)-<i>N</i>,<i>N</i>-dimethyl(3<i>H</i>-[1,2,3]triazolo[4,5-<i>b</i>]pyridin-3-yloxy)methaniminium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">Fmoc-Chg-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-2-{[(9<i>H</i>-fluoren-9-ylmethoxy)carbonyl](methyl)amino}-2-cyclohexylacetic acid</p></td></tr><tr><td class="NLM_term">Fmoc-<i>N</i>-Me-Ala-OH</td><td class="NLM_def"><p class="first last">(2<i>S</i>)-2-{[(9<i>H</i>-fluoren-9-ylmethoxy)carbonyl](methyl)amino}propanoic acid</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46460" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46460" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 58 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Kerr, J. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, A. R.</span><span> </span><span class="NLM_article-title">Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+R.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+A+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2eYLHA2AZhASFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520A%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Carson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribiero, J. M.</span><span> </span><span class="NLM_article-title">Apoptosis and disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1993&pages=1251-1254&author=D.+A.+Carsonauthor=J.+M.+Ribiero&title=Apoptosis+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DD.%2BA.%26aulast%3DRibiero%26aufirst%3DJ.%2BM.%26atitle%3DApoptosis%2520and%2520disease%26jtitle%3DLancet%26date%3D1993%26volume%3D341%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Solary, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eymin, B.</span><span> </span><span class="NLM_article-title">The role of apoptosis in the pathogenesis and treatment of disease</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1183%2F09031936.96.09061293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1293-1305&author=E.+Solaryauthor=L.+Dubrezauthor=B.+Eymin&title=The+role+of+apoptosis+in+the+pathogenesis+and+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of apoptosis in the pathogenesis and treatment of diseases</span></div><div class="casAuthors">Solary E; Dubrez L; Eymin B</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-305</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">In adult multicellular organisms, homeostasis is determined in each cell lineage by a balance between cell death and cell growth.  Dysregulation of cell death mechanisms is involved in the pathogenesis of an increasing number of diseases.  Defective apoptosis can participate in malignant transformation, viral latency and autoimmune diseases.  Excessive apoptotic cell death is involved in CD4+ T-cell depletion observed in acquired immune deficiency syndrome, in fulminant hepatitis associated with infection by hepatitis B and C viruses, in some neurodegenerative disorders and haematological diseases, in polycystic kidney disease and ischaemia.  Three steps can be distinguished in the pathway that leads to cell death.  The first step involves interactions between the extracellular and intracellular signals that decide whether a cell should live or die.  When death is chosen, a common pathway that involves at least the Bcl-2- family of proteins and the interleukin-1 beta (IL-1 beta)-converting enzyme-related cysteine proteases confirms whether or not the cell should die.  Finally, if death is allowed to occur, the apoptotic process itself is characterized by deoxyribonucleic acid (DNA) fragmentation, proteolysis and morphological changes that precede the engulfment of apoptotic cells by neighbouring cells and phagocytes.  Several inducers and inhibitors of apoptosis acting on one or several of these three steps that characterize the apoptotic process have been identified in vitro.  Their potential usefulness in improving the current therapeutic strategies and designing new strategies in several different diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSstdFlp_TrSMyail4HZd-ifW6udTcc2eYLHA2AZhASFrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D&md5=d297625b8ca78684e2fa14dc36e24605</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09031936.96.09061293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.96.09061293%26sid%3Dliteratum%253Aachs%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DEymin%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520apoptosis%2520in%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520disease%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1996%26volume%3D9%26spage%3D1293%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lh4wn5wMKLccQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, C. S.</span><span> </span><span class="NLM_article-title">IAP proteins: Blocking the road to death’s door</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+Blocking+the+road+to+death%E2%80%99s+door"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0lh4wn5wMKLccQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520Blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Gyrd-Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">IAPs: From caspase inhibitors to modulators of NF-κB, inflammation, and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrc2889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20651737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=561-574&author=M.+Gyrd-Hansenauthor=P.+Meier&title=IAPs%3A+From+caspase+inhibitors+to+modulators+of+NF-%CE%BAB%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-574</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are assocd. with chemoresistance, disease progression, and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacol. inhibitors of IAPs.  The development of such inhibitors has radically changed our knowledge of the signaling processes that are regulated by IAPs.  Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signaling and immunity, mitogenic kinase signaling, proliferation and mitosis, as well as cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNte9JiwXrbVg90H21EOLACvtfcHk0lh4wn5wMKLccQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D&md5=7cf8b18a0d79f00b36aa0b9caf9d66ed</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2889%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%253A%2520From%2520caspase%2520inhibitors%2520to%2520modulators%2520of%2520NF-%25CE%25BAB%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D561%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Shiozaki, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Mechanism of XIAP-mediated inhibition of caspase-9</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS1097-2765%2803%2900054-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12620238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=519-527&author=E.+N.+Shiozakiauthor=J.+Chaiauthor=D.+J.+Rigottiauthor=S.+J.+Riedlauthor=P.+Liauthor=S.+M.+Srinivasulaauthor=E.+S.+Alnemriauthor=R.+Fairmanauthor=Y.+Shi&title=Mechanism+of+XIAP-mediated+inhibition+of+caspase-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of XIAP-mediated inhibition of caspase-9</span></div><div class="casAuthors">Shiozaki, Eric N.; Chai, Jijie; Rigotti, Daniel J.; Riedl, Stefan J.; Li, Pingwei; Srinivasula, Srinivasa M.; Alnemri, Emad S.; Fairman, Robert; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins potently inhibit the catalytic activity of caspases.  While profound insight into the inhibition of the effector caspases has been gained in recent years, the mechanism of how the initiator caspase-9 is regulated by IAPs remains enigmatic.  This paper reports the crystal structure of caspase-9 in an inhibitory complex with the third baculoviral IAP repeat (BIR3) of XIAP at 2.4 Å resoln.  The structure reveals that the BIR3 domain forms a heterodimer with a caspase-9 monomer.  Strikingly, the surface of caspase-9 that interacts with BIR3 also mediates its homodimerization.  We demonstrate that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization.  Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity.  These studies, in conjunction with other observations, define a unified mechanism for the activation of all caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2rbChsxBIPbVg90H21EOLACvtfcHk0lh4wn5wMKLccQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D&md5=9e01d0078d4f8d676cb96d37c4027827</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900054-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900054-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DE.%2BN.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DRigotti%26aufirst%3DD.%2BJ.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DFairman%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520XIAP-mediated%2520inhibition%2520of%2520caspase-9%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D519%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dataa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of caspase-7 inhibition by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0092-8674%2801%2900272-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=769-780&author=J.+Chaiauthor=E.+Shiozakiauthor=S.+M.+Srinivasulaauthor=Q.+Wuauthor=P.+Dataaauthor=E.+S.+Alnemriauthor=Y.+Shi&title=Structural+basis+of+caspase-7+inhibition+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase-7 inhibition by XIAP</span></div><div class="casAuthors">Chai, Jijie; Shiozaki, Eric; Srinivasula, Srinivasa M.; Wu, Qi; Dataa, Pinaki; Alnemri, Emad S.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases.  Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Å resoln.  An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity.  Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO.  Our biochem. and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7.  This study provides a structural basis for the design of the next-generation caspase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolipWoAs9habVg90H21EOLACvtfcHk0liDSFWCjmXMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D&md5=fe072a2bacd6c76e3763fff9bc678897</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900272-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900272-0%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDataa%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520caspase-7%2520inhibition%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=781-790&author=Y.+Huangauthor=Y.+C.+Parkauthor=R.+L.+Richauthor=D.+Segalauthor=D.+G.+Myszkaauthor=H.+Wu&title=Structural+basis+of+caspase+inhibition+by+XIAP%3A+Differential+roles+of+the+linker+versus+the+BIR+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain</span></div><div class="casAuthors">Huang, Yihua; Park, Young Chul; Rich, Rebecca L.; Segal, Deena; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs).  Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker).  The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal.  The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition.  Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction.  Further biochem. characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjYs6k2CfhrVg90H21EOLACvtfcHk0liDSFWCjmXMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D&md5=c12e25afe67e2979324ba5bf6151c6bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520of%2520caspase%2520inhibition%2520by%2520XIAP%253A%2520Differential%2520roles%2520of%2520the%2520linker%2520versus%2520the%2520BIR%2520domain%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renatus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddington, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of caspase-3 by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0092-8674%2801%2900274-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=791-800&author=S.+J.+Riedlauthor=M.+Renatusauthor=R.+Schwarzenbacherauthor=Q.+Zhouauthor=C.+Sunauthor=S.+W.+Fesikauthor=R.+C.+Liddingtonauthor=G.+S.+Salvesen&title=Structural+basis+for+the+inhibition+of+caspase-3+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of caspase-3 by XIAP</span></div><div class="casAuthors">Riedl, Stefan J.; Renatus, Martin; Schwarzenbacher, Robert; Zhou, Qiao; Sun, Chaohong; Fesik, Stephen W.; Liddington, Robert C.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood.  The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7.  We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resoln. of 2.7 Å, revealing the structural basis for inhibition.  The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension.  This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding.  The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaCJZgSAEzrLVg90H21EOLACvtfcHk0liDSFWCjmXMgg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D&md5=7a06c657d5b3700b4dd8e77ab8569613</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900274-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900274-4%26sid%3Dliteratum%253Aachs%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DLiddington%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520caspase-3%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAPs, RINGs, and ubiquitylation</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrm1621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=15803136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=287-297&author=D.+L.+Vauxauthor=J.+Silke&title=IAPs%2C+RINGs%2C+and+ubiquitylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs, RINGs and ubiquitylation</span></div><div class="casAuthors">Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Here, the authors review the function of the RING domain of inhibitor of apoptosis proteins (IAPs), provide an overview of the biol. of E3 ubiquitin ligases, the enzymes which conjugate ubiquitin to substrate proteins, and its application to IAPs, and examine evidence for substrate ubiquitination by IAPs and for the importance of these ubiquitination events in the prevention of apoptosis.  The IAPs all contain one or more baculoviral IAP repeat motifs, through which they interact with various other proteins.  Many IAPs also have another Zn-binding motif, the RING domain, which can recruit E2 ubiquitin-conjugating enzymes and catalyze the transfer of ubiquitin onto target proteins.  The no. of targets of IAP-mediated ubiquitination is increasing, and recent results indicate that outcomes following ubiquitination are tantalizingly complex.  As well as regulating other proteins, the IAPs themselves are controlled by ubiquitin-mediated degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8gh0_du1aY7Vg90H21EOLACvtfcHk0lhvKk8DewvM4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D&md5=4d3040429bbac085dd33b46c8c74d955</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrm1621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1621%26sid%3Dliteratum%253Aachs%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAPs%252C%2520RINGs%252C%2520and%2520ubiquitylation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenship, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=18022362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Federovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+A.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-%CE%BAB+activation%2C+and+TNF%CE%B1-dependent+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span></div><div class="casAuthors">Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli.  They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics.  Herein, the authors demonstrate that small-mol. IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degrdn. of c-IAPs.  The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis.  Addnl., the c-IAP proteins were found to function as regulators of NF-κB signaling.  Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degrdn. of NIK, the central ser/thr kinase in the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV7cKeBeR_hrVg90H21EOLACvtfcHk0lhvKk8DewvM4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF&md5=c9a255030cc26db0519680d170ba91f9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFederova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-%25CE%25BAB%2520activation%252C%2520and%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Vince, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverkus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tergaonkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koentgen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.-L.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNF%CE%B1-dependent+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.-L.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fotin-Mleczek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichwein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmryd, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wajant, H.</span><span> </span><span class="NLM_article-title">Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2757</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12077366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=2757-2770&author=M.+Fotin-Mleczekauthor=F.+Henklerauthor=D.+Samelauthor=M.+Reichweinauthor=A.+Hausserauthor=I.+Parmrydauthor=P.+Scheurichauthor=J.+A.+Schmidauthor=H.+Wajant&title=Apoptotic+crosstalk+of+TNF+receptors%3A+TNF-R2-induces+depletion+of+TRAF2+and+IAP+proteins+and+accelerates+TNF-R1-dependent+activation+of+caspase-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8</span></div><div class="casAuthors">Fotin-Mleczek, Mariola; Henkler, Frank; Samel, Dierk; Reichwein, Monica; Hausser, Angelika; Parmryd, Ingela; Scheurich, Peter; Schmid, Johannes A.; Wajant, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2757-2770</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">We have recently shown that stimulation of TNF-R2 selectively enhances apoptosis induction by the death receptor TNF-R1.  Here, we demonstrate that stimulation of CD30 or CD40 also leads to selective enhancement of TNF-R1-induced cell death.  Enhancement of apoptosis was correlated with the depletion of endogenous TRAF2 within 1 to 6 h.  Selective prestimulation of TNF-R2 for several hours inhibited TNF-R2-induced activation of the anti-apoptotic NF-κB pathway up to 90% and dramatically enhanced apoptosis induction by this receptor.  When both TNF-receptors were stimulated simultaneously, TNF-R1-induced NF-κB activation remained unaffected but TNF-R1-induced apoptosis was still significantly enhanced.  Compared with FasL-induced cell death TNF-R1-induced activation of caspase-8 was significantly weaker and delayed.  Costimulation or prestimulation of TNF-R2 enhanced caspase-8 processing.  Life cell imaging and confocal microscopy revealed that both TNF-R1 and TNF-R2 recruited the anti-apoptotic factor cIAP1 in a TRAF2-dependent manner.  Thus, TNF-R2 may compete with TNF-R1 for the recruitment of newly synthesized TRAF2-bound anti-apoptotic factors, thereby promoting the formation of a caspase-8-activating TNF-R1 complex.  Hence, TNF-R2 triggering can interfere with TNF-R1-induced apoptosis by inhibition of NF-κB-dependent prodn. of anti-apoptotic factors and by blocking the action of anti-apoptotic factors at the post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-7stEso8NrVg90H21EOLACvtfcHk0likpSOaiwLw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFCrtLc%253D&md5=8624e97eefe4e51d3ac2f648103b54ee</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFotin-Mleczek%26aufirst%3DM.%26aulast%3DHenkler%26aufirst%3DF.%26aulast%3DSamel%26aufirst%3DD.%26aulast%3DReichwein%26aufirst%3DM.%26aulast%3DHausser%26aufirst%3DA.%26aulast%3DParmryd%26aufirst%3DI.%26aulast%3DScheurich%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DJ.%2BA.%26aulast%3DWajant%26aufirst%3DH.%26atitle%3DApoptotic%2520crosstalk%2520of%2520TNF%2520receptors%253A%2520TNF-R2-induces%2520depletion%2520of%2520TRAF2%2520and%2520IAP%2520proteins%2520and%2520accelerates%2520TNF-R1-dependent%2520activation%2520of%2520caspase-8%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D2757%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblau, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span> </span><span class="NLM_article-title">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1796</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=10815900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1796-1803&author=I.+Tammauthor=S.+M.+Kornblauauthor=H.+Segallauthor=S.+Krajewskiauthor=K.+Welshauthor=S.+Kitadaauthor=D.+A.+Scudieroauthor=G.+Tudorauthor=Y.+H.+Quiauthor=A.+Monksauthor=M.+Andreeffauthor=J.+C.+Reed&title=Expression+and+prognostic+significance+of+IAP-family+genes+in+human+cancers+and+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span></div><div class="casAuthors">Tamm, Ingo; Kornblau, Steven M.; Segall, Harry; Krajewski, Stanislaw; Welsh, Kate; Kitada, Shinichi; Scudiero, Dominic A.; Tudor, Gabriela; Qui, Yi Hua; Monks, Anne; Andreeff, Michael; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1796-1803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of several inhibitor of apoptosis proteins (IAPs) was investigated in the National Cancer Institute panel of 60 human tumor cell lines, and the expression and prognostic significance of one of these, XIAP, was evaluated in 78 previously untreated patients with acute myelogenous leukemia (AML).  XIAP and cIAP1 were expressed in most cancer lines analyzed, with substantial variability in their relative levels.  In contrast, NAIP mRNA was not detectable, and cIAP2 was found at the mRNA and protein levels in only 34 (56%) and 5 (8%) of the 60 tumor cell lines analyzed, resp.  Interestingly, XIAP, cIAP1, and cIAP2 mRNA levels did not correlate with protein levels in the tumor lines, indicating posttranscriptional regulation of expression.  High levels of XIAP protein in tumor cell lines were unexpectedly correlated with sensitivity to some anticancer drugs, particularly cytarabine and other nucleosides, whereas higher levels of cIAP1 protein levels were assocd. with resistance to several anticancer drugs.  The relevance of XIAP to in vivo responses to cytarabine was explored in AML, making correlations with patient outcome.  Patients with lower levels of XIAP protein had longer survival and a tendency toward longer remission duration than those with higher levels of XIAP.  Altogether, IAPs are widely but differentially expressed in human cancers and leukemias, and higher XIAP protein levels may have adverse prognostic significance for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBpTFu0KAgrVg90H21EOLACvtfcHk0likpSOaiwLw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D&md5=08ea4dd16cfe6106339fbe7ee7e47a77</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DKornblau%26aufirst%3DS.%2BM.%26aulast%3DSegall%26aufirst%3DH.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DTudor%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DY.%2BH.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520and%2520prognostic%2520significance%2520of%2520IAP-family%2520genes%2520in%2520human%2520cancers%2520and%2520myeloid%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D1796%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, W. C.</span><span> </span><span class="NLM_article-title">Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: Implication for cancer specific therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6815</span><span class="NLM_x">–</span> <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=14583479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6815-6824&author=L.+Yangauthor=Z.+Caoauthor=H.+Yanauthor=W.+C.+Wood&title=Coexistence+of+high+levels+of+apoptotic+signaling+and+inhibitor+of+apoptosis+proteins+in+human+tumor+cells%3A+Implication+for+cancer+specific+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy</span></div><div class="casAuthors">Yang, Lily; Cao, Zehong; Yan, Hui; Wood, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6815-6824</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">It is well known that dysfunction of the apoptotic pathway confers apoptosis resistance and results in a low sensitivity of human cancer cells to therapeutic agents.  A novel strategy to overcome the resistance is to target the apoptotic pathway directly.  To identify mol. targets in the apoptotic pathway that are differentially regulated in cancer and normal cells, we have examd. the levels of apoptotic effectors and inhibitors in human tumor and normal cell lines as well as in cancer and normal tissues.  These include three pancreatic cancer lines (BXPC-3, MIA PaCa-2, and Panc-1), four breast cancer cell lines (MDA-MB-231, MDA-MB-435, MDA-MB-361, and MCF-7), and colon carcinoma line (SW620).  Addnl., breast carcinoma tissue specimens were examd.  Compared with normal human fibroblast and mammary epithelial cell lines, we detected high basal levels of caspase-3 and caspase-8 activities and active caspase-3 fragments in the tumor cell lines and cancer tissues in the absence of apoptotic stimuli.  Furthermore, the tumor cells expressed high levels of survivin and XIAP, two members of the inhibitor of apoptosis (IAP) protein family.  When the activity of these IAPs was blocked by expression of dominant-neg. mutant survivin (survivinT34A) and XIAP-assocd. factor 1, resp., apoptosis was induced in tumor but not normal cell lines.  Moreover, down-regulation of both survivin and XIAP significantly enhanced tumor-cell apoptosis as compared with inhibition of either survivin or XIAP alone.  These results suggest that up-regulated IAP expression counteracts the high basal caspase-3 activity obsd. in these tumor cells and that apoptosis in tumor cells but not normal cells can be induced by blocking IAP activity.  Therefore, IAPs are important mol. targets for the development of cancer-specific therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnkSWDJOSCbVg90H21EOLACvtfcHk0likpSOaiwLw8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D&md5=f8b94616c5ddba25d9ac4ecd1e17eba8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DW.%2BC.%26atitle%3DCoexistence%2520of%2520high%2520levels%2520of%2520apoptotic%2520signaling%2520and%2520inhibitor%2520of%2520apoptosis%2520proteins%2520in%2520human%2520tumor%2520cells%253A%2520Implication%2520for%2520cancer%2520specific%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6815%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">The inhibitor of apoptosis proteins as therapeutic targets in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">6000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1158%2F1078-0432.CCR-07-0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=17947460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5995-6000&author=D.+Vucicauthor=W.+J.+Fairbrother&title=The+inhibitor+of+apoptosis+proteins+as+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer</span></div><div class="casAuthors">Vucic, Domagoj; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5995-6000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a cell suicide process with a major role in development and homeostasis in vertebrates and invertebrates.  Inhibition of apoptosis enhances the survival of cancer cells and facilitates their escape from immune surveillance and cytotoxic therapies.  Among the principal mols. contributing to this phenomenon are the inhibitor of apoptosis (IAP) proteins, a family of antiapoptotic regulators that block cell death in response to diverse stimuli through interactions with inducers and effectors of apoptosis.  IAP proteins are expressed in the majority of human malignancies at elevated levels and play an active role in promoting tumor maintenance through the inhibition of cellular death and participation in signaling pathways assocd. with malignancies.  Here, we discuss the role of IAP proteins in cancer and options for targeting IAP proteins for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyky7YXEnLVg90H21EOLACvtfcHk0ljeEcQMyF4fhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP&md5=bff042bce2006a510abb6814d43c6dc5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0729%26sid%3Dliteratum%253Aachs%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520proteins%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5995%26epage%3D6000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0ljeEcQMyF4fhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0ljeEcQMyF4fhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">Development of peptidomimetics targeting IAPs</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1007%2Fs10989-005-9003-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=21-32&author=S.+K.+Sharmaauthor=C.+Straubauthor=L.+Zawel&title=Development+of+peptidomimetics+targeting+IAPs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of peptidomimetics targeting IAPs</span></div><div class="casAuthors">Sharma, Sushil K.; Straub, Christopher; Zawel, Leigh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) such as XIAP subvert apoptosis by binding and inhibiting caspases.  Because occupation of the XIAP BIR3 peptide binding pocket by Smac abolishes the XIAP-caspase 9 interaction, it is a proapoptotic event of great therapeutic interest.  An assay for pocket binding was developed based on the displacement of Smac 7-mer from BIR3.  Through the phys. and biochem. anal. of a variety of peptides, we have detd. the min. sequence required for inhibition of the Smac-BIR3 interaction and detailed the dimensions and topol. of the BIR3 peptide binding pocket.  This work describes the structure-activity relationship (SAR) for peptide inhibitors of Smac-IAP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhtWKk4EEX7Vg90H21EOLACvtfcHk0ljeEcQMyF4fhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVKlu70%253D&md5=45ebc15463f17060b036d0c3011f1cef</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10989-005-9003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-005-9003-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520peptidomimetics%2520targeting%2520IAPs%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2006%26volume%3D12%26spage%3D21%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of small-molecule peptidic and nonpeptidic Smac mimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1277&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.-Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+small-molecule+peptidic+and+nonpeptidic+Smac+mimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor κB (NF-κB) and prodn. and secretion of tumor necrosis factor α (TNFα).  TNFα promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0lhK9U2Y58o4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520peptidic%2520and%2520nonpeptidic%2520Smac%2520mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span> </span><span class="NLM_article-title">IAP antagonists: Promising candidates for cancer therapy</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.drudis.2010.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20096368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFyns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=210-219&author=R.+Mannholdauthor=S.+Fuldaauthor=E.+Carosati&title=IAP+antagonists%3A+Promising+candidates+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists: promising candidates for cancer therapy</span></div><div class="casAuthors">Mannhold, Raimund; Fulda, Simone; Carosati, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">210-219</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A promising strategy in cancer therapy aims to promote apoptosis in cancer cells.  Targeting inhibitor of apoptosis proteins (IAPs) with small-mol. inhibitors has attracted increasing interest in triggering cancer cell death.  It is considered to have great potential for cancer drug discovery because IAPs block apoptosis at the core of the apoptotic machinery and are aberrantly expressed in various tumors.  This review focuses on the current development of small-mol. IAP antagonists for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6SLGZ0hrG7Vg90H21EOLACvtfcHk0lhK9U2Y58o4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFyns7w%253D&md5=d9c92239547c42cc3a5953868745fa8b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DCarosati%26aufirst%3DE.%26atitle%3DIAP%2520antagonists%253A%2520Promising%2520candidates%2520for%2520cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D210%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+A+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0lhK9U2Y58o4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The discovery and development of Smac-mimetics – small-molecule antagonists of the inhibitor of apoptosis proteins</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=211-226&author=S.+M.+Condon&title=The+discovery+and+development+of+Smac-mimetics+%E2%80%93+small-molecule+antagonists+of+the+inhibitor+of+apoptosis+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520Smac-mimetics%2520%25E2%2580%2593%2520small-molecule%2520antagonists%2520of%2520the%2520inhibitor%2520of%2520apoptosis%2520proteins%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrd3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=22293567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-124&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAP proteins for therapeutic intervention in cancer</span></div><div class="casAuthors">Fulda, Simone; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evasion of apoptosis is one of the crucial acquired capabilities used by cancer cells to fend off anticancer therapies.  Inhibitor of apoptosis (IAP) proteins exert a range of biol. activities that promote cancer cell survival and proliferation.  X chromosome-linked IAP is a direct inhibitor of caspases - pro-apoptotic executioner proteases - whereas cellular IAP proteins block the assembly of pro-apoptotic protein signalling complexes and mediate the expression of anti-apoptotic mols.  Furthermore, mutations, amplifications and chromosomal translocations of IAP genes are assocd. with various malignancies.  Among the therapeutic strategies that have been designed to target IAP proteins, the most widely used approach is based on mimicking the IAP-binding motif of second mitochondria-derived activator of caspase (SMAC), which functions as an endogenous IAP antagonist.  Alternative strategies include transcriptional repression and the use of antisense oligonucleotides.  This Review provides an update on IAP protein biol. as well as current and future perspectives on targeting IAP proteins for therapeutic intervention in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-R51O_sZcdLVg90H21EOLACvtfcHk0lhXGthHFvMSNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D&md5=219506817f8526ba0bbd27117ed4f290</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3627%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35022514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=10972280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=855-862&author=J.+Chaiauthor=C.+Duauthor=J.-W.+Wuauthor=S.+Kyinauthor=X.+Wangauthor=Y.+Shi&title=Structural+and+biochemical+basis+of+apoptotic+activation+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span></div><div class="casAuthors">Chai, Jijie; Du, Chunying; Wu, Jia-Wei; Kyin, Saw; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6798</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis (programmed cell death), an essential process in the development and homeostasis of metazoans, is carried out by caspases.  The mitochondrial protein Smac/DIABLO performs a crit. function in apoptosis by eliminating the inhibitory effect of IAPs (inhibitor of apoptosis proteins) on caspases.  Here we show that Smac/DIABLO promotes not only the proteolytic activation of procaspase-3 but also the enzymic activity of mature caspase-3, both of which depend upon its ability to interact phys. with IAPs.  The crystal structure of Smac/DIABLO at 2.2Å resoln. reveals that it homodimerizes through an extensive hydrophobic interface.  Missense mutations inactivating this dimeric interface significantly compromise the function of Smac/DIABLO.  As in the Drosophila proteins Reaper, Grim and Hid, the amino-terminal amino acids of Smac/DIABLO are indispensable for its function, and a seven-residue peptide derived from the amino terminus promotes procaspase-3 activation in vitro.  These results establish an evolutionarily conserved structural and biochem. basis for the activation of apoptosis by Smac/DIABLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4zPSamJORbVg90H21EOLACvtfcHk0lhXGthHFvMSNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D&md5=e3e65405a679b11556fa875b7c5dc9fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F35022514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35022514%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DKyin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520and%2520biochemical%2520basis%2520of%2520apoptotic%2520activation%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Brabander, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P. G.</span><span> </span><span class="NLM_article-title">A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+Smac+mimic+potentiates+TRAIL-+and+TNF%CE%B1-mediated+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520Smac%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNF%25CE%25B1-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">15279</span><span class="NLM_x">–</span> <span class="NLM_lpage">15294</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.-Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+Smac+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Cossu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrangelo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vachette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servida, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seneci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolastico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M.</span><span> </span><span class="NLM_article-title">Structural basis for bivalent Smac-mimetics recognition in the IAP protein family</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=2009&pages=630-644&author=F.+Cossuauthor=M.+Milaniauthor=E.+Mastrangeloauthor=P.+Vachetteauthor=F.+Servidaauthor=D.+Lecisauthor=G.+Canevariauthor=D.+Deliaauthor=C.+Dragoauthor=V.+Rizzoauthor=L.+Manzoniauthor=P.+Seneciauthor=C.+Scolasticoauthor=M.+Bolognesi&title=Structural+basis+for+bivalent+Smac-mimetics+recognition+in+the+IAP+protein+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCossu%26aufirst%3DF.%26aulast%3DMilani%26aufirst%3DM.%26aulast%3DMastrangelo%26aufirst%3DE.%26aulast%3DVachette%26aufirst%3DP.%26aulast%3DServida%26aufirst%3DF.%26aulast%3DLecis%26aufirst%3DD.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DDelia%26aufirst%3DD.%26aulast%3DDrago%26aufirst%3DC.%26aulast%3DRizzo%26aufirst%3DV.%26aulast%3DManzoni%26aufirst%3DL.%26aulast%3DSeneci%26aufirst%3DP.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520bivalent%2520Smac-mimetics%2520recognition%2520in%2520the%2520IAP%2520protein%2520family%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D392%26spage%3D630%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Assaad, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4417</span><span class="NLM_x">–</span> <span class="NLM_lpage">4426</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040037k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4417-4426&author=T.+K.+Oostauthor=C.+Sunauthor=R.+C.+Armstrongauthor=A.-S.+Al-Assaadauthor=S.+F.+Betzauthor=T.+L.+Deckwerthauthor=H.+Dingauthor=S.+W.+Elmoreauthor=R.+P.+Meadowsauthor=E.+T.+Olejniczakauthor=A.+Oleksijewauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=A.+R.+Shoemakerauthor=K.+J.+Tomaselliauthor=H.+Zouauthor=S.+W.+Fesik&title=Discovery+of+potent+antagonists+of+the+antiapoptotic+protein+XIAP+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer</span></div><div class="casAuthors">Oost, Thorsten K.; Sun, Chaohong; Armstrong, Robert C.; Al-Assaad, Ali-Samer; Betz, Stephen F.; Deckwerth, Thomas L.; Ding, Hong; Elmore, Steven W.; Meadows, Robert P.; Olejniczak, Edward T.; Oleksijew, Andrew; Oltersdorf, Tilman; Rosenberg, Saul H.; Shoemaker, Alexander R.; Tomaselli, Kevin J.; Zou, Hua; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4417-4426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been implicated in tumor growth, pathogenesis, and resistance to chemo- or radiotherapy.  On the basis of the NMR structure of a SMAC peptide complexed with the BIR3 domain of X-linked IAP (XIAP), a novel series of XIAP antagonists was discovered.  The most potent compds. in this series bind to the baculovirus IAP repeat 3 (BIR3) domain of XIAP with single-digit nanomolar affinity and promote cell death in several human cancer cell lines.  In a MDA-MB-231 breast cancer mouse xenograft model, these XIAP antagonists inhibited the growth of tumors.  Close structural analogs that showed only weak binding to the XIAP-BIR3 domain were inactive in the cellular assays and showed only marginal in vivo activity.  Our results are consistent with a mechanism in which ligands for the BIR3 domain of XIAP induce apoptosis by freeing up caspases.  The present study validates the BIR3 domain of XIAP as a target and supports the use of small mol. XIAP antagonists as a potential therapy for cancers that overexpress XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSXHFufBtZbVg90H21EOLACvtfcHk0ljqYKvXU4Cg-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D&md5=ccd77135a42ab84cd36f221abdb4fee7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm040037k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040037k%26sid%3Dliteratum%253Aachs%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAl-Assaad%26aufirst%3DA.-S.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520antiapoptotic%2520protein%2520XIAP%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4417%26epage%3D4426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Laurent, A.</span><span> </span><span class="NLM_article-title">IAP BIR domain binding compounds</span>. Patent US20070093428,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Laurent&title=IAP+BIR+domain+binding+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DA.%26atitle%3DIAP%2520BIR%2520domain%2520binding%2520compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin-Chin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNF%CE%B1+signaling+renders+human+cancer+cells+susceptible+to+Smac-mimetic-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNF%25CE%25B1%2520signaling%2520renders%2520human%2520cancer%2520cells%2520susceptible%2520to%2520Smac-mimetic-induced%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Ndubaku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb900083m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=557-566&author=C.+Ndubakuauthor=E.+Varfolomeevauthor=L.+Wangauthor=K.+Zobelauthor=K.+Lauauthor=L.+O.+Elliottauthor=B.+Maurerauthor=A.+V.+Federovaauthor=J.+N.+Dynekauthor=M.+Kohlerauthor=S.+G.+Hymowitzauthor=V.+Tsuiauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=D.+Vucic&title=Antagonism+of+c-IAP+and+XIAP+proteins+is+required+for+efficient+induction+of+cell+death+by+small-molecule+IAP+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists</span></div><div class="casAuthors">Ndubaku, Chudi; Varfolomeev, Eugene; Wang, Lan; Zobel, Kerry; Lau, Kevin; Elliott, Linda O.; Maurer, Brigitte; Fedorova, Anna V.; Dynek, Jasmin N.; Koehler, Michael; Hymowitz, Sarah G.; Tsui, Vickie; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival, which makes them attractive targets for therapeutic intervention in cancers.  Herein, the structure-based design of IAP antagonists with high affinities and selectivity (>2000-fold) for c-IAP1 over XIAP and their functional characterization as activators of apoptosis in tumor cells are described.  Although capable of inducing cell death and preventing clonogenic survival, c-IAP-selective antagonists are significantly less potent in promoting apoptosis when compared to pan-selective compds.  However, both pan-IAP- and c-IAP-selective antagonists stimulate c-IAP1 and c-IAP2 degrdn. and activation of NF-κB pathways with comparable potencies.  Therefore, although compds. that specifically target c-IAP1 and c-IAP2 are capable of inducing apoptosis, antagonism of the c-IAP proteins and XIAP is required for efficient induction of cancer cell death by IAP antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xO3yZNCyz7Vg90H21EOLACvtfcHk0ljqYKvXU4Cg-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D&md5=f1c82b7c5632453ba36e039441f039c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcb900083m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900083m%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DFederova%26aufirst%3DA.%2BV.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DKohler%26aufirst%3DM.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DAntagonism%2520of%2520c-IAP%2520and%2520XIAP%2520proteins%2520is%2520required%2520for%2520efficient%2520induction%2520of%2520cell%2520death%2520by%2520small-molecule%2520IAP%2520antagonists%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D557%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hennessy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquila, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laing, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span> </span><span class="NLM_article-title">Discovery of aminopiperidine-based Smac mimetics as IAP antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.bmcl.2011.12.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=22264476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVajtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1690-1694&author=E.+J.+Hennessyauthor=J.+C.+Saehauthor=L.+Shaauthor=T.+MacIntyreauthor=H.+Wangauthor=N.+A.+Larsenauthor=B.+M.+Aquilaauthor=A.+D.+Fergusonauthor=N.+M.+Laingauthor=C.+A.+Omer&title=Discovery+of+aminopiperidine-based+Smac+mimetics+as+IAP+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminopiperidine-based Smac mimetics as IAP antagonists</span></div><div class="casAuthors">Hennessy, Edward J.; Saeh, Jamal C.; Sha, Li; MacIntyre, Terry; Wang, Haiyun; Larsen, Nicholas A.; Aquila, Brian M.; Ferguson, Andrew D.; Laing, Naomi M.; Omer, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1690-1694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of structurally unique Smac mimetics that act as antagonists of inhibitor of apoptosis proteins (IAPs) has been discovered.  While most previously described Smac mimetics contain the proline ring (or a similar cyclic motif) found in Smac, a key feature of the compds. described herein is that this ring has been removed.  Despite this, compds. in this series potently bind to cIAP1 and elicit the expected phenotype of cIAP1 inhibition in cancer cells.  Marked selectivity for cIAP1 over XIAP is obsd. for these compds., which is attributed to a slight difference in the binding groove between the two proteins and the resulting steric interactions with the inhibitors.  XIAP binding can be improved by constraining the inhibitor so that these unfavorable steric interactions are minimized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxW_JEoe3-bVg90H21EOLACvtfcHk0lgnFDMeOifP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVajtL0%253D&md5=91ee3b34d5a9dbebd3ac7702444aa9ac</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.109%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520of%2520aminopiperidine-based%2520Smac%2520mimetics%2520as%2520IAP%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1690%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent bivalent Smac mimetics: Effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3306</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101651b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3306-3318&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=L.+Baiauthor=X.+Liauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=C.-Y.+Yangauthor=S.+Qiuauthor=H.+Yiauthor=D.+Sunauthor=S.+Wang&title=Potent+bivalent+Smac+mimetics%3A+Effect+of+the+linker+on+binding+to+inhibitor+of+apoptosis+proteins+%28IAPs%29+and+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm101651b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101651b%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520bivalent%2520Smac%2520mimetics%253A%2520Effect%2520of%2520the%2520linker%2520on%2520binding%2520to%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520and%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3306%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettjeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhidarmo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span> </span><span class="NLM_article-title">Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">17015</span><span class="NLM_x">–</span> <span class="NLM_lpage">17028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=17015-17028&author=R.+Felthamauthor=B.+Bettjemanauthor=R.+Budhidarmoauthor=P.+D.+Maceauthor=S.+Shirleyauthor=S.+M.+Condonauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=D.+L.+Vauxauthor=J.+Silkeauthor=C.+L.+Day&title=Smac+mimetics+activate+the+E3+ligase+activity+of+cIAP1+protein+by+promoting+RING+domain+dimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DBudhidarmo%26aufirst%3DR.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DShirley%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DSmac%2520mimetics%2520activate%2520the%2520E3%2520ligase%2520activity%2520of%2520cIAP1%2520protein%2520by%2520promoting%2520RING%2520domain%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D17015%26epage%3D17028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgnFDMeOifP8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Kipp, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wist, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albiniak, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semmelhack, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, G. L.</span><span> </span><span class="NLM_article-title">Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">7344</span><span class="NLM_x">–</span> <span class="NLM_lpage">7349</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0121454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=7344-7349&author=R.+A.+Kippauthor=M.+A.+Caseauthor=A.+D.+Wistauthor=C.+M.+Cressonauthor=M.+Carrellauthor=E.+Grinerauthor=A.+Wiitaauthor=P.+A.+Albiniakauthor=J.+Chaiauthor=Y.+Shiauthor=M.+F.+Semmelhackauthor=G.+L.+McLendon&title=Molecular+targeting+of+inhibitor+of+apoptosis+proteins+based+on+small+molecule+mimics+of+natural+binding+partners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners</span></div><div class="casAuthors">Kipp, Rachael A.; Case, Martin A.; Wist, Aislyn D.; Cresson, Catherine M.; Carrell, Maria; Griner, Erin; Wiita, Arun; Albiniak, Philip A.; Chai, Jijie; Shi, Yigong; Semmelhack, Martin F.; McLendon, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7344-7349</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay based on a solvent-sensitive fluorogenic dye mol., badan, is used to test the binding affinity of a library of tetrapeptide mols. for the BIR3 (baculovirus IAP repeat) domain of XIAP (X-linked inhibitor of apoptosis protein).  The fluorophore is attached to a tetrapeptide, Ala-Val-Pro-Cys-NH2, through a thiol linkage and, upon binding to XIAP, undergoes a solvatochromic shift in fluorescence emission.  When a mol. (e.g., a natural protein known to bind to XIAP or a tetrapeptide mimic) displaces the dye, the emission shifts back to the spectrum obsd. in water.  As emission intensity is related to the binding of the tetrapeptide, the intensity can be used to det. the equil. const., K, for the displacement of the dye by the tetrapeptide.  The results permit residue-specific anal. of the interaction.  Furthermore, we show that hydrophobic effects in the fourth position are general and can effectively increase overall affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jRD1J251H7Vg90H21EOLACvtfcHk0liM8YXSNBhIbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D&md5=ce6f8ed9b3a195523b98dc4943142312</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi0121454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0121454%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DR.%2BA.%26aulast%3DCase%26aufirst%3DM.%2BA.%26aulast%3DWist%26aufirst%3DA.%2BD.%26aulast%3DCresson%26aufirst%3DC.%2BM.%26aulast%3DCarrell%26aufirst%3DM.%26aulast%3DGriner%26aufirst%3DE.%26aulast%3DWiita%26aufirst%3DA.%26aulast%3DAlbiniak%26aufirst%3DP.%2BA.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DMcLendon%26aufirst%3DG.%2BL.%26atitle%3DMolecular%2520targeting%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520small%2520molecule%2520mimics%2520of%2520natural%2520binding%2520partners%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D7344%26epage%3D7349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Condon, S. M.; LaPorte, M. G.; Deng, Y.; Rippin, S. R.</span><span> </span><span class="NLM_article-title">Dimeric IAP inhibitors</span>. Patent WO2006091972,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+M.+Condon&author=M.+G.+LaPorte&author=Y.+Deng&author=S.+R.+Rippin&title=Dimeric+IAP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DDimeric%2520IAP%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Interaction of a cyclic, bivalent Smac mimetic with the X-linked inhibitor of apoptosis protein</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9811</span><span class="NLM_x">–</span> <span class="NLM_lpage">9824</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800785y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9811-9824&author=Z.+Nikolovska-Coleskaauthor=J.+L.+Meagherauthor=S.+Jiangauthor=C.-Y.+Yangauthor=S.+Qiuauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Interaction+of+a+cyclic%2C+bivalent+Smac+mimetic+with+the+X-linked+inhibitor+of+apoptosis+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Meagher, Jennifer L.; Jiang, Sheng; Yang, Chao-Yie; Qiu, Su; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9811-9824</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a cyclic, bivalent Smac mimetic (compd. 3) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP).  Compd. 3 binds to XIAP contg. both BIR2 and BIR3 domains with a biphasic dose-response curve representing two binding sites with IC50 values of 0.5 and 406 nM, resp.  Compd. 3 binds to XIAPs contg. the BIR3-only and BIR2-only domain with Ki values of 4 nM and 4.4 μM, resp.  Gel filtration expts. using wild-type and mutated XIAPs showed that 3 forms a 1:2 stoichiometric complex with XIAP contg. the BIR3-only domain.  However, it forms a 1:1 stoichiometric complex with XIAP contg. both BIR2 and BIR3 domains, and both BIR domains are involved in the binding.  Compd. 3 efficiently antagonizes inhibition of XIAP in a cell-free functional assay and is >200 times more potent than its corresponding monovalent compd. 2.  Detn. of the crystal structure of 3 in complex with the XIAP BIR3 domain confirms that 3 induces homodimerization of the XIAP BIR3 domain and provides a structural basis for the cooperative binding of one mol. of compd. 3 to two XIAP BIR3 mols.  On the basis of this crystal structure, a binding model of XIAP contg. both BIR2 and BIR3 domains and 3 was constructed, which sheds light on the ability of 3 to relieve the inhibition of XIAP with not only caspase-9 but also caspase-3/-7.  Compd. 3 is cell-permeable, effectively activates caspases in whole cells, and potently inhibits cancer cell growth.  Compd. 3 is a useful biochem. and pharmacol. tool for further elucidating the role of XIAP in regulation of apoptosis and represents a promising lead compd. for the design of potent, cell-permeable Smac mimetics for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEyxJPGLGNLVg90H21EOLACvtfcHk0liM8YXSNBhIbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK&md5=e4bc922befd427c343f908017286d6f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi800785y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800785y%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520a%2520cyclic%252C%2520bivalent%2520Smac%2520mimetic%2520with%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D9811%26epage%3D9824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Burton, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conradi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgers, A. R.</span><span> </span><span class="NLM_article-title">Transcellular mechanism of peptide and protein absorption: Passive aspects</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=365-386&author=P.+S.+Burtonauthor=R.+A.+Conradiauthor=A.+R.+Hilgers&title=Transcellular+mechanism+of+peptide+and+protein+absorption%3A+Passive+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DP.%2BS.%26aulast%3DConradi%26aufirst%3DR.%2BA.%26aulast%3DHilgers%26aufirst%3DA.%2BR.%26atitle%3DTranscellular%2520mechanism%2520of%2520peptide%2520and%2520protein%2520absorption%253A%2520Passive%2520aspects%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1991%26volume%3D7%26spage%3D365%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="note"><p class="first last">Because of technical difficulties in obtaining accurate experimental Log D measurements for these compounds, values calculated using the ACD LogD software (v.12.01, © 1997–2009 Advanced Chemistry Development, Inc.) are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> instead.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Stenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Prediction of membrane permeability to peptides from calculated dynamic molecular surface dynamics</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=205-212&author=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Prediction+of+membrane+permeability+to+peptides+from+calculated+dynamic+molecular+surface+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPrediction%2520of%2520membrane%2520permeability%2520to%2520peptides%2520from%2520calculated%2520dynamic%2520molecular%2520surface%2520dynamics%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49517</span><span class="NLM_x">–</span> <span class="NLM_lpage">49522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1074%2Fjbc.M310061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=14512414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49517-49522&author=Y.+Huangauthor=R.+L.+Richauthor=D.+G.+Myszkaauthor=H.+Wu&title=Requirement+of+both+the+second+and+third+BIR+domains+for+the+relief+of+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29-mediated+caspase+inhibition+by+Smac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac</span></div><div class="casAuthors">Huang, Yihua; Rich, Rebecca L.; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49517-49522</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAP) are endogenous caspase inhibitors in the metazoan and characterized by the presence of baculoviral IAP repeats (BIR).  X-linked IAP (XIAP) contains three BIR domains and directly inhibits effector caspases such as caspase-7 via a linker BIR2 fragment and initiator caspases such as caspase-9 via the BIR3 domain.  A mitochondrial protein Smac/DIABLO, which is released during apoptosis, antagonizes XIAP-mediated caspase inhibition by interacting directly with XIAP.  Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.  In addn., Smac forms a ternary complex with caspase-7 and linker BIR2, suggesting that Smac/linker BIR2 interaction does not sterically exclude linker BIR2/caspase-7 interaction.  However, Smac is effective in removing caspase-7 and caspase-9 inhibition by XIAP fragments contg. both the BIR2 and BIR3 domains.  Surface plasmon resonance measurements show that Smac interacts with the BIR2 or BIR3 domain in micromolar dissocn. consts.  On the other hand, Smac interacts with an XIAP construct contg. both BIR2 and BIR3 domains in a subnanomolar dissocn. const. by the simultaneous interaction of the Smac dimer with the BIR2 and BIR3 domains of a single XIAP mol.  This 2:1 Smac/XIAP interaction not only possesses enhanced affinity but also sterically excludes XIAP/caspase-7 interaction, demonstrating the requirement of both BIR2 and BIR3 domains for Smac to relieve XIAP-mediated caspase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdgJwimDMLVg90H21EOLACvtfcHk0lja57-8y2TG0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrtL8%253D&md5=10937a5499d990c1237753ed28cb9509</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310061200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DRequirement%2520of%2520both%2520the%2520second%2520and%2520third%2520BIR%2520domains%2520for%2520the%2520relief%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529-mediated%2520caspase%2520inhibition%2520by%2520Smac%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49517%26epage%3D49522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lja57-8y2TG0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+potent+and+orally+active+antagonist+%28SM-406%2FAT-406%29+of+multiple+inhibitor+of+apoptosis+proteins+%28IAPs%29+in+clinical+development+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0lja57-8y2TG0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520multiple%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520in%2520clinical%2520development%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">11936</span><span class="NLM_x">–</span> <span class="NLM_lpage">11941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1073%2Fpnas.1005667107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20547836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=11936-11941&author=S.+L.+Petersenauthor=M.+Peytonauthor=J.+D.+Minnaauthor=X.+Wang&title=Overcoming+cancer+cell+resistance+to+Smac+mimetic+induced+apoptosis+by+modulating+cIAP-2+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span></div><div class="casAuthors">Petersen, Sean L.; Peyton, Michael; Minna, John D.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">11936-11941, S11936/1-S11936/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smac mimetics target cancer cells in a TNFα-dependent manner, partly via proteasome degrdn. of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2.  Degrdn. of cIAPs triggers the release of receptor interacting protein kinase (RIPK1) from TNF receptor 1 (TNFR1) to form a caspase-8 activating complex together with the adaptor protein Fas-assocd. death domain (FADD).  We report here a means through which cancer cells mediate resistance to Smac mimetic/TNFα-induced apoptosis and corresponding strategies to overcome such resistance.  These human cancer cell lines evades Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds and is refractory to subsequent degrdn. clAP2 is induced by TNFa via NF-κB and modulation of the NF-κB signal renders otherwise resistant cells sensitive to Smac mimetics.  In addn., other signaling pathways, including phosphatidyl inositol-3 kinase (PI3K), have the potential to concurrently regulate cIAP2.  Using the P13K inhibitor, LY294002, dAP2 up-regulation was suppressed and resistance to Smac mimetics-induced apoptosis was also overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp5NQOxkS-wLVg90H21EOLACvtfcHk0lja57-8y2TG0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D&md5=278c84b651abd7af0357a7023977d54b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005667107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005667107%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DOvercoming%2520cancer%2520cell%2520resistance%2520to%2520Smac%2520mimetic%2520induced%2520apoptosis%2520by%2520modulating%2520cIAP-2%2520expression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D11936%26epage%3D11941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Darding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenev, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fcdd.2011.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=21331077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Gku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1376-1386&author=M.+Dardingauthor=R.+Felthamauthor=T.+Tenevauthor=K.+Bianchiauthor=C.+Benetatosauthor=J.+Silkeauthor=P.+Meier&title=Molecular+determinants+of+Smac+mimetic+induced+degradation+of+cIAP1+and+cIAP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2</span></div><div class="casAuthors">Darding, M.; Feltham, R.; Tenev, T.; Bianchi, K.; Benetatos, C.; Silke, J.; Meier, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1376-1386</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitors of apoptosis (IAP) proteins cIAP1 and cIAP2 have recently emerged as key ubiquitin-E3 ligases regulating innate immunity and cell survival.  Much of our knowledge of these IAPs stems from studies using pharmacol. inhibitors of IAPs, dubbed Smac mimetics (SMs).  Although SMs stimulate auto-ubiquitylation and degrdn. of cIAPs, little is known about the mol. determinants through which SMs activate the E3 activities of cIAPs.  In this study, we find that SM-induced rapid degrdn. of cIAPs requires binding to tumor necrosis factor (TNF) receptor-assocd. factor 2 (TRAF2).  Moreover, our data reveal an unexpected difference between cIAP1 and cIAP2.  Although SM-induced degrdn. of cIAP1 does not require cIAP2, degrdn. of cIAP2 critically depends on the presence of cIAP1.  In addn., degrdn. of cIAP2 also requires the ability of the cIAP2 RING finger to dimerize and to bind to E2s.  This has important implications because SM-mediated degrdn. of cIAP1 causes non-canonical activation of NF-κB, which results in the induction of cIAP2 gene expression.  In the absence of cIAP1, de novo synthesized cIAP2 is resistant to the SM and suppresses TNFα killing.  Furthermore, the cIAP2-MALT1 oncogene, which lacks cIAP2's RING, is resistant to SM treatment.  The identification of mechanisms through which cancer cells resist SM treatment will help to improve combination therapies aimed at enhancing treatment response.  Cell Death and Differentiation (2011) 18, 1376-1386; doi:10.1038/cdd.2011.10; published online 18 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4NOSBSh10pbVg90H21EOLACvtfcHk0li6XDBIG7JaVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Gku7Y%253D&md5=9b2f69d64a67edb7c9def4b6b6e3602a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.10%26sid%3Dliteratum%253Aachs%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBenetatos%26aufirst%3DC.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DMolecular%2520determinants%2520of%2520Smac%2520mimetic%2520induced%2520degradation%2520of%2520cIAP1%2520and%2520cIAP2%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1376%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1229-1238&author=L.+Baiauthor=D.+McEachernauthor=C.-Y.+Yangauthor=J.+Luauthor=H.+Sunauthor=S.+Wang&title=LRIG1+modulates+cancer+cell+sensitivity+to+Smac+mimetics+by+regulating+TNF%CE%B1+expression+and+receptor+tyrosine+kinase+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DLRIG1%2520modulates%2520cancer%2520cell%2520sensitivity%2520to%2520Smac%2520mimetics%2520by%2520regulating%2520TNF%25CE%25B1%2520expression%2520and%2520receptor%2520tyrosine%2520kinase%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D1229%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Bellucci, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umani-Ronchi, A.</span><span> </span><span class="NLM_article-title">Catalytic asymmetric synthesis of secondary alcohols using chiral <i>cis</i>-1-amino-2-hydroxy-1,2,3,4-tetrahydronapthalene as chiral ligand</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=895-902&author=C.+M.+Bellucciauthor=A.+Bergaminiauthor=P.+G.+Cozziauthor=A.+Papaauthor=E.+Tagliaviniauthor=A.+Umani-Ronchi&title=Catalytic+asymmetric+synthesis+of+secondary+alcohols+using+chiral+cis-1-amino-2-hydroxy-1%2C2%2C3%2C4-tetrahydronapthalene+as+chiral+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellucci%26aufirst%3DC.%2BM.%26aulast%3DBergamini%26aufirst%3DA.%26aulast%3DCozzi%26aufirst%3DP.%2BG.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DTagliavini%26aufirst%3DE.%26aulast%3DUmani-Ronchi%26aufirst%3DA.%26atitle%3DCatalytic%2520asymmetric%2520synthesis%2520of%2520secondary%2520alcohols%2520using%2520chiral%2520cis-1-amino-2-hydroxy-1%252C2%252C3%252C4-tetrahydronapthalene%2520as%2520chiral%2520ligand%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D895%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Winstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschan, R.</span><span> </span><span class="NLM_article-title">The role of neighboring groups in replacement reactions. XVII. Complex neighboring groups. The benzamido group</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">4669</span><span class="NLM_x">–</span> <span class="NLM_lpage">4677</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01166a090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1950&pages=4669-4677&author=S.+Winsteinauthor=R.+Boschan&title=The+role+of+neighboring+groups+in+replacement+reactions.+XVII.+Complex+neighboring+groups.+The+benzamido+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja01166a090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01166a090%26sid%3Dliteratum%253Aachs%26aulast%3DWinstein%26aufirst%3DS.%26aulast%3DBoschan%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520neighboring%2520groups%2520in%2520replacement%2520reactions.%2520XVII.%2520Complex%2520neighboring%2520groups.%2520The%2520benzamido%2520group%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1950%26volume%3D72%26spage%3D4669%26epage%3D4677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Higashijima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, S.</span><span> </span><span class="NLM_article-title"><i>cis</i>-1-Amino-1,2,3,4-tetrahydro-2-napthalenol: Resolution and application to the catalytic enantioselective reduction of ketones</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3107</span><span class="NLM_x">–</span> <span class="NLM_lpage">3110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=3107-3110&author=S.+Higashijimaauthor=H.+Itohauthor=Y.+Sendaauthor=S.+Nakano&title=cis-1-Amino-1%2C2%2C3%2C4-tetrahydro-2-napthalenol%3A+Resolution+and+application+to+the+catalytic+enantioselective+reduction+of+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHigashijima%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DSenda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DS.%26atitle%3Dcis-1-Amino-1%252C2%252C3%252C4-tetrahydro-2-napthalenol%253A%2520Resolution%2520and%2520application%2520to%2520the%2520catalytic%2520enantioselective%2520reduction%2520of%2520ketones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D3107%26epage%3D3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Lakshman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, S. M.</span><span> </span><span class="NLM_article-title">A general chemoenzymatic synthesis of enantiopure cis β-amino alcohols from microbially derived cis-glycols</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1055%2Fs-1998-6082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1352-1356&author=M.+K.+Lakshmanauthor=S.+Chaturvediauthor=B.+Zajcauthor=D.+T.+Gibsonauthor=S.+M.+Resnick&title=A+general+chemoenzymatic+synthesis+of+enantiopure+cis+%CE%B2-amino+alcohols+from+microbially+derived+cis-glycols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-6082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-6082%26sid%3Dliteratum%253Aachs%26aulast%3DLakshman%26aufirst%3DM.%2BK.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DZajc%26aufirst%3DB.%26aulast%3DGibson%26aufirst%3DD.%2BT.%26aulast%3DResnick%26aufirst%3DS.%2BM.%26atitle%3DA%2520general%2520chemoenzymatic%2520synthesis%2520of%2520enantiopure%2520cis%2520%25CE%25B2-amino%2520alcohols%2520from%2520microbially%2520derived%2520cis-glycols%26jtitle%3DSynthesis%26date%3D1998%26volume%3D30%26spage%3D1352%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Orsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestetti, G.</span><span> </span><span class="NLM_article-title">Enantiopure vic-amino alcohols and vic-diamines from (1<i>R</i>,2<i>S</i>)-1,2-dihydroxy-1,2-dihydronapthalene</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=2961-2969&author=F.+Orsiniauthor=G.+Selloauthor=G.+Bestetti&title=Enantiopure+vic-amino+alcohols+and+vic-diamines+from+%281R%2C2S%29-1%2C2-dihydroxy-1%2C2-dihydronapthalene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26aulast%3DBestetti%26aufirst%3DG.%26atitle%3DEnantiopure%2520vic-amino%2520alcohols%2520and%2520vic-diamines%2520from%2520%25281R%252C2S%2529-1%252C2-dihydroxy-1%252C2-dihydronapthalene%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2001%26volume%3D12%26spage%3D2961%26epage%3D2969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Shieh, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repic, O.</span><span> </span><span class="NLM_article-title">Synthesis of sterically-hindered peptidomimetics using 4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl-morpolinium chloride</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5359</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=5359-5362&author=W.-C.+Shiehauthor=Z.+Chenauthor=S.+Xueauthor=J.+McKennaauthor=R.-M.+Wangauthor=K.+Prasadauthor=O.+Repic&title=Synthesis+of+sterically-hindered+peptidomimetics+using+4-%284%2C6-dimethoxy-1%2C3%2C5-triazine-2-yl%29-4-methyl-morpolinium+chloride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShieh%26aufirst%3DW.-C.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DS.%26aulast%3DMcKenna%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.-M.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DRepic%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520sterically-hindered%2520peptidomimetics%2520using%25204-%25284%252C6-dimethoxy-1%252C3%252C5-triazine-2-yl%2529-4-methyl-morpolinium%2520chloride%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D5359%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Vu, T. C.; Brzozowksi, D. B.; Fox, R.; Godfrey, J. D.; Hanson, R. L.; Kolotuchin, S. V.; Mazzullo, J. A.; Patel, R. N.; Wang, J.; Wong, K.; Yu, J.; Zhu, J.; Magnin, D. R.; Augeri, D. J.; Hamann, L. G.</span><span> </span><span class="NLM_article-title">Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof</span>. Patent WO2004052850,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+C.+Vu&author=D.+B.+Brzozowksi&author=R.+Fox&author=J.+D.+Godfrey&author=R.+L.+Hanson&author=S.+V.+Kolotuchin&author=J.+A.+Mazzullo&author=R.+N.+Patel&author=J.+Wang&author=K.+Wong&author=J.+Yu&author=J.+Zhu&author=D.+R.+Magnin&author=D.+J.+Augeri&author=L.+G.+Hamann&title=Methods+and+compounds+producing+dipeptidyl+peptidase+IV+inhibitors+and+intermediates+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DT.%2BC.%26atitle%3DMethods%2520and%2520compounds%2520producing%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520and%2520intermediates%2520thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Nötzel, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labahn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Es-Sayed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Meijere, A.</span><span> </span><span class="NLM_article-title">A new and efficient access to thiazoline-4-carboxylates and cysteine derivatives incorporating cyclopropyl groups</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">3025</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=3025-3030&author=M.+W.+N%C3%B6tzelauthor=T.+Labahnauthor=M.+Es-Sayedauthor=A.+de+Meijere&title=A+new+and+efficient+access+to+thiazoline-4-carboxylates+and+cysteine+derivatives+incorporating+cyclopropyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25B6tzel%26aufirst%3DM.%2BW.%26aulast%3DLabahn%26aufirst%3DT.%26aulast%3DEs-Sayed%26aufirst%3DM.%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26atitle%3DA%2520new%2520and%2520efficient%2520access%2520to%2520thiazoline-4-carboxylates%2520and%2520cysteine%2520derivatives%2520incorporating%2520cyclopropyl%2520groups%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2001%26spage%3D3025%26epage%3D3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Walker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, P. J.</span><span> </span><span class="NLM_article-title">Stereospecific cis radical addition. Convincing evidence for a 1,3-radical transfer reaction</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=462-463&author=B.+J.+Walkerauthor=P.+J.+Wrobel&title=Stereospecific+cis+radical+addition.+Convincing+evidence+for+a+1%2C3-radical+transfer+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DB.%2BJ.%26aulast%3DWrobel%26aufirst%3DP.%2BJ.%26atitle%3DStereospecific%2520cis%2520radical%2520addition.%2520Convincing%2520evidence%2520for%2520a%25201%252C3-radical%2520transfer%2520reaction%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1980%26spage%3D462%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':[],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 52 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Tanaji T. Talele</span>. </span><span class="cited-content_cbyCitation_article-title">Acetylene Group, Friend or Foe in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (11)
                                     , 5625-5663. <a href="https://doi.org/10.1021/acs.jmedchem.9b01617" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01617</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01617%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAcetylene%252BGroup%25252C%252BFriend%252Bor%252BFoe%252Bin%252BMedicinal%252BChemistry%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D29092019%26date%3D19022020%26date%3D07022020%26volume%3D63%26issue%3D11%26spage%3D5625%26epage%3D5663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yassin M. Elbatrawi, Kyle P. Pedretty, Nicole Giddings, H. Lee Woodcock, <span class="NLM_string-name hlFld-ContribAuthor">Juan R. Del Valle</span>. </span><span class="cited-content_cbyCitation_article-title">δ-Azaproline and Its Oxidized Variants. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 4207-4219. <a href="https://doi.org/10.1021/acs.joc.9b03384" title="DOI URL">https://doi.org/10.1021/acs.joc.9b03384</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b03384&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b03384%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%2525CE%2525B4-Azaproline%252Band%252BIts%252BOxidized%252BVariants%26aulast%3DElbatrawi%26aufirst%3DYassin%2BM.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D09032020%26date%3D26022020%26volume%3D85%26issue%3D6%26spage%3D4207%26epage%3D4219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hui Cong, Lijuan Xu, Yougen Wu, Zhuo Qu, Tengfei Bian, Wannian Zhang, Chengguo Xing, <span class="NLM_string-name hlFld-ContribAuthor">Chunlin Zhuang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (12)
                                     , 5750-5772. <a href="https://doi.org/10.1021/acs.jmedchem.8b01668" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01668</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01668%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInhibitor%252Bof%252BApoptosis%252BProtein%252B%252528IAP%252529%252BAntagonists%252Bin%252BAnticancer%252BAgent%252BDiscovery%25253A%252BCurrent%252BStatus%252Band%252BPerspectives%26aulast%3DCong%26aufirst%3DHui%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D27102018%26date%3D01022019%26date%3D24012019%26volume%3D62%26issue%3D12%26spage%3D5750%26epage%3D5772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Guofeng Li, Ying Yao, Zheng Wang, Man Zhao, Jiecheng Xu, Liwu Huang, Gongming Zhu, Guangjun Bao, Wangsheng Sun, Liang Hong, <span class="NLM_string-name hlFld-ContribAuthor">Rui Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Switchable Skeletal Rearrangement of Dihydroisobenzofuran Acetals with Indoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2019,</strong> <em>21 </em>
                                    (11)
                                     , 4313-4317. <a href="https://doi.org/10.1021/acs.orglett.9b01488" title="DOI URL">https://doi.org/10.1021/acs.orglett.9b01488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.9b01488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.9b01488%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSwitchable%252BSkeletal%252BRearrangement%252Bof%252BDihydroisobenzofuran%252BAcetals%252Bwith%252BIndoles%26aulast%3DLi%26aufirst%3DGuofeng%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D28042019%26date%3D16052019%26volume%3D21%26issue%3D11%26spage%3D4313%26epage%3D4317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Solange Da Silva Pinto, Stephen G. Davies, Ai M. Fletcher, Paul M. Roberts, <span class="NLM_string-name hlFld-ContribAuthor">James E. Thomson</span>. </span><span class="cited-content_cbyCitation_article-title">Diastereoselective Ammonium-Directed Epoxidation in the Asymmetric Syntheses of Dihydroconduramines (+)-C-2, (−)-C-2, (+)-D-2, (+)-E-2, (+)-F-2, and (−)-F-2. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>83 </em>
                                    (17)
                                     , 9939-9957. <a href="https://doi.org/10.1021/acs.joc.8b01359" title="DOI URL">https://doi.org/10.1021/acs.joc.8b01359</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.8b01359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.8b01359%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDiastereoselective%252BAmmonium-Directed%252BEpoxidation%252Bin%252Bthe%252BAsymmetric%252BSyntheses%252Bof%252BDihydroconduramines%252B%252528%25252B%252529-C-2%25252C%252B%252528%2525E2%252588%252592%252529-C-2%25252C%252B%252528%25252B%252529-D-2%25252C%252B%252528%25252B%252529-E-2%25252C%252B%252528%25252B%252529-F-2%25252C%252Band%252B%252528%2525E2%252588%252592%252529-F-2%26aulast%3DDa%2BSilva%2BPinto%26aufirst%3DSolange%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30052018%26date%3D07082018%26date%3D24072018%26volume%3D83%26issue%3D17%26spage%3D9939%26epage%3D9957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher N. Johnson, Jong Sook Ahn, Ildiko M. Buck, Elisabetta Chiarparin, James E. H. Day, Anna Hopkins, Steven Howard, Edward J. Lewis, Vanessa Martins, Alessia Millemaggi, Joanne M. Munck, Lee W. Page, Torren Peakman, Michael Reader, Sharna J. Rich, Gordon Saxty, Tomoko Smyth, Neil T. Thompson, George A. Ward, Pamela A. Williams, Nicola E. Wilsher, <span class="NLM_string-name hlFld-ContribAuthor">Gianni Chessari</span>. </span><span class="cited-content_cbyCitation_article-title">A Fragment-Derived Clinical Candidate for Antagonism of X-Linked and Cellular Inhibitor of Apoptosis Proteins: 1-(6-[(4-Fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-1H,2H,3H-pyrrolo[3,2-b]pyridin-1-yl)-2-[(2R,5R)-5-methyl-2-([(3R)-3-methylmorpholin-4-yl]methyl)piperazin-1-yl]ethan-1-one (ASTX660). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (16)
                                     , 7314-7329. <a href="https://doi.org/10.1021/acs.jmedchem.8b00900" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00900</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00900&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00900%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DA%252BFragment-Derived%252BClinical%252BCandidate%252Bfor%252BAntagonism%252Bof%252BX-Linked%252Band%252BCellular%252BInhibitor%252Bof%252BApoptosis%252BProteins%25253A%252B1-%2525286-%25255B%2525284-Fluorophenyl%252529methyl%25255D-5-%252528hydroxymethyl%252529-3%25252C3-dimethyl-1H%25252C2H%25252C3H-pyrrolo%25255B3%25252C2-b%25255Dpyridin-1-yl%252529-2-%25255B%2525282R%25252C5R%252529-5-methyl-2-%252528%25255B%2525283R%252529-3-methylmorpholin-4-yl%25255Dmethyl%252529piperazin-1-yl%25255Dethan-1-one%252B%252528ASTX660%252529%26aulast%3DJohnson%26aufirst%3DChristopher%2BN.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D06062018%26date%3D09082018%26volume%3D61%26issue%3D16%26spage%3D7314%26epage%3D7329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qiupeng  Hu</span>, <span class="hlFld-ContribAuthor ">Jianzhong  Chen</span>, <span class="hlFld-ContribAuthor ">Zhenfeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Yangang  Liu</span>, and <span class="hlFld-ContribAuthor ">Wanbin  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Rh-Catalyzed One-Pot Sequential Asymmetric Hydrogenation of α-Dehydroamino Ketones for the Synthesis of Chiral Cyclic trans-β-Amino Alcohols. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (6)
                                     , 1290-1293. <a href="https://doi.org/10.1021/acs.orglett.6b00212" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b00212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b00212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b00212%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DRh-Catalyzed%252BOne-Pot%252BSequential%252BAsymmetric%252BHydrogenation%252Bof%252B%2525CE%2525B1-Dehydroamino%252BKetones%252Bfor%252Bthe%252BSynthesis%252Bof%252BChiral%252BCyclic%252Btrans-%2525CE%2525B2-Amino%252BAlcohols%26aulast%3DHu%26aufirst%3DQiupeng%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D22012016%26date%3D08032016%26date%3D18032016%26volume%3D18%26issue%3D6%26spage%3D1290%26epage%3D1293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gianni  Chessari</span>, <span class="hlFld-ContribAuthor ">Ildiko M.  Buck</span>, <span class="hlFld-ContribAuthor ">James E. H.  Day</span>, <span class="hlFld-ContribAuthor ">Philip J.  Day</span>, <span class="hlFld-ContribAuthor ">Aman  Iqbal</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Johnson</span>, <span class="hlFld-ContribAuthor ">Edward J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Vanessa  Martins</span>, <span class="hlFld-ContribAuthor ">Darcey  Miller</span>, <span class="hlFld-ContribAuthor ">Michael  Reader</span>, <span class="hlFld-ContribAuthor ">David C.  Rees</span>, <span class="hlFld-ContribAuthor ">Sharna J.  Rich</span>, <span class="hlFld-ContribAuthor ">Emiliano  Tamanini</span>, <span class="hlFld-ContribAuthor ">Marc  Vitorino</span>, <span class="hlFld-ContribAuthor ">George A.  Ward</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Williams</span>, <span class="hlFld-ContribAuthor ">Glyn  Williams</span>, <span class="hlFld-ContribAuthor ">Nicola E.  Wilsher</span>, and <span class="hlFld-ContribAuthor ">Alison J.-A.  Woolford</span>  . </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Drug Discovery Targeting Inhibitor of Apoptosis Proteins: Discovery of a Non-Alanine Lead Series with Dual Activity Against cIAP1 and XIAP. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (16)
                                     , 6574-6588. <a href="https://doi.org/10.1021/acs.jmedchem.5b00706" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00706</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00706%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFragment-Based%252BDrug%252BDiscovery%252BTargeting%252BInhibitor%252Bof%252BApoptosis%252BProteins%25253A%252BDiscovery%252Bof%252Ba%252BNon-Alanine%252BLead%252BSeries%252Bwith%252BDual%252BActivity%252BAgainst%252BcIAP1%252Band%252BXIAP%26aulast%3DChessari%26aufirst%3DGianni%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07052015%26date%3D07082015%26date%3D27082015%26date%3D28072015%26volume%3D58%26issue%3D16%26spage%3D6574%26epage%3D6588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Zhang</span>, <span class="hlFld-ContribAuthor ">Benjamin A.  Seigal</span>, <span class="hlFld-ContribAuthor ">Nicholas K.  Terrett</span>, <span class="hlFld-ContribAuthor ">Randy L.  Talbott</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Naglich</span>, <span class="hlFld-ContribAuthor ">Charu  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Shana L.  Posy</span>, <span class="hlFld-ContribAuthor ">Ragini  Vuppugalla</span>, <span class="hlFld-ContribAuthor ">Georgia  Cornelius</span>, <span class="hlFld-ContribAuthor ">Ming  Lei</span>, <span class="hlFld-ContribAuthor ">Chunlei  Wang</span>, <span class="hlFld-ContribAuthor ">Yingru  Zhang</span>, <span class="hlFld-ContribAuthor ">Robert J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Donna D.  Wei</span>, <span class="hlFld-ContribAuthor ">Michael M.  Miller</span>, <span class="hlFld-ContribAuthor ">Martin P.  Allen</span>, <span class="hlFld-ContribAuthor ">Ling  Li</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Vite</span>, and <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>  . </span><span class="cited-content_cbyCitation_article-title">Dimeric Macrocyclic Antagonists of Inhibitor of Apoptosis Proteins for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (7)
                                     , 770-775. <a href="https://doi.org/10.1021/acsmedchemlett.5b00091" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00091</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00091%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDimeric%252BMacrocyclic%252BAntagonists%252Bof%252BInhibitor%252Bof%252BApoptosis%252BProteins%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DZhang%26aufirst%3DYong%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D26022015%26date%3D27052015%26date%3D12062015%26date%3D09072015%26date%3D27052015%26volume%3D6%26issue%3D7%26spage%3D770%26epage%3D775" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin A.  Seigal</span>, <span class="hlFld-ContribAuthor ">William H.  Connors</span>, <span class="hlFld-ContribAuthor ">Andrew  Fraley</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Percy H.  Carter</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Emanuel</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Ming  Lei</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Naglich</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Pokross</span>, <span class="hlFld-ContribAuthor ">Shana L.  Posy</span>, <span class="hlFld-ContribAuthor ">Henry  Shen</span>, <span class="hlFld-ContribAuthor ">Neha  Surti</span>, <span class="hlFld-ContribAuthor ">Randy  Talbott</span>, <span class="hlFld-ContribAuthor ">Yong  Zhang</span>, and <span class="hlFld-ContribAuthor ">Nicholas K.  Terrett</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Macrocyclic XIAP Antagonists from a DNA-Programmed Chemistry Library, and Their Optimization To Give Lead Compounds with in Vivo Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2855-2861. <a href="https://doi.org/10.1021/jm501892g" title="DOI URL">https://doi.org/10.1021/jm501892g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501892g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501892g%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BMacrocyclic%252BXIAP%252BAntagonists%252Bfrom%252Ba%252BDNA-Programmed%252BChemistry%252BLibrary%25252C%252Band%252BTheir%252BOptimization%252BTo%252BGive%252BLead%252BCompounds%252Bwith%252Bin%252BVivo%252BAntitumor%252BActivity%26aulast%3DSeigal%26aufirst%3DBenjamin%2BA.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05122014%26date%3D12032015%26date%3D26032015%26date%3D19022015%26volume%3D58%26issue%3D6%26spage%3D2855%26epage%3D2861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heidi L.  Perez</span>, <span class="hlFld-ContribAuthor ">Charu  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Stuart L.  Emanuel</span>, <span class="hlFld-ContribAuthor ">Caroline  Fanslau</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Jinping  Gan</span>, <span class="hlFld-ContribAuthor ">Kyoung S.  Kim</span>, <span class="hlFld-ContribAuthor ">Ming  Lei</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Naglich</span>, <span class="hlFld-ContribAuthor ">Sarah C.  Traeger</span>, <span class="hlFld-ContribAuthor ">Ragini  Vuppugalla</span>, <span class="hlFld-ContribAuthor ">Donna D.  Wei</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Vite</span>, <span class="hlFld-ContribAuthor ">Randy L.  Talbott</span>, and <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Heterodimeric Antagonists of Inhibitor of Apoptosis Proteins (IAPs) with Sustained Antitumor Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (3)
                                     , 1556-1562. <a href="https://doi.org/10.1021/jm501482t" title="DOI URL">https://doi.org/10.1021/jm501482t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501482t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501482t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BHeterodimeric%252BAntagonists%252Bof%252BInhibitor%252Bof%252BApoptosis%252BProteins%252B%252528IAPs%252529%252Bwith%252BSustained%252BAntitumor%252BActivity%26aulast%3DPerez%26aufirst%3DHeidi%2BL.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D25092014%26date%3D23012015%26date%3D12022015%26date%3D13012015%26volume%3D58%26issue%3D3%26spage%3D1556%26epage%3D1562" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagis  Polykretis</span>, <span class="hlFld-ContribAuthor ">Enrico  Luchinat</span>. </span><span class="cited-content_cbyCitation_article-title">Biophysical characterization of the interaction between the full-length XIAP and Smac/DIABLO. </span><span class="cited-content_cbyCitation_journal-name">Biochemical and Biophysical Research Communications</span><span> <strong>2021,</strong> <em>568 </em>, 180-185. <a href="https://doi.org/10.1016/j.bbrc.2021.06.077" title="DOI URL">https://doi.org/10.1016/j.bbrc.2021.06.077</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbrc.2021.06.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbrc.2021.06.077%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520and%2520Biophysical%2520Research%2520Communications%26atitle%3DBiophysical%252Bcharacterization%252Bof%252Bthe%252Binteraction%252Bbetween%252Bthe%252Bfull-length%252BXIAP%252Band%252BSmac%25252FDIABLO%26aulast%3DPolykretis%26aufirst%3DPanagis%26date%3D2021%26volume%3D568%26spage%3D180%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Huan  Hou</span>, <span class="hlFld-ContribAuthor ">Kui  Su</span>, <span class="hlFld-ContribAuthor ">Chaohong  Huang</span>, <span class="hlFld-ContribAuthor ">Qian  Yuan</span>, <span class="hlFld-ContribAuthor ">Shuyi  Li</span>, <span class="hlFld-ContribAuthor ">Jianwu  Sun</span>, <span class="hlFld-ContribAuthor ">Yue  Lin</span>, <span class="hlFld-ContribAuthor ">Zhiyun  Du</span>, <span class="hlFld-ContribAuthor ">Changhong  Ke</span>, <span class="hlFld-ContribAuthor ">Zhengqiang  Yuan</span>. </span><span class="cited-content_cbyCitation_article-title">TRAIL‐Armed ER Nanosomes Induce Drastically Enhanced Apoptosis in Resistant Tumor in Combination with the Antagonist of IAPs (AZD5582). </span><span class="cited-content_cbyCitation_journal-name">Advanced Healthcare Materials</span><span> <strong>2021,</strong> <em>10 </em>
                                    (11)
                                     , 2100030. <a href="https://doi.org/10.1002/adhm.202100030" title="DOI URL">https://doi.org/10.1002/adhm.202100030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adhm.202100030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadhm.202100030%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Healthcare%2520Materials%26atitle%3DTRAIL%2525E2%252580%252590Armed%252BER%252BNanosomes%252BInduce%252BDrastically%252BEnhanced%252BApoptosis%252Bin%252BResistant%252BTumor%252Bin%252BCombination%252Bwith%252Bthe%252BAntagonist%252Bof%252BIAPs%252B%252528AZD5582%252529%26aulast%3DHou%26aufirst%3DHuan%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D11%26spage%3D2100030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott E.  Wolkenberg</span>, <span class="hlFld-ContribAuthor ">Abdellatif El  Marrouni</span>, <span class="hlFld-ContribAuthor ">Antonella  Converso</span>, <span class="hlFld-ContribAuthor ">David M.  Tellers</span>, <span class="hlFld-ContribAuthor ">Richard J. O.  Barnard</span>, <span class="hlFld-ContribAuthor ">Tracy L.  Diamond</span>. </span><span class="cited-content_cbyCitation_article-title">Current Status of Approaches to Eradicate
              HIV
              Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-27. <a href="https://doi.org/10.1002/0471266949.bmc281" title="DOI URL">https://doi.org/10.1002/0471266949.bmc281</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc281%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BStatus%252Bof%252BApproaches%252Bto%252BEradicate%252BHIV%252BInfection%26aulast%3DWolkenberg%26aufirst%3DScott%2BE.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D27%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D51" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mari  Hashimoto</span>, <span class="hlFld-ContribAuthor ">Yoriko  Saito</span>, <span class="hlFld-ContribAuthor ">Ryo  Nakagawa</span>, <span class="hlFld-ContribAuthor ">Ikuko  Ogahara</span>, <span class="hlFld-ContribAuthor ">Shinsuke  Takagi</span>, <span class="hlFld-ContribAuthor ">Sadaaki  Takata</span>, <span class="hlFld-ContribAuthor ">Hanae  Amitani</span>, <span class="hlFld-ContribAuthor ">Mikiko  Endo</span>, <span class="hlFld-ContribAuthor ">Hitomi  Yuki</span>, <span class="hlFld-ContribAuthor ">Jordan A.  Ramilowski</span>, <span class="hlFld-ContribAuthor ">Jessica  Severin</span>, <span class="hlFld-ContribAuthor ">Ri-ichiroh  Manabe</span>, <span class="hlFld-ContribAuthor ">Takashi  Watanabe</span>, <span class="hlFld-ContribAuthor ">Kokoro  Ozaki</span>, <span class="hlFld-ContribAuthor ">Akiko  Kaneko</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Kajita</span>, <span class="hlFld-ContribAuthor ">Saera  Fujiki</span>, <span class="hlFld-ContribAuthor ">Kaori  Sato</span>, <span class="hlFld-ContribAuthor ">Teruki  Honma</span>, <span class="hlFld-ContribAuthor ">Naoyuki  Uchida</span>, <span class="hlFld-ContribAuthor ">Takehiro  Fukami</span>, <span class="hlFld-ContribAuthor ">Yasushi  Okazaki</span>, <span class="hlFld-ContribAuthor ">Osamu  Ohara</span>, <span class="hlFld-ContribAuthor ">Leonard D.  Shultz</span>, <span class="hlFld-ContribAuthor ">Makoto  Yamada</span>, <span class="hlFld-ContribAuthor ">Shuichi  Taniguchi</span>, <span class="hlFld-ContribAuthor ">Paresh  Vyas</span>, <span class="hlFld-ContribAuthor ">Michiel  de Hoon</span>, <span class="hlFld-ContribAuthor ">Yukihide  Momozawa</span>, <span class="hlFld-ContribAuthor ">Fumihiko  Ishikawa</span>. </span><span class="cited-content_cbyCitation_article-title">Combined inhibition of XIAP and BCL2 drives maximal therapeutic efficacy in genetically diverse aggressive acute myeloid leukemia. </span><span class="cited-content_cbyCitation_journal-name">Nature Cancer</span><span> <strong>2021,</strong> <em>2 </em>
                                    (3)
                                     , 340-356. <a href="https://doi.org/10.1038/s43018-021-00177-w" title="DOI URL">https://doi.org/10.1038/s43018-021-00177-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s43018-021-00177-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs43018-021-00177-w%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Cancer%26atitle%3DCombined%252Binhibition%252Bof%252BXIAP%252Band%252BBCL2%252Bdrives%252Bmaximal%252Btherapeutic%252Befficacy%252Bin%252Bgenetically%252Bdiverse%252Baggressive%252Bacute%252Bmyeloid%252Bleukemia%26aulast%3DHashimoto%26aufirst%3DMari%26date%3D2021%26date%3D2021%26volume%3D2%26issue%3D3%26spage%3D340%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Animal models of disease states. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 371-420. <a href="https://doi.org/10.1016/B978-0-12-817214-8.00007-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-817214-8.00007-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-817214-8.00007-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-817214-8.00007-5%26sid%3Dliteratum%253Aachs%26atitle%3DAnimal%252Bmodels%252Bof%252Bdisease%252Bstates%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2021%26spage%3D371%26epage%3D420%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2021%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chun Hei Antonio  Cheung</span>, <span class="hlFld-ContribAuthor ">Yung-Chieh  Chang</span>, <span class="hlFld-ContribAuthor ">Tzu-Yu  Lin</span>, <span class="hlFld-ContribAuthor ">Siao Muk  Cheng</span>, <span class="hlFld-ContribAuthor ">Euphemia  Leung</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2020,</strong> <em>27 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-020-0627-5" title="DOI URL">https://doi.org/10.1186/s12929-020-0627-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-020-0627-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-020-0627-5%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DAnti-apoptotic%252Bproteins%252Bin%252Bthe%252Bautophagic%252Bworld%25253A%252Ban%252Bupdate%252Bon%252Bfunctions%252Bof%252BXIAP%25252C%252BSurvivin%25252C%252Band%252BBRUCE%26aulast%3DCheung%26aufirst%3DChun%2BHei%2BAntonio%26date%3D2020%26date%3D2020%26volume%3D27%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter D.  Koch</span>, <span class="hlFld-ContribAuthor ">Mikael J.  Pittet</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>. </span><span class="cited-content_cbyCitation_article-title">The chemical biology of IL-12 production
              via
              the non-canonical NFkB pathway. </span><span class="cited-content_cbyCitation_journal-name">RSC Chemical Biology</span><span> <strong>2020,</strong> <em>1 </em>
                                    (4)
                                     , 166-176. <a href="https://doi.org/10.1039/D0CB00022A" title="DOI URL">https://doi.org/10.1039/D0CB00022A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CB00022A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CB00022A%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Chemical%2520Biology%26atitle%3DThe%252Bchemical%252Bbiology%252Bof%252BIL-12%252Bproduction%252Bvia%252Bthe%252Bnon-canonical%252BNFkB%252Bpathway%26aulast%3DKoch%26aufirst%3DPeter%2BD.%26date%3D2020%26date%3D2020%26volume%3D1%26issue%3D4%26spage%3D166%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Swati  Kumar</span>, <span class="hlFld-ContribAuthor ">Ciaran  Fairmichael</span>, <span class="hlFld-ContribAuthor ">Daniel B.  Longley</span>, <span class="hlFld-ContribAuthor ">Richard C.  Turkington</span>. </span><span class="cited-content_cbyCitation_article-title">The Multiple Roles of the IAP Super-family in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>214 </em>, 107610. <a href="https://doi.org/10.1016/j.pharmthera.2020.107610" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2020.107610</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2020.107610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2020.107610%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DThe%252BMultiple%252BRoles%252Bof%252Bthe%252BIAP%252BSuper-family%252Bin%252Bcancer%26aulast%3DKumar%26aufirst%3DSwati%26date%3D2020%26volume%3D214%26spage%3D107610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antonio Victor  Campos Coelho</span>, <span class="hlFld-ContribAuthor ">Ronald Rodrigues de  Moura</span>, <span class="hlFld-ContribAuthor ">Sergio  Crovella</span>. </span><span class="cited-content_cbyCitation_article-title">Reanalysis of Gene Expression Profiles of CD4+ T Cells Treated with HIV-1 Latency Reversal Agents. </span><span class="cited-content_cbyCitation_journal-name">Microorganisms</span><span> <strong>2020,</strong> <em>8 </em>
                                    (10)
                                     , 1505. <a href="https://doi.org/10.3390/microorganisms8101505" title="DOI URL">https://doi.org/10.3390/microorganisms8101505</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/microorganisms8101505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmicroorganisms8101505%26sid%3Dliteratum%253Aachs%26jtitle%3DMicroorganisms%26atitle%3DReanalysis%252Bof%252BGene%252BExpression%252BProfiles%252Bof%252BCD4%25252B%252BT%252BCells%252BTreated%252Bwith%252BHIV-1%252BLatency%252BReversal%252BAgents%26aulast%3DCampos%2BCoelho%26aufirst%3DAntonio%2BVictor%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D10%26spage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Maotuan  Huang</span>, <span class="hlFld-ContribAuthor ">Weihong  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaojie  Jiang</span>, <span class="hlFld-ContribAuthor ">Wei  Su</span>, <span class="hlFld-ContribAuthor ">Xiaoqian  Wang</span>, <span class="hlFld-ContribAuthor ">Nanhong  Tang</span>, <span class="hlFld-ContribAuthor ">Feifei  She</span>, <span class="hlFld-ContribAuthor ">Yanling  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Smac mimetic promotes TNF-α to induce apoptosis of gallbladder carcinoma cells. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2020,</strong> <em>72 </em>, 109654. <a href="https://doi.org/10.1016/j.cellsig.2020.109654" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109654</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109654&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109654%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DSmac%252Bmimetic%252Bpromotes%252BTNF-%2525CE%2525B1%252Bto%252Binduce%252Bapoptosis%252Bof%252Bgallbladder%252Bcarcinoma%252Bcells%26aulast%3DChen%26aufirst%3DMingyuan%26date%3D2020%26volume%3D72%26spage%3D109654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yung-Chih  Kuo</span>, <span class="hlFld-ContribAuthor ">Rajendiran  Rajesh</span>. </span><span class="cited-content_cbyCitation_article-title">Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins. </span><span class="cited-content_cbyCitation_journal-name">Journal of the Taiwan Institute of Chemical Engineers</span><span> <strong>2020,</strong> <em>111 </em>, 1-10. <a href="https://doi.org/10.1016/j.jtice.2020.05.011" title="DOI URL">https://doi.org/10.1016/j.jtice.2020.05.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jtice.2020.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jtice.2020.05.011%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520Taiwan%2520Institute%2520of%2520Chemical%2520Engineers%26atitle%3DBiomaterial-based%252Bdrug%252Bdelivery%252Bsystems%252Bused%252Bto%252Bimprove%252Bchemotherapeutic%252Bactivity%252Bof%252Bpharmaceuticals%252Band%252Bto%252Btarget%252Binhibitors%252Bof%252Bapoptosis%252Bproteins%26aulast%3DKuo%26aufirst%3DYung-Chih%26date%3D2020%26volume%3D111%26spage%3D1%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lars  Pache</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Marsden</span>, <span class="hlFld-ContribAuthor ">Peter  Teriete</span>, <span class="hlFld-ContribAuthor ">Alex J.  Portillo</span>, <span class="hlFld-ContribAuthor ">Dominik  Heimann</span>, <span class="hlFld-ContribAuthor ">Jocelyn T.  Kim</span>, <span class="hlFld-ContribAuthor ">Mohamed S.A.  Soliman</span>, <span class="hlFld-ContribAuthor ">Melanie  Dimapasoc</span>, <span class="hlFld-ContribAuthor ">Camille  Carmona</span>, <span class="hlFld-ContribAuthor ">Maria  Celeridad</span>, <span class="hlFld-ContribAuthor ">Adam M.  Spivak</span>, <span class="hlFld-ContribAuthor ">Vicente  Planelles</span>, <span class="hlFld-ContribAuthor ">Nicholas D.P.  Cosford</span>, <span class="hlFld-ContribAuthor ">Jerome A.  Zack</span>, <span class="hlFld-ContribAuthor ">Sumit K.  Chanda</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports Medicine</span><span> <strong>2020,</strong> <em>1 </em>
                                    (3)
                                     , 100037. <a href="https://doi.org/10.1016/j.xcrm.2020.100037" title="DOI URL">https://doi.org/10.1016/j.xcrm.2020.100037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.xcrm.2020.100037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.xcrm.2020.100037%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%2520Medicine%26atitle%3DPharmacological%252BActivation%252Bof%252BNon-canonical%252BNF-%2525CE%2525BAB%252BSignaling%252BActivates%252BLatent%252BHIV-1%252BReservoirs%252BIn%2525C2%2525A0Vivo%26aulast%3DPache%26aufirst%3DLars%26date%3D2020%26volume%3D1%26issue%3D3%26spage%3D100037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley  Boice</span>, <span class="hlFld-ContribAuthor ">Lisa  Bouchier-Hayes</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting apoptotic caspases in cancer. </span><span class="cited-content_cbyCitation_journal-name">Biochimica et Biophysica Acta (BBA) - Molecular Cell Research</span><span> <strong>2020,</strong> <em>1867 </em>
                                    (6)
                                     , 118688. <a href="https://doi.org/10.1016/j.bbamcr.2020.118688" title="DOI URL">https://doi.org/10.1016/j.bbamcr.2020.118688</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bbamcr.2020.118688&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bbamcr.2020.118688%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochimica%2520et%2520Biophysica%2520Acta%2520%2528BBA%2529%2520-%2520Molecular%2520Cell%2520Research%26atitle%3DTargeting%252Bapoptotic%252Bcaspases%252Bin%252Bcancer%26aulast%3DBoice%26aufirst%3DAshley%26date%3D2020%26volume%3D1867%26issue%3D6%26spage%3D118688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Li</span>, <span class="hlFld-ContribAuthor ">Pengfei  Zhou</span>, <span class="hlFld-ContribAuthor ">Gonglin  Li</span>, <span class="hlFld-ContribAuthor ">Lili  Lin</span>, <span class="hlFld-ContribAuthor ">Xiaoming  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic Asymmetric Halohydroxylation of α,β‐Unsaturated Ketones with Water as the Nucleophile. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2020,</strong> <em>362 </em>
                                    (10)
                                     , 1982-1987. <a href="https://doi.org/10.1002/adsc.202000080" title="DOI URL">https://doi.org/10.1002/adsc.202000080</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.202000080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.202000080%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DCatalytic%252BAsymmetric%252BHalohydroxylation%252Bof%252B%2525CE%2525B1%25252C%2525CE%2525B2%2525E2%252580%252590Unsaturated%252BKetones%252Bwith%252BWater%252Bas%252Bthe%252BNucleophile%26aulast%3DLi%26aufirst%3DWeiwei%26date%3D2020%26date%3D2020%26volume%3D362%26issue%3D10%26spage%3D1982%26epage%3D1987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Heng  Xu</span>, <span class="hlFld-ContribAuthor ">Zhengkuan  Tang</span>, <span class="hlFld-ContribAuthor ">Yu  Zuo</span>, <span class="hlFld-ContribAuthor ">Fengmin  Xiong</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Hao  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics simulation revealed the intrinsic conformational change of cellular inhibitor of apoptosis protein-1. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>38 </em>
                                    (4)
                                     , 975-984. <a href="https://doi.org/10.1080/07391102.2019.1591303" title="DOI URL">https://doi.org/10.1080/07391102.2019.1591303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2019.1591303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2019.1591303%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DMolecular%252Bdynamics%252Bsimulation%252Brevealed%252Bthe%252Bintrinsic%252Bconformational%252Bchange%252Bof%252Bcellular%252Binhibitor%252Bof%252Bapoptosis%252Bprotein-1%26aulast%3DXu%26aufirst%3DHeng%26date%3D2020%26date%3D2019%26volume%3D38%26issue%3D4%26spage%3D975%26epage%3D984" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher C.  Nixon</span>, <span class="hlFld-ContribAuthor ">Maud  Mavigner</span>, <span class="hlFld-ContribAuthor ">Gavin C.  Sampey</span>, <span class="hlFld-ContribAuthor ">Alyssa D.  Brooks</span>, <span class="hlFld-ContribAuthor ">Rae Ann  Spagnuolo</span>, <span class="hlFld-ContribAuthor ">David M.  Irlbeck</span>, <span class="hlFld-ContribAuthor ">Cameron  Mattingly</span>, <span class="hlFld-ContribAuthor ">Phong T.  Ho</span>, <span class="hlFld-ContribAuthor ">Nils  Schoof</span>, <span class="hlFld-ContribAuthor ">Corinne G.  Cammon</span>, <span class="hlFld-ContribAuthor ">Greg K.  Tharp</span>, <span class="hlFld-ContribAuthor ">Matthew  Kanke</span>, <span class="hlFld-ContribAuthor ">Zhang  Wang</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Cleary</span>, <span class="hlFld-ContribAuthor ">Amit A.  Upadhyay</span>, <span class="hlFld-ContribAuthor ">Chandrav  De</span>, <span class="hlFld-ContribAuthor ">Saintedym R.  Wills</span>, <span class="hlFld-ContribAuthor ">Shane D.  Falcinelli</span>, <span class="hlFld-ContribAuthor ">Cristin  Galardi</span>, <span class="hlFld-ContribAuthor ">Hasse  Walum</span>, <span class="hlFld-ContribAuthor ">Nathaniel J.  Schramm</span>, <span class="hlFld-ContribAuthor ">Jennifer  Deutsch</span>, <span class="hlFld-ContribAuthor ">Jeffrey D.  Lifson</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fennessey</span>, <span class="hlFld-ContribAuthor ">Brandon F.  Keele</span>, <span class="hlFld-ContribAuthor ">Sherrie  Jean</span>, <span class="hlFld-ContribAuthor ">Sean  Maguire</span>, <span class="hlFld-ContribAuthor ">Baolin  Liao</span>, <span class="hlFld-ContribAuthor ">Edward P.  Browne</span>, <span class="hlFld-ContribAuthor ">Robert G.  Ferris</span>, <span class="hlFld-ContribAuthor ">Jessica H.  Brehm</span>, <span class="hlFld-ContribAuthor ">David  Favre</span>, <span class="hlFld-ContribAuthor ">Thomas H.  Vanderford</span>, <span class="hlFld-ContribAuthor ">Steven E.  Bosinger</span>, <span class="hlFld-ContribAuthor ">Corbin D.  Jones</span>, <span class="hlFld-ContribAuthor ">Jean-Pierre  Routy</span>, <span class="hlFld-ContribAuthor ">Nancie M.  Archin</span>, <span class="hlFld-ContribAuthor ">David M.  Margolis</span>, <span class="hlFld-ContribAuthor ">Angela  Wahl</span>, <span class="hlFld-ContribAuthor ">Richard M.  Dunham</span>, <span class="hlFld-ContribAuthor ">Guido  Silvestri</span>, <span class="hlFld-ContribAuthor ">Ann  Chahroudi</span>, <span class="hlFld-ContribAuthor ">J. Victor  Garcia</span>. </span><span class="cited-content_cbyCitation_article-title">Systemic HIV and SIV latency reversal via non-canonical NF-κB signalling in vivo. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2020,</strong> <em>578 </em>
                                    (7793)
                                     , 160-165. <a href="https://doi.org/10.1038/s41586-020-1951-3" title="DOI URL">https://doi.org/10.1038/s41586-020-1951-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-020-1951-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-020-1951-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DSystemic%252BHIV%252Band%252BSIV%252Blatency%252Breversal%252Bvia%252Bnon-canonical%252BNF-%2525CE%2525BAB%252Bsignalling%252Bin%252Bvivo%26aulast%3DNixon%26aufirst%3DChristopher%2BC.%26date%3D2020%26date%3D2020%26volume%3D578%26issue%3D7793%26spage%3D160%26epage%3D165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongping  Zhu</span>, <span class="hlFld-ContribAuthor ">Yi  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Liu</span>, <span class="hlFld-ContribAuthor ">Bo  Han</span>. </span><span class="cited-content_cbyCitation_article-title">Bivalent SMAC Mimetics for Treating Cancer by Antagonizing Inhibitor of Apoptosis Proteins. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2019,</strong> <em>14 </em>
                                    (23)
                                     , 1951-1962. <a href="https://doi.org/10.1002/cmdc.201900410" title="DOI URL">https://doi.org/10.1002/cmdc.201900410</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201900410&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201900410%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DBivalent%252BSMAC%252BMimetics%252Bfor%252BTreating%252BCancer%252Bby%252BAntagonizing%252BInhibitor%252Bof%252BApoptosis%252BProteins%26aulast%3DZhu%26aufirst%3DHongping%26date%3D2019%26date%3D2019%26volume%3D14%26issue%3D23%26spage%3D1951%26epage%3D1962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arcan  Guven</span>, <span class="hlFld-ContribAuthor ">Wenfang S.  Wu</span>, <span class="hlFld-ContribAuthor ">Saurabh  Patil</span>, <span class="hlFld-ContribAuthor ">Karthiga  Gokul</span>, <span class="hlFld-ContribAuthor ">Poornima  Tekumalla</span>, <span class="hlFld-ContribAuthor ">Shefali  Sharma</span>, <span class="hlFld-ContribAuthor ">Anne  Diers</span>, <span class="hlFld-ContribAuthor ">Stephane  Gesta</span>, <span class="hlFld-ContribAuthor ">Vivek  Vishnudas</span>, <span class="hlFld-ContribAuthor ">Rangaprasad  Sarangarajan</span>, <span class="hlFld-ContribAuthor ">Mark D.  Kellogg</span>, <span class="hlFld-ContribAuthor ">Niven R.  Narain</span>, <span class="hlFld-ContribAuthor ">Michael A.  Kiebish</span>. </span><span class="cited-content_cbyCitation_article-title">Diablo ubiquitination analysis by sandwich immunoassay. </span><span class="cited-content_cbyCitation_journal-name">Journal of Pharmaceutical and Biomedical Analysis</span><span> <strong>2019,</strong> <em>173 </em>, 40-46. <a href="https://doi.org/10.1016/j.jpba.2019.05.005" title="DOI URL">https://doi.org/10.1016/j.jpba.2019.05.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jpba.2019.05.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jpba.2019.05.005%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Pharmaceutical%2520and%2520Biomedical%2520Analysis%26atitle%3DDiablo%252Bubiquitination%252Banalysis%252Bby%252Bsandwich%252Bimmunoassay%26aulast%3DGuven%26aufirst%3DArcan%26date%3D2019%26volume%3D173%26spage%3D40%26epage%3D46" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Panagis  Polykretis</span>, <span class="hlFld-ContribAuthor ">Enrico  Luchinat</span>, <span class="hlFld-ContribAuthor ">Alessio  Bonucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Giachetti</span>, <span class="hlFld-ContribAuthor ">Melissa A.  Graewert</span>, <span class="hlFld-ContribAuthor ">Dmitri I.  Svergun</span>, <span class="hlFld-ContribAuthor ">Lucia  Banci</span>. </span><span class="cited-content_cbyCitation_article-title">Conformational characterization of full-length X-chromosome-linked inhibitor of apoptosis protein (XIAP) through an integrated approach. </span><span class="cited-content_cbyCitation_journal-name">IUCrJ</span><span> <strong>2019,</strong> <em>6 </em>
                                    (5)
                                     , 948-957. <a href="https://doi.org/10.1107/S205225251901073X" title="DOI URL">https://doi.org/10.1107/S205225251901073X</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1107/S205225251901073X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1107%2FS205225251901073X%26sid%3Dliteratum%253Aachs%26jtitle%3DIUCrJ%26atitle%3DConformational%252Bcharacterization%252Bof%252Bfull-length%252BX-chromosome-linked%252Binhibitor%252Bof%252Bapoptosis%252Bprotein%252B%252528XIAP%252529%252Bthrough%252Ban%252Bintegrated%252Bapproach%26aulast%3DPolykretis%26aufirst%3DPanagis%26date%3D2019%26date%3D2019%26volume%3D6%26issue%3D5%26spage%3D948%26epage%3D957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Junjie  Ma</span>, <span class="hlFld-ContribAuthor ">Xin  Ni</span>, <span class="hlFld-ContribAuthor ">Yali  Gao</span>, <span class="hlFld-ContribAuthor ">Kun  Huang</span>, <span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Jiaan  Liu</span>, <span class="hlFld-ContribAuthor ">Guowei  Gong</span>. </span><span class="cited-content_cbyCitation_article-title">Semicarbazone Derivatives Bearing Phenyl Moiety: Synthesis, Anticancer Activity, Cell Cycle, Apoptosis-Inducing and Metabolic Stability Study. </span><span class="cited-content_cbyCitation_journal-name">Chemical and Pharmaceutical Bulletin</span><span> <strong>2019,</strong> <em>67 </em>
                                    (4)
                                     , 351-360. <a href="https://doi.org/10.1248/cpb.c18-00738" title="DOI URL">https://doi.org/10.1248/cpb.c18-00738</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1248/cpb.c18-00738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1248%2Fcpb.c18-00738%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520and%2520Pharmaceutical%2520Bulletin%26atitle%3DSemicarbazone%252BDerivatives%252BBearing%252BPhenyl%252BMoiety%25253A%252BSynthesis%25252C%252BAnticancer%252BActivity%25252C%252BCell%252BCycle%25252C%252BApoptosis-Inducing%252Band%252BMetabolic%252BStability%252BStudy%26aulast%3DMa%26aufirst%3DJunjie%26date%3D2019%26volume%3D67%26issue%3D4%26spage%3D351%26epage%3D360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dilys T.H.  Leung</span>, <span class="hlFld-ContribAuthor ">Trang  Nguyen</span>, <span class="hlFld-ContribAuthor ">Edwina May  Oliver</span>, <span class="hlFld-ContribAuthor ">Juliana  Matti</span>, <span class="hlFld-ContribAuthor ">Maria  Alexiadis</span>, <span class="hlFld-ContribAuthor ">John  Silke</span>, <span class="hlFld-ContribAuthor ">Thomas W.  Jobling</span>, <span class="hlFld-ContribAuthor ">Peter J.  Fuller</span>, <span class="hlFld-ContribAuthor ">Simon  Chu</span>. </span><span class="cited-content_cbyCitation_article-title">Combined PPARγ Activation and XIAP Inhibition as a Potential Therapeutic Strategy for Ovarian Granulosa Cell Tumors. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (2)
                                     , 364-375. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0078" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0078</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0078&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0078%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DCombined%252BPPAR%2525CE%2525B3%252BActivation%252Band%252BXIAP%252BInhibition%252Bas%252Ba%252BPotential%252BTherapeutic%252BStrategy%252Bfor%252BOvarian%252BGranulosa%252BCell%252BTumors%26aulast%3DLeung%26aufirst%3DDilys%2BT.H.%26date%3D2019%26date%3D2018%26volume%3D18%26issue%3D2%26spage%3D364%26epage%3D375" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fokhrul  Hossain</span>, <span class="hlFld-ContribAuthor ">Claudia  Sorrentino</span>, <span class="hlFld-ContribAuthor ">Deniz A.  Ucar</span>, <span class="hlFld-ContribAuthor ">Yin  Peng</span>, <span class="hlFld-ContribAuthor ">Margarite  Matossian</span>, <span class="hlFld-ContribAuthor ">Dorota  Wyczechowska</span>, <span class="hlFld-ContribAuthor ">Judy  Crabtree</span>, <span class="hlFld-ContribAuthor ">Jovanny  Zabaleta</span>, <span class="hlFld-ContribAuthor ">Silvana  Morello</span>, <span class="hlFld-ContribAuthor ">Luis  Del Valle</span>, <span class="hlFld-ContribAuthor ">Matthew  Burow</span>, <span class="hlFld-ContribAuthor ">Bridgette  Collins-Burow</span>, <span class="hlFld-ContribAuthor ">Antonio  Pannuti</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Minter</span>, <span class="hlFld-ContribAuthor ">Todd E.  Golde</span>, <span class="hlFld-ContribAuthor ">Barbara A.  Osborne</span>, <span class="hlFld-ContribAuthor ">Lucio  Miele</span>. </span><span class="cited-content_cbyCitation_article-title">Notch Signaling Regulates Mitochondrial Metabolism and NF-κB Activity in Triple-Negative Breast Cancer Cells via IKKα-Dependent Non-canonical Pathways. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Oncology</span><span> <strong>2018,</strong> <em>8 </em><a href="https://doi.org/10.3389/fonc.2018.00575" title="DOI URL">https://doi.org/10.3389/fonc.2018.00575</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fonc.2018.00575&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffonc.2018.00575%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Oncology%26atitle%3DNotch%252BSignaling%252BRegulates%252BMitochondrial%252BMetabolism%252Band%252BNF-%2525CE%2525BAB%252BActivity%252Bin%252BTriple-Negative%252BBreast%252BCancer%252BCells%252Bvia%252BIKK%2525CE%2525B1-Dependent%252BNon-canonical%252BPathways%26aulast%3DHossain%26aufirst%3DFokhrul%26date%3D2018%26date%3D2018%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher S.  Garris</span>, <span class="hlFld-ContribAuthor ">Sean P.  Arlauckas</span>, <span class="hlFld-ContribAuthor ">Rainer H.  Kohler</span>, <span class="hlFld-ContribAuthor ">Marcel P.  Trefny</span>, <span class="hlFld-ContribAuthor ">Seth  Garren</span>, <span class="hlFld-ContribAuthor ">Cécile  Piot</span>, <span class="hlFld-ContribAuthor ">Camilla  Engblom</span>, <span class="hlFld-ContribAuthor ">Christina  Pfirschke</span>, <span class="hlFld-ContribAuthor ">Marie  Siwicki</span>, <span class="hlFld-ContribAuthor ">Jeremy  Gungabeesoon</span>, <span class="hlFld-ContribAuthor ">Gordon J.  Freeman</span>, <span class="hlFld-ContribAuthor ">Sarah E.  Warren</span>, <span class="hlFld-ContribAuthor ">SuFey  Ong</span>, <span class="hlFld-ContribAuthor ">Erica  Browning</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Twitty</span>, <span class="hlFld-ContribAuthor ">Robert H.  Pierce</span>, <span class="hlFld-ContribAuthor ">Mai H.  Le</span>, <span class="hlFld-ContribAuthor ">Alain P.  Algazi</span>, <span class="hlFld-ContribAuthor ">Adil I.  Daud</span>, <span class="hlFld-ContribAuthor ">Sara I.  Pai</span>, <span class="hlFld-ContribAuthor ">Alfred  Zippelius</span>, <span class="hlFld-ContribAuthor ">Ralph  Weissleder</span>, <span class="hlFld-ContribAuthor ">Mikael J.  Pittet</span>. </span><span class="cited-content_cbyCitation_article-title">Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12. </span><span class="cited-content_cbyCitation_journal-name">Immunity</span><span> <strong>2018,</strong> <em>49 </em>
                                    (6)
                                     , 1148-1161.e7. <a href="https://doi.org/10.1016/j.immuni.2018.09.024" title="DOI URL">https://doi.org/10.1016/j.immuni.2018.09.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.immuni.2018.09.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.immuni.2018.09.024%26sid%3Dliteratum%253Aachs%26jtitle%3DImmunity%26atitle%3DSuccessful%252BAnti-PD-1%252BCancer%252BImmunotherapy%252BRequires%252BT%252BCell-Dendritic%252BCell%252BCrosstalk%252BInvolving%252Bthe%252BCytokines%252BIFN-%2525CE%2525B3%252Band%252BIL-12%26aulast%3DGarris%26aufirst%3DChristopher%2BS.%26date%3D2018%26volume%3D49%26issue%3D6%26spage%3D1148%26epage%3D1161.e7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Krzysztof  Owsianik</span>, <span class="hlFld-ContribAuthor ">Ewa  Krawczyk</span>, <span class="hlFld-ContribAuthor ">Grażyna  Mielniczak</span>, <span class="hlFld-ContribAuthor ">Marek  Koprowski</span>, <span class="hlFld-ContribAuthor ">Lesław  Sieroń</span>. </span><span class="cited-content_cbyCitation_article-title">Three-step synthesis of chiral and sterically hindered amino alcohols based on cyclic enol phosphates. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2018,</strong> <em>74 </em>
                                    (51)
                                     , 7343-7350. <a href="https://doi.org/10.1016/j.tet.2018.10.072" title="DOI URL">https://doi.org/10.1016/j.tet.2018.10.072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2018.10.072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2018.10.072%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DThree-step%252Bsynthesis%252Bof%252Bchiral%252Band%252Bsterically%252Bhindered%252Bamino%252Balcohols%252Bbased%252Bon%252Bcyclic%252Benol%252Bphosphates%26aulast%3DOwsianik%26aufirst%3DKrzysztof%26date%3D2018%26volume%3D74%26issue%3D51%26spage%3D7343%26epage%3D7350" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qin  Hao</span>, <span class="hlFld-ContribAuthor ">Hua  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Interferon-γ and Smac mimetics synergize to induce apoptosis of lung cancer cells in a TNFα-independent manner. </span><span class="cited-content_cbyCitation_journal-name">Cancer Cell International</span><span> <strong>2018,</strong> <em>18 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12935-018-0579-y" title="DOI URL">https://doi.org/10.1186/s12935-018-0579-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12935-018-0579-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12935-018-0579-y%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Cell%2520International%26atitle%3DInterferon-%2525CE%2525B3%252Band%252BSmac%252Bmimetics%252Bsynergize%252Bto%252Binduce%252Bapoptosis%252Bof%252Blung%252Bcancer%252Bcells%252Bin%252Ba%252BTNF%2525CE%2525B1-independent%252Bmanner%26aulast%3DHao%26aufirst%3DQin%26date%3D2018%26date%3D2018%26volume%3D18%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">George A.  Ward</span>, <span class="hlFld-ContribAuthor ">Edward J.  Lewis</span>, <span class="hlFld-ContribAuthor ">Jong Sook  Ahn</span>, <span class="hlFld-ContribAuthor ">Christopher N.  Johnson</span>, <span class="hlFld-ContribAuthor ">John F.  Lyons</span>, <span class="hlFld-ContribAuthor ">Vanessa  Martins</span>, <span class="hlFld-ContribAuthor ">Joanne M.  Munck</span>, <span class="hlFld-ContribAuthor ">Sharna J.  Rich</span>, <span class="hlFld-ContribAuthor ">Tomoko  Smyth</span>, <span class="hlFld-ContribAuthor ">Neil T.  Thompson</span>, <span class="hlFld-ContribAuthor ">Pamela A.  Williams</span>, <span class="hlFld-ContribAuthor ">Nicola E.  Wilsher</span>, <span class="hlFld-ContribAuthor ">Nicola G.  Wallis</span>, <span class="hlFld-ContribAuthor ">Gianni  Chessari</span>. </span><span class="cited-content_cbyCitation_article-title">ASTX660, a Novel Non-peptidomimetic Antagonist of cIAP1/2 and XIAP, Potently Induces TNFα-Dependent Apoptosis in Cancer Cell Lines and Inhibits Tumor Growth. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (7)
                                     , 1381-1391. <a href="https://doi.org/10.1158/1535-7163.MCT-17-0848" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-0848</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-0848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-0848%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DASTX660%25252C%252Ba%252BNovel%252BNon-peptidomimetic%252BAntagonist%252Bof%252BcIAP1%25252F2%252Band%252BXIAP%25252C%252BPotently%252BInduces%252BTNF%2525CE%2525B1-Dependent%252BApoptosis%252Bin%252BCancer%252BCell%252BLines%252Band%252BInhibits%252BTumor%252BGrowth%26aulast%3DWard%26aufirst%3DGeorge%2BA.%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D7%26spage%3D1381%26epage%3D1391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierfausto  Seneci</span>. </span><span class="cited-content_cbyCitation_article-title">Step IIIb: The Drug-Like Chemical Diversity Pool: Diverse and Targeted Compound Collections. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 115-177. <a href="https://doi.org/10.1016/B978-0-08-099420-8.00004-3" title="DOI URL">https://doi.org/10.1016/B978-0-08-099420-8.00004-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099420-8.00004-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099420-8.00004-3%26sid%3Dliteratum%253Aachs%26atitle%3DStep%252BIIIb%25253A%252BThe%252BDrug-Like%252BChemical%252BDiversity%252BPool%25253A%252BDiverse%252Band%252BTargeted%252BCompound%252BCollections%26aulast%3DSeneci%26aufirst%3DPierfausto%26date%3D2018%26spage%3D115%26epage%3D177%26pub%3DElsevier%26atitle%3DChemical%252BSciences%252Bin%252BEarly%252BDrug%252BDiscovery%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas K.  Terrett</span>. </span><span class="cited-content_cbyCitation_article-title">The Discovery of Macrocyclic IAP Inhibitors for the Treatment of Cancer. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 501-518. <a href="https://doi.org/10.1002/9781119092599.ch17" title="DOI URL">https://doi.org/10.1002/9781119092599.ch17</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119092599.ch17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119092599.ch17%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BDiscovery%252Bof%252BMacrocyclic%252BIAP%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BCancer%26aulast%3DTerrett%26aufirst%3DNicholas%2BK.%26date%3D2017%26date%3D2017%26spage%3D501%26epage%3D518%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPractical%252BMedicinal%252BChemistry%252Bwith%252BMacrocycles%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2017%26volume%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darren  Finlay</span>, <span class="hlFld-ContribAuthor ">Peter  Teriete</span>, <span class="hlFld-ContribAuthor ">Mitchell  Vamos</span>, <span class="hlFld-ContribAuthor ">Nicholas D. P.  Cosford</span>, <span class="hlFld-ContribAuthor ">Kristiina  Vuori</span>. </span><span class="cited-content_cbyCitation_article-title">Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins. </span><span class="cited-content_cbyCitation_journal-name">F1000Research</span><span> <strong>2017,</strong> <em>6 </em>, 587. <a href="https://doi.org/10.12688/f1000research.10625.1" title="DOI URL">https://doi.org/10.12688/f1000research.10625.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.12688/f1000research.10625.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.12688%2Ff1000research.10625.1%26sid%3Dliteratum%253Aachs%26jtitle%3DF1000Research%26atitle%3DInducing%252Bdeath%252Bin%252Btumor%252Bcells%25253A%252Broles%252Bof%252Bthe%252Binhibitor%252Bof%252Bapoptosis%252Bproteins%26aulast%3DFinlay%26aufirst%3DDarren%26date%3D2017%26date%3D2017%26volume%3D6%26spage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">GG  Jinesh</span>, <span class="hlFld-ContribAuthor ">JR  Molina</span>, <span class="hlFld-ContribAuthor ">L  Huang</span>, <span class="hlFld-ContribAuthor ">NM  Laing</span>, <span class="hlFld-ContribAuthor ">GB  Mills</span>, <span class="hlFld-ContribAuthor ">M  Bar-Eli</span>, <span class="hlFld-ContribAuthor ">AM  Kamat</span>. </span><span class="cited-content_cbyCitation_article-title">Mitochondrial oligomers boost glycolysis in cancer stem cells to facilitate blebbishield-mediated transformation after apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Cell Death Discovery</span><span> <strong>2016,</strong> <em>2 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/cddiscovery.2016.3" title="DOI URL">https://doi.org/10.1038/cddiscovery.2016.3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddiscovery.2016.3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddiscovery.2016.3%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520Discovery%26atitle%3DMitochondrial%252Boligomers%252Bboost%252Bglycolysis%252Bin%252Bcancer%252Bstem%252Bcells%252Bto%252Bfacilitate%252Bblebbishield-mediated%252Btransformation%252Bafter%252Bapoptosis%26aulast%3DJinesh%26aufirst%3DGG%26date%3D2016%26date%3D2016%26volume%3D2%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bowen  Ke</span>, <span class="hlFld-ContribAuthor ">Mao  Tian</span>, <span class="hlFld-ContribAuthor ">Jingjing  Li</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Gu  He</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Programmed Cell Death Using Small-Molecule Compounds to Improve Potential Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2016,</strong> <em>36 </em>
                                    (6)
                                     , 983-1035. <a href="https://doi.org/10.1002/med.21398" title="DOI URL">https://doi.org/10.1002/med.21398</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21398&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21398%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DTargeting%252BProgrammed%252BCell%252BDeath%252BUsing%252BSmall-Molecule%252BCompounds%252Bto%252BImprove%252BPotential%252BCancer%252BTherapy%26aulast%3DKe%26aufirst%3DBowen%26date%3D2016%26date%3D2016%26volume%3D36%26issue%3D6%26spage%3D983%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Goodwin G.  Jinesh</span>, <span class="hlFld-ContribAuthor ">Naomi M.  Laing</span>, <span class="hlFld-ContribAuthor ">Ashish M.  Kamat</span>. </span><span class="cited-content_cbyCitation_article-title">Smac mimetic with TNF-α targets Pim-1 isoforms and reactive oxygen species production to abrogate transformation from blebbishields. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2016,</strong> <em>473 </em>
                                    (1)
                                     , 99-107. <a href="https://doi.org/10.1042/BJ20150877" title="DOI URL">https://doi.org/10.1042/BJ20150877</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BJ20150877&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBJ20150877%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DSmac%252Bmimetic%252Bwith%252BTNF-%2525CE%2525B1%252Btargets%252BPim-1%252Bisoforms%252Band%252Breactive%252Boxygen%252Bspecies%252Bproduction%252Bto%252Babrogate%252Btransformation%252Bfrom%252Bblebbishields%26aulast%3DJinesh%26aufirst%3DGoodwin%25C2%25A0G.%26date%3D2016%26date%3D2015%26volume%3D473%26issue%3D1%26spage%3D99%26epage%3D107" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Randy L.  Talbott</span>, <span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Charu  Chaudhry</span>, <span class="hlFld-ContribAuthor ">Joseph  Fargnoli</span>, <span class="hlFld-ContribAuthor ">Henry  Shen</span>, <span class="hlFld-ContribAuthor ">Craig  Fairchild</span>, <span class="hlFld-ContribAuthor ">Bryan  Barnhart</span>, <span class="hlFld-ContribAuthor ">Marie  Ortega</span>, <span class="hlFld-ContribAuthor ">Thomas E.  McDonagh</span>, <span class="hlFld-ContribAuthor ">Ragini  Vuppugalla</span>, <span class="hlFld-ContribAuthor ">Gregory D.  Vite</span>, <span class="hlFld-ContribAuthor ">John T.  Hunt</span>, <span class="hlFld-ContribAuthor ">Marco  Gottardis</span>, <span class="hlFld-ContribAuthor ">Joseph G.  Naglich</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of smac mimetics; chemotype differentiation based on physical association with caspase regulators and cellular transport. </span><span class="cited-content_cbyCitation_journal-name">Experimental Cell Research</span><span> <strong>2015,</strong> <em>338 </em>
                                    (2)
                                     , 251-260. <a href="https://doi.org/10.1016/j.yexcr.2015.08.011" title="DOI URL">https://doi.org/10.1016/j.yexcr.2015.08.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.yexcr.2015.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.yexcr.2015.08.011%26sid%3Dliteratum%253Aachs%26jtitle%3DExperimental%2520Cell%2520Research%26atitle%3DPharmacology%252Bof%252Bsmac%252Bmimetics%25253B%252Bchemotype%252Bdifferentiation%252Bbased%252Bon%252Bphysical%252Bassociation%252Bwith%252Bcaspase%252Bregulators%252Band%252Bcellular%252Btransport%26aulast%3DTalbott%26aufirst%3DRandy%2BL.%26date%3D2015%26volume%3D338%26issue%3D2%26spage%3D251%26epage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">R  Polanski</span>, <span class="hlFld-ContribAuthor ">J  Vincent</span>, <span class="hlFld-ContribAuthor ">U M  Polanska</span>, <span class="hlFld-ContribAuthor ">T  Petreus</span>, <span class="hlFld-ContribAuthor ">E K Y  Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Caspase-8 activation by TRAIL monotherapy predicts responses to IAPi and TRAIL combination treatment in breast cancer cell lines. </span><span class="cited-content_cbyCitation_journal-name">Cell Death & Disease</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , e1893-e1893. <a href="https://doi.org/10.1038/cddis.2015.234" title="DOI URL">https://doi.org/10.1038/cddis.2015.234</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/cddis.2015.234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fcddis.2015.234%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Death%2520%2526%2520Disease%26atitle%3DCaspase-8%252Bactivation%252Bby%252BTRAIL%252Bmonotherapy%252Bpredicts%252Bresponses%252Bto%252BIAPi%252Band%252BTRAIL%252Bcombination%252Btreatment%252Bin%252Bbreast%252Bcancer%252Bcell%252Blines%26aulast%3DPolanski%26aufirst%3DR%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D10%26spage%3De1893%26epage%3De1893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jai-Hee  Moon</span>, <span class="hlFld-ContribAuthor ">Jae-Sik  Shin</span>, <span class="hlFld-ContribAuthor ">Seung-Woo  Hong</span>, <span class="hlFld-ContribAuthor ">Soo-A  Jung</span>, <span class="hlFld-ContribAuthor ">Ih-Yeon  Hwang</span>, <span class="hlFld-ContribAuthor ">Jeong Hee  Kim</span>, <span class="hlFld-ContribAuthor ">Eun Kyoung  Choi</span>, <span class="hlFld-ContribAuthor ">Seung-Hee  Ha</span>, <span class="hlFld-ContribAuthor ">Jin-Sun  Kim</span>, <span class="hlFld-ContribAuthor ">Kyoung-Mok  Kim</span>, <span class="hlFld-ContribAuthor ">Dae-Won  Hong</span>, <span class="hlFld-ContribAuthor ">Daejin  Kim</span>, <span class="hlFld-ContribAuthor ">Yeong Seok  Kim</span>, <span class="hlFld-ContribAuthor ">Jeong Eun  Kim</span>, <span class="hlFld-ContribAuthor ">Kyu-Pyo  Kim</span>, <span class="hlFld-ContribAuthor ">Yong Sang  Hong</span>, <span class="hlFld-ContribAuthor ">Eun Kyung  Choi</span>, <span class="hlFld-ContribAuthor ">Jung Shin  Lee</span>, <span class="hlFld-ContribAuthor ">Maureen  Hattersley</span>, <span class="hlFld-ContribAuthor ">Dong-Hoon  Jin</span>, <span class="hlFld-ContribAuthor ">Tae Won  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">A novel small-molecule IAP antagonist, AZD5582, draws Mcl-1 down-regulation for induction of apoptosis through targeting of cIAP1 and XIAP in human pancreatic cancer. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2015,</strong> <em>6 </em>
                                    (29)
                                     , 26895-26908. <a href="https://doi.org/10.18632/oncotarget.4822" title="DOI URL">https://doi.org/10.18632/oncotarget.4822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.4822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.4822%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DA%252Bnovel%252Bsmall-molecule%252BIAP%252Bantagonist%25252C%252BAZD5582%25252C%252Bdraws%252BMcl-1%252Bdown-regulation%252Bfor%252Binduction%252Bof%252Bapoptosis%252Bthrough%252Btargeting%252Bof%252BcIAP1%252Band%252BXIAP%252Bin%252Bhuman%252Bpancreatic%252Bcancer%26aulast%3DMoon%26aufirst%3DJai-Hee%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D29%26spage%3D26895%26epage%3D26908" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander W  Hird</span>, <span class="hlFld-ContribAuthor ">Brian M  Aquila</span>, <span class="hlFld-ContribAuthor ">Edward J  Hennessy</span>, <span class="hlFld-ContribAuthor ">Melissa M  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule inhibitor of apoptosis proteins antagonists: a patent review. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2015,</strong> <em>25 </em>
                                    (7)
                                     , 755-774. <a href="https://doi.org/10.1517/13543776.2015.1041922" title="DOI URL">https://doi.org/10.1517/13543776.2015.1041922</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2015.1041922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2015.1041922%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall%252Bmolecule%252Binhibitor%252Bof%252Bapoptosis%252Bproteins%252Bantagonists%25253A%252Ba%252Bpatent%252Breview%26aulast%3DHird%26aufirst%3DAlexander%2BW%26date%3D2015%26date%3D2015%26volume%3D25%26issue%3D7%26spage%3D755%26epage%3D774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benjamin E.  Blass</span>. </span><span class="cited-content_cbyCitation_article-title">Animal Models of Disease States. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 307-343. <a href="https://doi.org/10.1016/B978-0-12-411508-8.00007-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-411508-8.00007-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-411508-8.00007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-411508-8.00007-4%26sid%3Dliteratum%253Aachs%26atitle%3DAnimal%252BModels%252Bof%252BDisease%252BStates%26aulast%3DBlass%26aufirst%3DBenjamin%2BE.%26date%3D2015%26spage%3D307%26epage%3D343%26pub%3DElsevier%26atitle%3DBasic%252BPrinciples%252Bof%252BDrug%252BDiscovery%252Band%252BDevelopment%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ke-Guang  Cheng</span>, <span class="hlFld-ContribAuthor ">Chun-Hua  Su</span>, <span class="hlFld-ContribAuthor ">Lin-Dong  Yang</span>, <span class="hlFld-ContribAuthor ">Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Zhen-Feng  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of oleanolic acid dimers linked at C-28 and evaluation of anti-tumor activity. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>89 </em>, 480-489. <a href="https://doi.org/10.1016/j.ejmech.2014.10.066" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.10.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.10.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.10.066%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Bof%252Boleanolic%252Bacid%252Bdimers%252Blinked%252Bat%252BC-28%252Band%252Bevaluation%252Bof%252Banti-tumor%252Bactivity%26aulast%3DCheng%26aufirst%3DKe-Guang%26date%3D2015%26volume%3D89%26spage%3D480%26epage%3D489" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianguo  Zhuang</span>, <span class="hlFld-ContribAuthor ">Naomi  Laing</span>, <span class="hlFld-ContribAuthor ">Melanie  Oates</span>, <span class="hlFld-ContribAuthor ">Ke  Lin</span>, <span class="hlFld-ContribAuthor ">Gillian  Johnson</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Pettitt</span>. </span><span class="cited-content_cbyCitation_article-title">Selective IAP inhibition results in sensitization of unstimulated but not CD40-stimulated chronic lymphocytic leukaemia cells to TRAIL-induced apoptosis. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology Research & Perspectives</span><span> <strong>2014,</strong> <em>2 </em>
                                    (6)
                                     , e00081. <a href="https://doi.org/10.1002/prp2.81" title="DOI URL">https://doi.org/10.1002/prp2.81</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/prp2.81&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fprp2.81%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520Research%2520%2526%2520Perspectives%26atitle%3DSelective%252BIAP%252Binhibition%252Bresults%252Bin%252Bsensitization%252Bof%252Bunstimulated%252Bbut%252Bnot%252BCD40-stimulated%252Bchronic%252Blymphocytic%252Bleukaemia%252Bcells%252Bto%252BTRAIL-induced%252Bapoptosis%26aulast%3DZhuang%26aufirst%3DJianguo%26date%3D2014%26date%3D2014%26volume%3D2%26issue%3D6%26spage%3De00081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James B  Jaquith</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the Inhibitor of Apoptosis Protein BIR3 Binding Domains. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (3)
                                     , 297-312. <a href="https://doi.org/10.4155/ppa.14.16" title="DOI URL">https://doi.org/10.4155/ppa.14.16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.16%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DTargeting%252Bthe%252BInhibitor%252Bof%252BApoptosis%252BProtein%252BBIR3%252BBinding%252BDomains%26aulast%3DJaquith%26aufirst%3DJames%2BB%26date%3D2014%26volume%3D3%26issue%3D3%26spage%3D297%26epage%3D312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander W.  Hird</span>, <span class="hlFld-ContribAuthor ">Brian M.  Aquila</span>, <span class="hlFld-ContribAuthor ">Michael H.  Block</span>, <span class="hlFld-ContribAuthor ">Edward J.  Hennessy</span>, <span class="hlFld-ContribAuthor ">Victor M.  Kamhi</span>, <span class="hlFld-ContribAuthor ">Charles A.  Omer</span>, <span class="hlFld-ContribAuthor ">Naomi M.  Laing</span>, <span class="hlFld-ContribAuthor ">Jamal C.  Saeh</span>, <span class="hlFld-ContribAuthor ">Li  Sha</span>, <span class="hlFld-ContribAuthor ">Bin  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and synthesis of tricyclic IAP (Inhibitors of Apoptosis Proteins) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (7)
                                     , 1820-1824. <a href="https://doi.org/10.1016/j.bmcl.2014.02.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.02.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.02.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.02.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bsynthesis%252Bof%252Btricyclic%252BIAP%252B%252528Inhibitors%252Bof%252BApoptosis%252BProteins%252529%252Binhibitors%26aulast%3DHird%26aufirst%3DAlexander%2BW.%26date%3D2014%26volume%3D24%26issue%3D7%26spage%3D1820%26epage%3D1824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of AVPI (<b>1</b>) and monomeric Smac mimetics containing tetrahydronaphthyl or indanyl groups at the P4 position (<b>2</b> and <b>3</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Dimerization strategy based on incorporating a linker at the 2-position of the tetrahydronaphthyl ring.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Effect of compound <b>14</b> on caspase-9–XIAP interaction. MDA-MB-231 cells were either untreated or exposed to 1 μM <b>14</b> for 4 h, and then caspase-9 was immunoprecipitated from the protein lysates. The levels of caspase-9–XIAP complexes were determined by blotting.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Treatment of cells with compound <b>14</b> promotes caspase-3 cleavage and results in cell death. MDA-MB-231 cells were exposed to <b>14</b> for 1 or 3 h, and then the culture media was removed and replaced with drug-free media. (A) Apoptosis was assessed by determining the level of active caspase-3 in each well after 24 h total. (B) Cell survival was determined by MTS assay after 72 h total. A reading of 0% survival represents complete death of the cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Pharmacodynamic data following a single intravenous dose of compound <b>14</b> to mice bearing MDA-MB-231 xenografts. (A) Measured tumor levels of cIAP1 protein degradation. (B) Levels of intratumoral cleaved caspase-3.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Antitumor activity of <b>14</b> in the MDA-MB-231 xenograft efficacy model. Tumors were allowed to grow to an average size of 120 mm<sup>3</sup>, and the mice were then treated with either vehicle or <b>14</b> intravenously once a week for 2 weeks (as indicated by the two black arrows). Tumor volumes were monitored twice a week for 78 days and are plotted as the geometric mean volumes ± standard error (SE).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Antiproliferative activity of <b>14</b> across a panel of 200 cancer cell lines. The cell lines are ranked in order of decreasing sensitivity to <b>14</b>. The horizontal line at pGI<sub>50</sub> = 6 reflects an antiproliferative GI<sub>50</sub> of 1 μM; those cell lines in which <b>14</b> is more potent (i.e., sensitive cell lines) are colored green, whereas those in which <b>14</b> is less potent (i.e., resistant cell lines) are colored red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Chiral Tetrahydronaphthyl Aminoalcohols<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <i>N</i>-bromosuccinimide, THF/H<sub>2</sub>O, rt; (b) NH<sub>4</sub>OH, MeOH/H<sub>2</sub>O, rt; (c) benzoyl chloride, NEt<sub>3</sub>, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C; (d) NaOH, EtOH/H<sub>2</sub>O, 80 °C; (e) SOCl<sub>2</sub>, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) HCl, dioxane/H<sub>2</sub>O, 100 °C.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Representative Preparation of Monomeric and Dimeric Smac Mimetics<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc-Pro-OH, EDCI, HOBt hydrate, DMF, 0 °C to rt; (b) propargyl bromide, KOH, DMF, 0 °C; (c) 4 N HCl/dioxane, rt; (d) Boc-Tle-OH, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (e) Boc-<i>N</i>-Me-Ala-OH, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (f) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of Aminoindanol-Containing Dimeric Smac Mimetics<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Boc-Pro-OH, ethyl chloroformate, 4-methylmorpholine, EtOAc, 0 °C to rt; (b) propargyl bromide, KOH, DMF, 0 °C; (c) 4 N HCl/dioxane, rt, or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (d) NaH, propargyl bromide, THF, 0 °C to reflux; (e) EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (f) isobutyl chloroformate, 4-methylmorpholine, THF, 0 °C; (g) LiOH·H<sub>2</sub>O, THF/H<sub>2</sub>O, rt; (h) DMTMM, 4-methylmorpholine, EtOAc, 0 °C to rt; (i) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of Spiro-Cyclopropylthiaproline Used in the Synthesis of Compound <b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 37% aqueous formaldehyde, water, rt; (b) di-<i>tert</i>-butyldicarbonate, NaHCO<sub>3</sub>, water, rt</p></p></figure><figure data-id="sch5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of Compound <b>26</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) isobutyl chloroformate, 4-methylmorpholine, Chg-OMe·HCl, THF/CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (b) LiOH·H<sub>2</sub>O, acetone/H<sub>2</sub>O, 0 °C; (c) DMTMM, 4-methylmorpholine, Pro-OMe·HCl; (d) <i>p</i>-TsCl, triethylamine, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (e) NaH, (1<i>S</i>,2<i>R</i>)-<i>cis</i>-1-amino-2-indanol, THF, 0 °C to reflux; (f) DMTMM, 4-methylmorpholine, THF/DMF, rt; (g) HCl, dioxane, rt.</p></p></figure><figure data-id="sch6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of Compound <b>27</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, Raney Ni, HCl, MeOH, rt; (b) propargyl bromide, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN/MeOH, rt; (c) DPPA, triethylamine, <i>tert</i>-BuOH, 80 °C; (d) chiral chromatography; (e) HCl, dioxane, rt; (f) <b>48</b>, EDCI, HOBt hydrate, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C to rt; (g) Cu(OAc)<sub>2</sub>, pyridine, CH<sub>3</sub>CN, 80 °C.</p></p></figure><figure data-id="sch7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of Compound <b>28</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>48</b>, EDCI, HOBt hydrate, 4-methylmorpholine, DMF, 0 °C to rt; (b) NaOH, MeOH/water, rt; (c) EDCI, HOBt hydrate, 4-methylmorpholine, propargylamine, DMF, 0 °C to rt; (d) Cu(OAc)<sub>2</sub>, triethylamine, CH<sub>3</sub>CN, 70 °C; (e) HCl, MeOH, rt.</p></p></figure><figure data-id="sch8" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/medium/jm-2013-01075x_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Synthesis of Dimeric Smac Mimetics Containing a 1,2-Diaminoindane Moiety<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-24/jm401075x/production/images/large/jm-2013-01075x_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm401075x&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Ca(OCl)<sub>2</sub>, HCl, CH<sub>2</sub>Cl<sub>2</sub>/H<sub>2</sub>O, 0 °C; (b) indene, toluene, 35–40 °C, then NaHSO<sub>3</sub>, water, 5–10 °C; (c) NaN<sub>3</sub>, DMF, rt; (d) Pd/C, H<sub>2</sub>, EtOH, rt; (e) Fmoc-Pro-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (f) EtNH<sub>2</sub>, THF, rt; (g) Fmoc-Chg-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (h) Fmoc-<i>N</i>-Me-Ala-OH, HATU, DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, rt; (i) 4 N HCl/dioxane, rt; (j) diacid dichloride (for <b>29</b>, terephthaloyl chloride; for <b>30</b>, biphenyl-4,4′-dicarbonyl dichloride; for <b>31</b>, decanedioyl dichloride), DIPEA, CH<sub>2</sub>Cl<sub>2</sub>, 0 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i91">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58341" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58341" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 58 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Kerr, J. F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyllie, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Currie, A. R.</span><span> </span><span class="NLM_article-title">Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">239</span><span class="NLM_x">–</span> <span class="NLM_lpage">257</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fbjc.1972.33" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=4561027" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=1972&pages=239-257&author=J.+F.+R.+Kerrauthor=A.+H.+Wyllieauthor=A.+R.+Currie&title=Apoptosis%3A+A+basic+biological+phenomenon+with+wide-ranging+implications+in+tissue+kinetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics</span></div><div class="casAuthors">Kerr J F; Wyllie A H; Currie A R</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">239-57</span>
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    </div><div class="casAbstract">The term apoptosis is proposed for a hitherto little recognized mechanism of controlled cell deletion, which appears to play a complementary but opposite role to mitosis in the regulation of animal cell populations.  Its morphological features suggest that it is an active, inherently programmed phenomenon, and it has been shown that it can be initiated or inhibited by a variety of environmental stimuli, both physiological and pathological.The structural changes take place in two discrete stages.  The first comprises nuclear and cytoplasmic condensation and breaking up of the cell into a number of membrane-bound, ultrastructurally well-preserved fragments.  In the second stage these apoptotic bodies are shed from epithelial-lined surfaces or are taken up by other cells, where they undergo a series of changes resembling in vitro autolysis within phagosomes, and are rapidly degraded by lysosomal enzymes derived from the ingesting cells.Apoptosis seems to be involved in cell turnover in many healthy adult tissues and is responsible for focal elimination of cells during normal embryonic development.  It occurs spontaneously in untreated malignant neoplasms, and participates in at least some types of therapeutically induced tumour regression.  It is implicated in both physiological involution and atrophy of various tissues and organs.  It can also be triggered by noxious agents, both in the embryo and adult animal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNWEBcjRkVZzW1zwg2yUK5fW6udTcc2eZbMwntD1GCqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3s%252FgsFSksw%253D%253D&md5=60211d4b22f18156fa64206b2cad983d</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1972.33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1972.33%26sid%3Dliteratum%253Aachs%26aulast%3DKerr%26aufirst%3DJ.%2BF.%2BR.%26aulast%3DWyllie%26aufirst%3DA.%2BH.%26aulast%3DCurrie%26aufirst%3DA.%2BR.%26atitle%3DApoptosis%253A%2520A%2520basic%2520biological%2520phenomenon%2520with%2520wide-ranging%2520implications%2520in%2520tissue%2520kinetics%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1972%26volume%3D26%26spage%3D239%26epage%3D257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Carson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribiero, J. M.</span><span> </span><span class="NLM_article-title">Apoptosis and disease</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">1251</span><span class="NLM_x">–</span> <span class="NLM_lpage">1254</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=1993&pages=1251-1254&author=D.+A.+Carsonauthor=J.+M.+Ribiero&title=Apoptosis+and+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarson%26aufirst%3DD.%2BA.%26aulast%3DRibiero%26aufirst%3DJ.%2BM.%26atitle%3DApoptosis%2520and%2520disease%26jtitle%3DLancet%26date%3D1993%26volume%3D341%26spage%3D1251%26epage%3D1254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Solary, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dubrez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eymin, B.</span><span> </span><span class="NLM_article-title">The role of apoptosis in the pathogenesis and treatment of disease</span> <span class="citation_source-journal">Eur. Respir. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1293</span><span class="NLM_x">–</span> <span class="NLM_lpage">1305</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1183%2F09031936.96.09061293" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1996&pages=1293-1305&author=E.+Solaryauthor=L.+Dubrezauthor=B.+Eymin&title=The+role+of+apoptosis+in+the+pathogenesis+and+treatment+of+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of apoptosis in the pathogenesis and treatment of diseases</span></div><div class="casAuthors">Solary E; Dubrez L; Eymin B</div><div class="citationInfo"><span class="NLM_cas:title">The European respiratory journal</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1293-305</span>
        ISSN:<span class="NLM_cas:issn">0903-1936</span>.
    </div><div class="casAbstract">In adult multicellular organisms, homeostasis is determined in each cell lineage by a balance between cell death and cell growth.  Dysregulation of cell death mechanisms is involved in the pathogenesis of an increasing number of diseases.  Defective apoptosis can participate in malignant transformation, viral latency and autoimmune diseases.  Excessive apoptotic cell death is involved in CD4+ T-cell depletion observed in acquired immune deficiency syndrome, in fulminant hepatitis associated with infection by hepatitis B and C viruses, in some neurodegenerative disorders and haematological diseases, in polycystic kidney disease and ischaemia.  Three steps can be distinguished in the pathway that leads to cell death.  The first step involves interactions between the extracellular and intracellular signals that decide whether a cell should live or die.  When death is chosen, a common pathway that involves at least the Bcl-2- family of proteins and the interleukin-1 beta (IL-1 beta)-converting enzyme-related cysteine proteases confirms whether or not the cell should die.  Finally, if death is allowed to occur, the apoptotic process itself is characterized by deoxyribonucleic acid (DNA) fragmentation, proteolysis and morphological changes that precede the engulfment of apoptotic cells by neighbouring cells and phagocytes.  Several inducers and inhibitors of apoptosis acting on one or several of these three steps that characterize the apoptotic process have been identified in vitro.  Their potential usefulness in improving the current therapeutic strategies and designing new strategies in several different diseases is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSstdFlp_TrSMyail4HZd-ifW6udTcc2eZbMwntD1GCqLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28zpvVSltQ%253D%253D&md5=d297625b8ca78684e2fa14dc36e24605</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1183%2F09031936.96.09061293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1183%252F09031936.96.09061293%26sid%3Dliteratum%253Aachs%26aulast%3DSolary%26aufirst%3DE.%26aulast%3DDubrez%26aufirst%3DL.%26aulast%3DEymin%26aufirst%3DB.%26atitle%3DThe%2520role%2520of%2520apoptosis%2520in%2520the%2520pathogenesis%2520and%2520treatment%2520of%2520disease%26jtitle%3DEur.%2520Respir.%2520J.%26date%3D1996%26volume%3D9%26spage%3D1293%26epage%3D1305" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hanahan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span> </span><span class="NLM_article-title">Hallmarks of cancer: The next generation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">646</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.cell.2011.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=21376230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2011&pages=646-674&author=D.+Hanahanauthor=R.+A.+Weinberg&title=Hallmarks+of+cancer%3A+The+next+generation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Hallmarks of cancer: the next generation</span></div><div class="casAuthors">Hanahan, Douglas; Weinberg, Robert A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">646-674</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review.  The hallmarks of cancer comprise six biol. capabilities acquired during the multistep development of human tumors.  The hallmarks constitute an organizing principle for rationalizing the complexities of neoplastic disease.  They include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis.  Underlying these hallmarks are genome instability, which generates the genetic diversity that expedites their acquisition, and inflammation, which fosters multiple hallmark functions.  Conceptual progress in the last decade has added two emerging hallmarks of potential generality to this list-reprogramming of energy metab. and evading immune destruction.  In addn. to cancer cells, tumors exhibit another dimension of complexity: they contain a repertoire of recruited, ostensibly normal cells that contribute to the acquisition of hallmark traits by creating the "tumor microenvironment.".  Recognition of the widespread applicability of these concepts will increasingly affect the development of new means to treat human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcpqXALcb6LVg90H21EOLACvtfcHk0lhUWw_Ima-Pzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjsFeqtrk%253D&md5=b36f160c417a712e83cb83c577f0018e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2011.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2011.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DHanahan%26aufirst%3DD.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26atitle%3DHallmarks%2520of%2520cancer%253A%2520The%2520next%2520generation%26jtitle%3DCell%26date%3D2011%26volume%3D144%26spage%3D646%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Salvesen, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duckett, C. S.</span><span> </span><span class="NLM_article-title">IAP proteins: Blocking the road to death’s door</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">401</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrm830" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12042762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=401-410&author=G.+S.+Salvesenauthor=C.+S.+Duckett&title=IAP+proteins%3A+Blocking+the+road+to+death%E2%80%99s+door"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis: IAP proteins: blocking the road to death's door</span></div><div class="casAuthors">Salvesen, Guy S.; Duckett, Colin S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">401-410</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The 'inhibitor of apoptosis' (IAP) gene family, which was discovered less than a decade ago, encodes a group of structurally related proteins that, in addn. to their ability to suppress apoptotic cell death, are involved in an increasing no. of seemingly unrelated cellular functions.  Here, we review the functional and structural properties of this fascinating group of proteins, and of several recently identified IAP-binding factors that regulate IAP function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofMWLW8mAr_LVg90H21EOLACvtfcHk0litLvZ2ogM6Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltlartL4%253D&md5=0f967aad318a34d988ad40486950ed62</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrm830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm830%26sid%3Dliteratum%253Aachs%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26aulast%3DDuckett%26aufirst%3DC.%2BS.%26atitle%3DIAP%2520proteins%253A%2520Blocking%2520the%2520road%2520to%2520death%25E2%2580%2599s%2520door%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2002%26volume%3D3%26spage%3D401%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Gyrd-Hansen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">IAPs: From caspase inhibitors to modulators of NF-κB, inflammation, and cancer</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrc2889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20651737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=561-574&author=M.+Gyrd-Hansenauthor=P.+Meier&title=IAPs%3A+From+caspase+inhibitors+to+modulators+of+NF-%CE%BAB%2C+inflammation%2C+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs: from caspase inhibitors to modulators of NF-κB, inflammation and cancer</span></div><div class="casAuthors">Gyrd-Hansen, Mads; Meier, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">561-574</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The realization that alterations in inhibitor of apoptosis (IAP) proteins are found in many types of human cancer and are assocd. with chemoresistance, disease progression, and poor prognosis, has sparked a worldwide frenzy in the development of small pharmacol. inhibitors of IAPs.  The development of such inhibitors has radically changed our knowledge of the signaling processes that are regulated by IAPs.  Recent studies indicate that IAPs not only regulate caspases and apoptosis, but also modulate inflammatory signaling and immunity, mitogenic kinase signaling, proliferation and mitosis, as well as cell invasion and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNNte9JiwXrbVg90H21EOLACvtfcHk0litLvZ2ogM6Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtbw%253D&md5=7cf8b18a0d79f00b36aa0b9caf9d66ed</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1038%2Fnrc2889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2889%26sid%3Dliteratum%253Aachs%26aulast%3DGyrd-Hansen%26aufirst%3DM.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DIAPs%253A%2520From%2520caspase%2520inhibitors%2520to%2520modulators%2520of%2520NF-%25CE%25BAB%252C%2520inflammation%252C%2520and%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D561%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Shiozaki, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rigotti, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Mechanism of XIAP-mediated inhibition of caspase-9</span> <span class="citation_source-journal">Mol. Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">519</span><span class="NLM_x">–</span> <span class="NLM_lpage">527</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS1097-2765%2803%2900054-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12620238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=519-527&author=E.+N.+Shiozakiauthor=J.+Chaiauthor=D.+J.+Rigottiauthor=S.+J.+Riedlauthor=P.+Liauthor=S.+M.+Srinivasulaauthor=E.+S.+Alnemriauthor=R.+Fairmanauthor=Y.+Shi&title=Mechanism+of+XIAP-mediated+inhibition+of+caspase-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of XIAP-mediated inhibition of caspase-9</span></div><div class="casAuthors">Shiozaki, Eric N.; Chai, Jijie; Rigotti, Daniel J.; Riedl, Stefan J.; Li, Pingwei; Srinivasula, Srinivasa M.; Alnemri, Emad S.; Fairman, Robert; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cell</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-527</span>CODEN:
                <span class="NLM_cas:coden">MOCEFL</span>;
        ISSN:<span class="NLM_cas:issn">1097-2765</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins potently inhibit the catalytic activity of caspases.  While profound insight into the inhibition of the effector caspases has been gained in recent years, the mechanism of how the initiator caspase-9 is regulated by IAPs remains enigmatic.  This paper reports the crystal structure of caspase-9 in an inhibitory complex with the third baculoviral IAP repeat (BIR3) of XIAP at 2.4 Å resoln.  The structure reveals that the BIR3 domain forms a heterodimer with a caspase-9 monomer.  Strikingly, the surface of caspase-9 that interacts with BIR3 also mediates its homodimerization.  We demonstrate that monomeric caspase-9 is catalytically inactive due to the absence of a supporting sequence element that could be provided by homodimerization.  Thus, XIAP sequesters caspase-9 in a monomeric state, which serves to prevent catalytic activity.  These studies, in conjunction with other observations, define a unified mechanism for the activation of all caspases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2rbChsxBIPbVg90H21EOLACvtfcHk0litLvZ2ogM6Mg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXit1WgsLg%253D&md5=9e01d0078d4f8d676cb96d37c4027827</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FS1097-2765%2803%2900054-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1097-2765%252803%252900054-6%26sid%3Dliteratum%253Aachs%26aulast%3DShiozaki%26aufirst%3DE.%2BN.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DRigotti%26aufirst%3DD.%2BJ.%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DFairman%26aufirst%3DR.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DMechanism%2520of%2520XIAP-mediated%2520inhibition%2520of%2520caspase-9%26jtitle%3DMol.%2520Cell%26date%3D2003%26volume%3D11%26spage%3D519%26epage%3D527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiozaki, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srinivasula, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dataa, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alnemri, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of caspase-7 inhibition by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">769</span><span class="NLM_x">–</span> <span class="NLM_lpage">780</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0092-8674%2801%2900272-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=769-780&author=J.+Chaiauthor=E.+Shiozakiauthor=S.+M.+Srinivasulaauthor=Q.+Wuauthor=P.+Dataaauthor=E.+S.+Alnemriauthor=Y.+Shi&title=Structural+basis+of+caspase-7+inhibition+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase-7 inhibition by XIAP</span></div><div class="casAuthors">Chai, Jijie; Shiozaki, Eric; Srinivasula, Srinivasa M.; Wu, Qi; Dataa, Pinaki; Alnemri, Emad S.; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">769-780</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins suppress cell death by inhibiting the catalytic activity of caspases.  Here we present the crystal structure of caspase-7 in complex with a potent inhibitory fragment from XIAP at 2.45 Å resoln.  An 18-residue XIAP peptide binds the catalytic groove of caspase-7, making extensive contacts to the residues that are essential for its catalytic activity.  Strikingly, despite a reversal of relative orientation, a subset of interactions between caspase-7 and XIAP closely resemble those between caspase-7 and its tetrapeptide inhibitor DEVD-CHO.  Our biochem. and structural analyses reveal that the BIR domains are dispensable for the inhibition of caspase-3 and -7.  This study provides a structural basis for the design of the next-generation caspase inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolipWoAs9habVg90H21EOLACvtfcHk0lg6EWR8KhzdkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurg%253D&md5=fe072a2bacd6c76e3763fff9bc678897</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900272-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900272-0%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShiozaki%26aufirst%3DE.%26aulast%3DSrinivasula%26aufirst%3DS.%2BM.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DDataa%26aufirst%3DP.%26aulast%3DAlnemri%26aufirst%3DE.%2BS.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520caspase-7%2520inhibition%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D769%26epage%3D780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segal, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Structural basis of caspase inhibition by XIAP: Differential roles of the linker versus the BIR domain</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">781</span><span class="NLM_x">–</span> <span class="NLM_lpage">790</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257231" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=781-790&author=Y.+Huangauthor=Y.+C.+Parkauthor=R.+L.+Richauthor=D.+Segalauthor=D.+G.+Myszkaauthor=H.+Wu&title=Structural+basis+of+caspase+inhibition+by+XIAP%3A+Differential+roles+of+the+linker+versus+the+BIR+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of caspase inhibition by XIAP: differential roles of the linker versus the BIR domain</span></div><div class="casAuthors">Huang, Yihua; Park, Young Chul; Rich, Rebecca L.; Segal, Deena; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">781-790</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAPs) represent the only endogenous caspase inhibitors and are characterized by the presence of baculoviral IAP repeats (BIRs).  Here, we report the crystal structure of the complex between human caspase-7 and XIAP (BIR2 and the proceeding linker).  The structure surprisingly reveals that the linker is the only contacting element for the caspase, while the BIR2 domain is invisible in the crystal.  The linker interacts with and blocks the substrate groove of the caspase in a backward fashion, distinct from substrate recognition.  Structural analyses suggest that the linker is the energetic and specificity determinant of the interaction.  Further biochem. characterizations clearly establish that the linker harbors the major energetic determinant, while the BIR2 domain serves as a regulatory element for caspase binding and Smac neutralization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZjYs6k2CfhrVg90H21EOLACvtfcHk0lg6EWR8KhzdkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurk%253D&md5=c12e25afe67e2979324ba5bf6151c6bf</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPark%26aufirst%3DY.%2BC.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DSegal%26aufirst%3DD.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DStructural%2520basis%2520of%2520caspase%2520inhibition%2520by%2520XIAP%253A%2520Differential%2520roles%2520of%2520the%2520linker%2520versus%2520the%2520BIR%2520domain%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D781%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Riedl, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renatus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzenbacher, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liddington, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvesen, G. S.</span><span> </span><span class="NLM_article-title">Structural basis for the inhibition of caspase-3 by XIAP</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">104</span><span class="NLM_x">, </span> <span class="NLM_fpage">791</span><span class="NLM_x">–</span> <span class="NLM_lpage">800</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0092-8674%2801%2900274-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11257232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2001&pages=791-800&author=S.+J.+Riedlauthor=M.+Renatusauthor=R.+Schwarzenbacherauthor=Q.+Zhouauthor=C.+Sunauthor=S.+W.+Fesikauthor=R.+C.+Liddingtonauthor=G.+S.+Salvesen&title=Structural+basis+for+the+inhibition+of+caspase-3+by+XIAP"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for the inhibition of caspase-3 by XIAP</span></div><div class="casAuthors">Riedl, Stefan J.; Renatus, Martin; Schwarzenbacher, Robert; Zhou, Qiao; Sun, Chaohong; Fesik, Stephen W.; Liddington, Robert C.; Salvesen, Guy S.</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, Massachusetts)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">791-800</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">The mol. mechanism(s) that regulate apoptosis by caspase inhibition remain poorly understood.  The main endogenous inhibitors are members of the IAP family and are exemplified by XIAP, which regulates the initiator caspase-9, and the executioner caspases-3 and -7.  We report the crystal structure of the second BIR domain of XIAP (BIR2) in complex with caspase-3, at a resoln. of 2.7 Å, revealing the structural basis for inhibition.  The inhibitor makes limited contacts through its BIR domain to the surface of the enzyme, and most contacts to caspase-3 originate from the N-terminal extension.  This lies across the substrate binding cleft, but in reverse orientation compared to substrate binding.  The mechanism of inhibition is due to a steric blockade prohibitive of substrate binding, and is distinct from the mechanism utilized by synthetic substrate analog inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaCJZgSAEzrLVg90H21EOLACvtfcHk0lg6EWR8KhzdkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitFakurY%253D&md5=7a06c657d5b3700b4dd8e77ab8569613</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2801%2900274-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252801%252900274-4%26sid%3Dliteratum%253Aachs%26aulast%3DRiedl%26aufirst%3DS.%2BJ.%26aulast%3DRenatus%26aufirst%3DM.%26aulast%3DSchwarzenbacher%26aufirst%3DR.%26aulast%3DZhou%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26aulast%3DLiddington%26aufirst%3DR.%2BC.%26aulast%3DSalvesen%26aufirst%3DG.%2BS.%26atitle%3DStructural%2520basis%2520for%2520the%2520inhibition%2520of%2520caspase-3%2520by%2520XIAP%26jtitle%3DCell%26date%3D2001%26volume%3D104%26spage%3D791%26epage%3D800" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAPs, RINGs, and ubiquitylation</span> <span class="citation_source-journal">Nat. Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">287</span><span class="NLM_x">–</span> <span class="NLM_lpage">297</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrm1621" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=15803136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2005&pages=287-297&author=D.+L.+Vauxauthor=J.+Silke&title=IAPs%2C+RINGs%2C+and+ubiquitylation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">IAPs, RINGs and ubiquitylation</span></div><div class="casAuthors">Vaux, David L.; Silke, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">287-297</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Here, the authors review the function of the RING domain of inhibitor of apoptosis proteins (IAPs), provide an overview of the biol. of E3 ubiquitin ligases, the enzymes which conjugate ubiquitin to substrate proteins, and its application to IAPs, and examine evidence for substrate ubiquitination by IAPs and for the importance of these ubiquitination events in the prevention of apoptosis.  The IAPs all contain one or more baculoviral IAP repeat motifs, through which they interact with various other proteins.  Many IAPs also have another Zn-binding motif, the RING domain, which can recruit E2 ubiquitin-conjugating enzymes and catalyze the transfer of ubiquitin onto target proteins.  The no. of targets of IAP-mediated ubiquitination is increasing, and recent results indicate that outcomes following ubiquitination are tantalizingly complex.  As well as regulating other proteins, the IAPs themselves are controlled by ubiquitin-mediated degrdn.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8gh0_du1aY7Vg90H21EOLACvtfcHk0lg6EWR8KhzdkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXivVaktb8%253D&md5=4d3040429bbac085dd33b46c8c74d955</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fnrm1621&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm1621%26sid%3Dliteratum%253Aachs%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAPs%252C%2520RINGs%252C%2520and%2520ubiquitylation%26jtitle%3DNat.%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2005%26volume%3D6%26spage%3D287%26epage%3D297" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blankenship, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wayson, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kayagaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallweber, H. J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dixit, V. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">–</span> <span class="NLM_lpage">681</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.cell.2007.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=18022362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=669-681&author=E.+Varfolomeevauthor=J.+W.+Blankenshipauthor=S.+M.+Waysonauthor=A.+V.+Federovaauthor=N.+Kayagakiauthor=P.+Gargauthor=K.+Zobelauthor=J.+N.+Dynekauthor=L.+O.+Elliottauthor=H.+J.+A.+Wallweberauthor=J.+A.+Flygareauthor=W.+J.+Fairbrotherauthor=K.+Deshayesauthor=V.+M.+Dixitauthor=D.+Vucic&title=IAP+antagonists+induce+autoubiquitination+of+c-IAPs%2C+NF-%CE%BAB+activation%2C+and+TNF%CE%B1-dependent+apoptosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis</span></div><div class="casAuthors">Varfolomeev, Eugene; Blankenship, John W.; Wayson, Sarah M.; Fedorova, Anna V.; Kayagaki, Nobuhiko; Garg, Parie; Zobel, Kerry; Dynek, Jasmin N.; Elliott, Linda O.; Wallweber, Heidi J. A.; Flygare, John A.; Fairbrother, Wayne J.; Deshayes, Kurt; Dixit, Vishva M.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">131</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">669-681</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are antiapoptotic regulators that block cell death in response to diverse stimuli.  They are expressed at elevated levels in human malignancies and are attractive targets for the development of novel cancer therapeutics.  Herein, the authors demonstrate that small-mol. IAP antagonists bind to select baculovirus IAP repeat (BIR) domains resulting in dramatic induction of autoubiquitination activity and rapid proteasomal degrdn. of c-IAPs.  The IAP antagonists also induce cell death that is dependent on TNF signaling and de novo protein biosynthesis.  Addnl., the c-IAP proteins were found to function as regulators of NF-κB signaling.  Through their ubiquitin E3 ligase activities c-IAP1 and c-IAP2 promote proteasomal degrdn. of NIK, the central ser/thr kinase in the noncanonical NF-κB pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV7cKeBeR_hrVg90H21EOLACvtfcHk0ljLwMONeD4Hwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVSgurzF&md5=c9a255030cc26db0519680d170ba91f9</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2007.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2007.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DBlankenship%26aufirst%3DJ.%2BW.%26aulast%3DWayson%26aufirst%3DS.%2BM.%26aulast%3DFederova%26aufirst%3DA.%2BV.%26aulast%3DKayagaki%26aufirst%3DN.%26aulast%3DGarg%26aufirst%3DP.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DWallweber%26aufirst%3DH.%2BJ.%2BA.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DDixit%26aufirst%3DV.%2BM.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DIAP%2520antagonists%2520induce%2520autoubiquitination%2520of%2520c-IAPs%252C%2520NF-%25CE%25BAB%2520activation%252C%2520and%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D669%26epage%3D681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Vince, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, W. W.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khan, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chau, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, A. U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brink, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leverkus, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tergaonkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneider, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callus, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koentgen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span> </span><span class="NLM_article-title">IAP antagonists target cIAP1 to induce TNFα-dependent apoptosis</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">131</span><span class="NLM_x">, </span> <span class="NLM_fpage">682</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=131&publication_year=2007&pages=682-693&author=J.+E.+Vinceauthor=W.+W.-L.+Wongauthor=N.+Khanauthor=R.+Felthamauthor=D.+Chauauthor=A.+U.+Ahmedauthor=C.+A.+Benetatosauthor=S.+K.+Chunduruauthor=S.+M.+Condonauthor=M.+McKinlayauthor=R.+Brinkauthor=M.+Leverkusauthor=V.+Tergaonkarauthor=P.+Schneiderauthor=B.+A.+Callusauthor=F.+Koentgenauthor=D.+L.+Vauxauthor=J.+Silke&title=IAP+antagonists+target+cIAP1+to+induce+TNF%CE%B1-dependent+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVince%26aufirst%3DJ.%2BE.%26aulast%3DWong%26aufirst%3DW.%2BW.-L.%26aulast%3DKhan%26aufirst%3DN.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DChau%26aufirst%3DD.%26aulast%3DAhmed%26aufirst%3DA.%2BU.%26aulast%3DBenetatos%26aufirst%3DC.%2BA.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DMcKinlay%26aufirst%3DM.%26aulast%3DBrink%26aufirst%3DR.%26aulast%3DLeverkus%26aufirst%3DM.%26aulast%3DTergaonkar%26aufirst%3DV.%26aulast%3DSchneider%26aufirst%3DP.%26aulast%3DCallus%26aufirst%3DB.%2BA.%26aulast%3DKoentgen%26aufirst%3DF.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26atitle%3DIAP%2520antagonists%2520target%2520cIAP1%2520to%2520induce%2520TNF%25CE%25B1-dependent%2520apoptosis%26jtitle%3DCell%26date%3D2007%26volume%3D131%26spage%3D682%26epage%3D693" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fotin-Mleczek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henkler, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samel, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichwein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hausser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmryd, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheurich, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wajant, H.</span><span> </span><span class="NLM_article-title">Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8</span> <span class="citation_source-journal">J. Cell Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">115</span><span class="NLM_x">, </span> <span class="NLM_fpage">2757</span><span class="NLM_x">–</span> <span class="NLM_lpage">2770</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=12077366" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2002&pages=2757-2770&author=M.+Fotin-Mleczekauthor=F.+Henklerauthor=D.+Samelauthor=M.+Reichweinauthor=A.+Hausserauthor=I.+Parmrydauthor=P.+Scheurichauthor=J.+A.+Schmidauthor=H.+Wajant&title=Apoptotic+crosstalk+of+TNF+receptors%3A+TNF-R2-induces+depletion+of+TRAF2+and+IAP+proteins+and+accelerates+TNF-R1-dependent+activation+of+caspase-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8</span></div><div class="casAuthors">Fotin-Mleczek, Mariola; Henkler, Frank; Samel, Dierk; Reichwein, Monica; Hausser, Angelika; Parmryd, Ingela; Scheurich, Peter; Schmid, Johannes A.; Wajant, Harald</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Science</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2757-2770</span>CODEN:
                <span class="NLM_cas:coden">JNCSAI</span>;
        ISSN:<span class="NLM_cas:issn">0021-9533</span>.
    
            (<span class="NLM_cas:orgname">Company of Biologists Ltd.</span>)
        </div><div class="casAbstract">We have recently shown that stimulation of TNF-R2 selectively enhances apoptosis induction by the death receptor TNF-R1.  Here, we demonstrate that stimulation of CD30 or CD40 also leads to selective enhancement of TNF-R1-induced cell death.  Enhancement of apoptosis was correlated with the depletion of endogenous TRAF2 within 1 to 6 h.  Selective prestimulation of TNF-R2 for several hours inhibited TNF-R2-induced activation of the anti-apoptotic NF-κB pathway up to 90% and dramatically enhanced apoptosis induction by this receptor.  When both TNF-receptors were stimulated simultaneously, TNF-R1-induced NF-κB activation remained unaffected but TNF-R1-induced apoptosis was still significantly enhanced.  Compared with FasL-induced cell death TNF-R1-induced activation of caspase-8 was significantly weaker and delayed.  Costimulation or prestimulation of TNF-R2 enhanced caspase-8 processing.  Life cell imaging and confocal microscopy revealed that both TNF-R1 and TNF-R2 recruited the anti-apoptotic factor cIAP1 in a TRAF2-dependent manner.  Thus, TNF-R2 may compete with TNF-R1 for the recruitment of newly synthesized TRAF2-bound anti-apoptotic factors, thereby promoting the formation of a caspase-8-activating TNF-R1 complex.  Hence, TNF-R2 triggering can interfere with TNF-R1-induced apoptosis by inhibition of NF-κB-dependent prodn. of anti-apoptotic factors and by blocking the action of anti-apoptotic factors at the post-transcriptional level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1-7stEso8NrVg90H21EOLACvtfcHk0ljLwMONeD4Hwg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsFCrtLc%253D&md5=8624e97eefe4e51d3ac2f648103b54ee</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFotin-Mleczek%26aufirst%3DM.%26aulast%3DHenkler%26aufirst%3DF.%26aulast%3DSamel%26aufirst%3DD.%26aulast%3DReichwein%26aufirst%3DM.%26aulast%3DHausser%26aufirst%3DA.%26aulast%3DParmryd%26aufirst%3DI.%26aulast%3DScheurich%26aufirst%3DP.%26aulast%3DSchmid%26aufirst%3DJ.%2BA.%26aulast%3DWajant%26aufirst%3DH.%26atitle%3DApoptotic%2520crosstalk%2520of%2520TNF%2520receptors%253A%2520TNF-R2-induces%2520depletion%2520of%2520TRAF2%2520and%2520IAP%2520proteins%2520and%2520accelerates%2520TNF-R1-dependent%2520activation%2520of%2520caspase-8%26jtitle%3DJ.%2520Cell%2520Sci.%26date%3D2002%26volume%3D115%26spage%3D2757%26epage%3D2770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tamm, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kornblau, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segall, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welsh, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tudor, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreeff, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reed, J. C.</span><span> </span><span class="NLM_article-title">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1796</span><span class="NLM_x">–</span> <span class="NLM_lpage">1803</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=10815900" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2000&pages=1796-1803&author=I.+Tammauthor=S.+M.+Kornblauauthor=H.+Segallauthor=S.+Krajewskiauthor=K.+Welshauthor=S.+Kitadaauthor=D.+A.+Scudieroauthor=G.+Tudorauthor=Y.+H.+Quiauthor=A.+Monksauthor=M.+Andreeffauthor=J.+C.+Reed&title=Expression+and+prognostic+significance+of+IAP-family+genes+in+human+cancers+and+myeloid+leukemias"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias</span></div><div class="casAuthors">Tamm, Ingo; Kornblau, Steven M.; Segall, Harry; Krajewski, Stanislaw; Welsh, Kate; Kitada, Shinichi; Scudiero, Dominic A.; Tudor, Gabriela; Qui, Yi Hua; Monks, Anne; Andreeff, Michael; Reed, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1796-1803</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Expression of several inhibitor of apoptosis proteins (IAPs) was investigated in the National Cancer Institute panel of 60 human tumor cell lines, and the expression and prognostic significance of one of these, XIAP, was evaluated in 78 previously untreated patients with acute myelogenous leukemia (AML).  XIAP and cIAP1 were expressed in most cancer lines analyzed, with substantial variability in their relative levels.  In contrast, NAIP mRNA was not detectable, and cIAP2 was found at the mRNA and protein levels in only 34 (56%) and 5 (8%) of the 60 tumor cell lines analyzed, resp.  Interestingly, XIAP, cIAP1, and cIAP2 mRNA levels did not correlate with protein levels in the tumor lines, indicating posttranscriptional regulation of expression.  High levels of XIAP protein in tumor cell lines were unexpectedly correlated with sensitivity to some anticancer drugs, particularly cytarabine and other nucleosides, whereas higher levels of cIAP1 protein levels were assocd. with resistance to several anticancer drugs.  The relevance of XIAP to in vivo responses to cytarabine was explored in AML, making correlations with patient outcome.  Patients with lower levels of XIAP protein had longer survival and a tendency toward longer remission duration than those with higher levels of XIAP.  Altogether, IAPs are widely but differentially expressed in human cancers and leukemias, and higher XIAP protein levels may have adverse prognostic significance for patients with AML.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPBpTFu0KAgrVg90H21EOLACvtfcHk0licB6tR-rKXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXktVWis7k%253D&md5=08ea4dd16cfe6106339fbe7ee7e47a77</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTamm%26aufirst%3DI.%26aulast%3DKornblau%26aufirst%3DS.%2BM.%26aulast%3DSegall%26aufirst%3DH.%26aulast%3DKrajewski%26aufirst%3DS.%26aulast%3DWelsh%26aufirst%3DK.%26aulast%3DKitada%26aufirst%3DS.%26aulast%3DScudiero%26aufirst%3DD.%2BA.%26aulast%3DTudor%26aufirst%3DG.%26aulast%3DQui%26aufirst%3DY.%2BH.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DAndreeff%26aufirst%3DM.%26aulast%3DReed%26aufirst%3DJ.%2BC.%26atitle%3DExpression%2520and%2520prognostic%2520significance%2520of%2520IAP-family%2520genes%2520in%2520human%2520cancers%2520and%2520myeloid%2520leukemias%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2000%26volume%3D6%26spage%3D1796%26epage%3D1803" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Yang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, W. C.</span><span> </span><span class="NLM_article-title">Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: Implication for cancer specific therapy</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x">, </span> <span class="NLM_fpage">6815</span><span class="NLM_x">–</span> <span class="NLM_lpage">6824</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=14583479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2003&pages=6815-6824&author=L.+Yangauthor=Z.+Caoauthor=H.+Yanauthor=W.+C.+Wood&title=Coexistence+of+high+levels+of+apoptotic+signaling+and+inhibitor+of+apoptosis+proteins+in+human+tumor+cells%3A+Implication+for+cancer+specific+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Coexistence of High Levels of Apoptotic Signaling and Inhibitor of Apoptosis Proteins in Human Tumor Cells: Implication for Cancer Specific Therapy</span></div><div class="casAuthors">Yang, Lily; Cao, Zehong; Yan, Hui; Wood, William C.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6815-6824</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">It is well known that dysfunction of the apoptotic pathway confers apoptosis resistance and results in a low sensitivity of human cancer cells to therapeutic agents.  A novel strategy to overcome the resistance is to target the apoptotic pathway directly.  To identify mol. targets in the apoptotic pathway that are differentially regulated in cancer and normal cells, we have examd. the levels of apoptotic effectors and inhibitors in human tumor and normal cell lines as well as in cancer and normal tissues.  These include three pancreatic cancer lines (BXPC-3, MIA PaCa-2, and Panc-1), four breast cancer cell lines (MDA-MB-231, MDA-MB-435, MDA-MB-361, and MCF-7), and colon carcinoma line (SW620).  Addnl., breast carcinoma tissue specimens were examd.  Compared with normal human fibroblast and mammary epithelial cell lines, we detected high basal levels of caspase-3 and caspase-8 activities and active caspase-3 fragments in the tumor cell lines and cancer tissues in the absence of apoptotic stimuli.  Furthermore, the tumor cells expressed high levels of survivin and XIAP, two members of the inhibitor of apoptosis (IAP) protein family.  When the activity of these IAPs was blocked by expression of dominant-neg. mutant survivin (survivinT34A) and XIAP-assocd. factor 1, resp., apoptosis was induced in tumor but not normal cell lines.  Moreover, down-regulation of both survivin and XIAP significantly enhanced tumor-cell apoptosis as compared with inhibition of either survivin or XIAP alone.  These results suggest that up-regulated IAP expression counteracts the high basal caspase-3 activity obsd. in these tumor cells and that apoptosis in tumor cells but not normal cells can be induced by blocking IAP activity.  Therefore, IAPs are important mol. targets for the development of cancer-specific therapeutic approaches.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrnkSWDJOSCbVg90H21EOLACvtfcHk0licB6tR-rKXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXosVGnsrk%253D&md5=f8b94616c5ddba25d9ac4ecd1e17eba8</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DZ.%26aulast%3DYan%26aufirst%3DH.%26aulast%3DWood%26aufirst%3DW.%2BC.%26atitle%3DCoexistence%2520of%2520high%2520levels%2520of%2520apoptotic%2520signaling%2520and%2520inhibitor%2520of%2520apoptosis%2520proteins%2520in%2520human%2520tumor%2520cells%253A%2520Implication%2520for%2520cancer%2520specific%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2003%26volume%3D63%26spage%3D6815%26epage%3D6824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Vucic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">The inhibitor of apoptosis proteins as therapeutic targets in cancer</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">5995</span><span class="NLM_x">–</span> <span class="NLM_lpage">6000</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1158%2F1078-0432.CCR-07-0729" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=17947460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=5995-6000&author=D.+Vucicauthor=W.+J.+Fairbrother&title=The+inhibitor+of+apoptosis+proteins+as+therapeutic+targets+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer</span></div><div class="casAuthors">Vucic, Domagoj; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5995-6000</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Apoptosis is a cell suicide process with a major role in development and homeostasis in vertebrates and invertebrates.  Inhibition of apoptosis enhances the survival of cancer cells and facilitates their escape from immune surveillance and cytotoxic therapies.  Among the principal mols. contributing to this phenomenon are the inhibitor of apoptosis (IAP) proteins, a family of antiapoptotic regulators that block cell death in response to diverse stimuli through interactions with inducers and effectors of apoptosis.  IAP proteins are expressed in the majority of human malignancies at elevated levels and play an active role in promoting tumor maintenance through the inhibition of cellular death and participation in signaling pathways assocd. with malignancies.  Here, we discuss the role of IAP proteins in cancer and options for targeting IAP proteins for therapeutic intervention.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosUyky7YXEnLVg90H21EOLACvtfcHk0licB6tR-rKXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFygs7vP&md5=bff042bce2006a510abb6814d43c6dc5</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-07-0729&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-07-0729%26sid%3Dliteratum%253Aachs%26aulast%3DVucic%26aufirst%3DD.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DThe%2520inhibitor%2520of%2520apoptosis%2520proteins%2520as%2520therapeutic%2520targets%2520in%2520cancer%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D5995%26epage%3D6000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oost, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1004</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35050006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11140637" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1004-1008&author=Z.+Liuauthor=C.+Sunauthor=E.+T.+Olejniczakauthor=R.+P.+Meadowsauthor=S.+F.+Betzauthor=T.+Oostauthor=J.+Herrmannauthor=J.+C.+Wuauthor=S.+W.+Fesik&title=Structural+basis+for+binding+of+Smac%2FDIABLO+to+the+XIAP+BIR3+domain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain</span></div><div class="casAuthors">Liu, Zhlhong; Sun, Chaohong; Olejniczak, Edward T.; Meadows, Robert P.; Betz, Stephen F.; Oost, Thorsten; Hemnann, Julia; Wu, Joe C.; Feslk, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1004-1008</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitor-of-apoptosis proteins (IAPs) regulate programmed cell death by inhibiting members of the caspase family of enzymes.  Recently, a mammalian protein called Smac (also named DIABLO) was identified that binds to the LAPs and promotes caspase activation.  Although undefined in the x-ray structure, the amino-terminal residues of Smac are crit. for its function.  To understand the structural basis for mol. recognition between Smac and the IAPs, we detd. the soln. structure of the BIR3 domain of X-linked IAP (XIAP) complexed with a functionally active nine-residue peptide derived from the N terminus of Smac.  The peptide binds across the third β-strand of the BIR3 domain in an extended conformation with only the first four residues contacting the protein.  The complex is stabilized by four intermol. hydrogen bonds, an electrostatic interaction involving the N terminus of the peptide, and several hydrophobic interactions.  This structural information, along with the binding data from BIR3 and Smac peptide mutants reported here, should aid in the design of small mols. that may be used for the treatment of cancers that overexpress IAPs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqM4pZbM96xmrVg90H21EOLACvtfcHk0licB6tR-rKXEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslaiug%253D%253D&md5=d81bd94ecd9cf9c11d96ee228ff371aa</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2F35050006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050006%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DOost%26aufirst%3DT.%26aulast%3DHerrmann%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%2BC.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DStructural%2520basis%2520for%2520binding%2520of%2520Smac%252FDIABLO%2520to%2520the%2520XIAP%2520BIR3%2520domain%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1004%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Wu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suber, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural basis of IAP recognition by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">1008</span><span class="NLM_x">–</span> <span class="NLM_lpage">1012</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35050012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11140638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=1008-1012&author=G.+Wuauthor=J.+Chaiauthor=T.+L.+Suberauthor=J.-W.+Wuauthor=C.+Duauthor=X.+Wangauthor=Y.+Shi&title=Structural+basis+of+IAP+recognition+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural basis of IAP recognition by Smac/DIABLO</span></div><div class="casAuthors">Wu, Geng; Chai, Jijie; Suber, Tomeka L.; Wu, Jia-Wel; Du, Chunying; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6815</span>),
    <span class="NLM_cas:pages">1008-1012</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis is an essential process in the development and homeostasis of all metazoans.  The inhibitor-of-apoptosis (IAP) proteins suppress cell death by inhibiting the activity of caspases; this inhibition is performed by the zinc-binding BIR domains of the IAP proteins.  The mitochondrial protein Smac/DIABLO promotes apoptosis by eliminating the inhibitory effect of IAPs through phys. interactions.  Amino-terminal sequences in Smac/DIABLO are required for this function, as mutation of the very first amino acid leads to loss of interaction with LAPs and concomitant loss of Smac/DIABLO function.  Here we report the high-resoln. crystal structure of Smac/DIABLO complexed with the third BIR domain (BIR3) of XIAP.  Our results show that the N-terminal four residues (Ala-Val-Pro-Ile) in Smac/DIABLO recognize a surface groove on BIR3, with the first residue Ala binding a hydrophobic pocket and making five hydrogen bonds to neighboring residues on BIR3.  These observations provide a structural explanation for the roles of the Smac N terminus as well as the conserved N-terminal sequences in the Drosophila proteins Hid/Grim/Reaper.  In conjunction with other observations, our results reveal how Smac may relieve IAP inhibition of caspase-9 activity.  In addn. to explaining a no. of biol. observations, our structural anal. identifies potential targets for drug screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoV3qy8uKazsrVg90H21EOLACvtfcHk0lgUfYaEPLIfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhslahsQ%253D%253D&md5=fab609edfb1833053eeb78dd2d4ed536</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2F35050012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35050012%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DG.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DSuber%26aufirst%3DT.%2BL.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520basis%2520of%2520IAP%2520recognition%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D1008%26epage%3D1012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Sharma, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Straub, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zawel, L.</span><span> </span><span class="NLM_article-title">Development of peptidomimetics targeting IAPs</span> <span class="citation_source-journal">Int. J. Pept. Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">21</span><span class="NLM_x">–</span> <span class="NLM_lpage">32</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1007%2Fs10989-005-9003-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD28XktVKlu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=21-32&author=S.+K.+Sharmaauthor=C.+Straubauthor=L.+Zawel&title=Development+of+peptidomimetics+targeting+IAPs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Development of peptidomimetics targeting IAPs</span></div><div class="casAuthors">Sharma, Sushil K.; Straub, Christopher; Zawel, Leigh</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Peptide Research and Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">21-32</span>CODEN:
                <span class="NLM_cas:coden">IJPRFC</span>;
        ISSN:<span class="NLM_cas:issn">1573-3149</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis proteins (IAPs) such as XIAP subvert apoptosis by binding and inhibiting caspases.  Because occupation of the XIAP BIR3 peptide binding pocket by Smac abolishes the XIAP-caspase 9 interaction, it is a proapoptotic event of great therapeutic interest.  An assay for pocket binding was developed based on the displacement of Smac 7-mer from BIR3.  Through the phys. and biochem. anal. of a variety of peptides, we have detd. the min. sequence required for inhibition of the Smac-BIR3 interaction and detailed the dimensions and topol. of the BIR3 peptide binding pocket.  This work describes the structure-activity relationship (SAR) for peptide inhibitors of Smac-IAP binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDhtWKk4EEX7Vg90H21EOLACvtfcHk0lgUfYaEPLIfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XktVKlu70%253D&md5=45ebc15463f17060b036d0c3011f1cef</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2Fs10989-005-9003-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10989-005-9003-2%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DS.%2BK.%26aulast%3DStraub%26aufirst%3DC.%26aulast%3DZawel%26aufirst%3DL.%26atitle%3DDevelopment%2520of%2520peptidomimetics%2520targeting%2520IAPs%26jtitle%3DInt.%2520J.%2520Pept.%2520Res.%2520Ther.%26date%3D2006%26volume%3D12%26spage%3D21%26epage%3D32" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design of small-molecule peptidic and nonpeptidic Smac mimetics</span> <span class="citation_source-journal">Acc. Chem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1264</span><span class="NLM_x">–</span> <span class="NLM_lpage">1277</span></span><div class="citationLinks">[<a href="/doi/10.1021/ar8000553" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2008&pages=1264-1277&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=C.-Y.+Yangauthor=D.+Qianauthor=J.+Luauthor=S.+Qiuauthor=L.+Baiauthor=Y.+Pengauthor=Q.+Caiauthor=S.+Wang&title=Design+of+small-molecule+peptidic+and+nonpeptidic+Smac+mimetics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Small-Molecule Peptidic and Nonpeptidic Smac Mimetics</span></div><div class="casAuthors">Sun, Haiying; Nikolovska-Coleska, Zaneta; Yang, Chao-Yie; Qian, Dongguang; Lu, Jianfeng; Qiu, Su; Bai, Longchuan; Peng, Yuefeng; Cai, Qian; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1264-1277</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Smac/DIABLO is a protein released from mitochondria into the cytosol in response to apoptotic stimuli.  Smac promotes apoptosis at least in part through antagonizing inhibitor of apoptosis proteins (IAPs), including XIAP, cIAP-1, and cIAP-2.  Smac interacts with these IAPs via its N-terminal AVPI binding motif.  There has been an enormous interest in academic labs. and pharmaceutical companies in the design of small-mol. Smac mimetics as potential anticancer agents.  This task is particularly challenging because it involves targeting protein-protein interactions.  Nevertheless, intense research has now generated potent, specific, cell-permeable small-mol. peptidomimetics and nonpeptidic mimetics.  To date, two types of Smac mimetics have been reported, namely, monovalent and bivalent Smac mimetics.  The monovalent compds. are designed to mimic the binding of a single AVPI binding motif to IAP proteins, whereas the bivalent compds. contain two AVPI binding motif mimetics tethered together through a linker.  Studies from several groups have clearly demonstrated that both monovalent and bivalent Smac mimetics not only enhance the antitumor activity of other anticancer agents but also can induce apoptosis as single agents in a subset of human cancer cell lines in vitro and are capable of achieving tumor regression in animal models of human cancer.  In general, bivalent Smac mimetics are 100-1000 times more potent than their corresponding monovalent Smac mimetics in induction of apoptosis in tumor cells.  However, properly designed monovalent Smac mimetics can achieve oral bioavailability and may have major advantages over bivalent Smac mimetics as potential drug candidates.  In-depth insights on the mol. mechanism of action of Smac mimetics have been provided by several independent studies.  It was shown that Smac mimetics induce apoptosis in tumor cells by targeting cIAP-1/-2 for the rapid degrdn. of these proteins, which leads to activation of nuclear factor κB (NF-κB) and prodn. and secretion of tumor necrosis factor α (TNFα).  TNFα promotes formation of a receptor-interacting serine-threonine kinase 1 (RIPK1)-dependent caspase-8-activating complex, leading to activation of caspase-8 and -3/-7 and ultimately to apoptosis.  For the most efficient apoptosis induction, Smac mimetics also need to remove the inhibition of XIAP to caspase-3/-7.  Hence, Smac mimetics induce apoptosis in tumor cells by targeting not only cIAP-1/-2 but also XIAP.  The employment of potent, cell-permeable, small-mol. Smac mimetics has yielded important insights into the regulation of apoptosis by IAP proteins.  To date, at least one Smac mimetic has been advanced into clin. development.  Several other Smac mimetics are in an advanced preclin. development stage and are expected to enter human clin. testing for the treatment of cancer in the near future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF2ORbmgx5q7Vg90H21EOLACvtfcHk0lgUfYaEPLIfqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1Kiur3L&md5=434530329024b75e59f7f88e29ea0de1</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Far8000553&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Far8000553%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQian%26aufirst%3DD.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%2520of%2520small-molecule%2520peptidic%2520and%2520nonpeptidic%2520Smac%2520mimetics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2008%26volume%3D41%26spage%3D1264%26epage%3D1277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Mannhold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carosati, E.</span><span> </span><span class="NLM_article-title">IAP antagonists: Promising candidates for cancer therapy</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">219</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.drudis.2010.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20096368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFyns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2010&pages=210-219&author=R.+Mannholdauthor=S.+Fuldaauthor=E.+Carosati&title=IAP+antagonists%3A+Promising+candidates+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">IAP antagonists: promising candidates for cancer therapy</span></div><div class="casAuthors">Mannhold, Raimund; Fulda, Simone; Carosati, Emanuele</div><div class="citationInfo"><span class="NLM_cas:title">Drug Discovery Today</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5/6</span>),
    <span class="NLM_cas:pages">210-219</span>CODEN:
                <span class="NLM_cas:coden">DDTOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  A promising strategy in cancer therapy aims to promote apoptosis in cancer cells.  Targeting inhibitor of apoptosis proteins (IAPs) with small-mol. inhibitors has attracted increasing interest in triggering cancer cell death.  It is considered to have great potential for cancer drug discovery because IAPs block apoptosis at the core of the apoptotic machinery and are aberrantly expressed in various tumors.  This review focuses on the current development of small-mol. IAP antagonists for cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpt6SLGZ0hrG7Vg90H21EOLACvtfcHk0lgE9pvBC1shVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFyns7w%253D&md5=d9c92239547c42cc3a5953868745fa8b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.drudis.2010.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.drudis.2010.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMannhold%26aufirst%3DR.%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DCarosati%26aufirst%3DE.%26atitle%3DIAP%2520antagonists%253A%2520Promising%2520candidates%2520for%2520cancer%2520therapy%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2010%26volume%3D15%26spage%3D210%26epage%3D219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span> </span><span class="NLM_article-title">Small-molecule pan-IAP antagonists: A patent review</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">251</span><span class="NLM_x">–</span> <span class="NLM_lpage">267</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1517%2F13543770903567077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=251-267&author=J.+A.+Flygareauthor=W.+J.+Fairbrother&title=Small-molecule+pan-IAP+antagonists%3A+A+patent+review"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule pan-IAP antagonists: a patent review</span></div><div class="casAuthors">Flygare, John A.; Fairbrother, Wayne J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">251-267</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Importance of the field: The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival that have become important targets for therapeutic intervention in human malignancies.  One strategy for targeting IAP proteins involves agents that mimic the amino terminus of the endogenous IAP protein antagonist second mitochondria-derived activator of caspases (Smac)/direct IAP-binding protein with low pI (DIABLO) and thus block crit. IAP protein interactions.  Areas covered in this review: This review of the IAP antagonist patent literature covers the period from 2000 to mid-2009.  Over 50 patents and patent applications pertaining to IAP antagonists have been published over the past 10 years.  In the case of several filings, only the original source is reviewed in this anal.  What the reader will gain: Readers will gain an overview of IAP protein antagonist scaffolds, with representative examples including monovalent and bivalent Smac mimetics, and an understanding of their structure-activity relationships.  Take home message: The feasibility of disrupting IAP protein interactions with pro-apoptotic proteins using monovalent and bivalent Smac-derived peptidomimetic compds. has been broadly established.  Four such compds. have entered or been approved to enter human clin. trials, which will hopefully allow the utility of this potential therapeutic approach to be evaluated in cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN1K-xLSDlXrVg90H21EOLACvtfcHk0lgE9pvBC1shVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtVGktb0%253D&md5=9017c8266da17502a6c081d5ca2955ac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1517%2F13543770903567077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903567077%26sid%3Dliteratum%253Aachs%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26atitle%3DSmall-molecule%2520pan-IAP%2520antagonists%253A%2520A%2520patent%2520review%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2010%26volume%3D20%26spage%3D251%26epage%3D267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Condon, S. M.</span><span> </span><span class="NLM_article-title">The discovery and development of Smac-mimetics – small-molecule antagonists of the inhibitor of apoptosis proteins</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">211</span><span class="NLM_x">–</span> <span class="NLM_lpage">226</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2011&pages=211-226&author=S.+M.+Condon&title=The+discovery+and+development+of+Smac-mimetics+%E2%80%93+small-molecule+antagonists+of+the+inhibitor+of+apoptosis+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DThe%2520discovery%2520and%2520development%2520of%2520Smac-mimetics%2520%25E2%2580%2593%2520small-molecule%2520antagonists%2520of%2520the%2520inhibitor%2520of%2520apoptosis%2520proteins%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2011%26volume%3D46%26spage%3D211%26epage%3D226" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Fulda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Targeting IAP proteins for therapeutic intervention in cancer</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">109</span><span class="NLM_x">–</span> <span class="NLM_lpage">124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrd3627" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=22293567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=109-124&author=S.+Fuldaauthor=D.+Vucic&title=Targeting+IAP+proteins+for+therapeutic+intervention+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting IAP proteins for therapeutic intervention in cancer</span></div><div class="casAuthors">Fulda, Simone; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">109-124</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Evasion of apoptosis is one of the crucial acquired capabilities used by cancer cells to fend off anticancer therapies.  Inhibitor of apoptosis (IAP) proteins exert a range of biol. activities that promote cancer cell survival and proliferation.  X chromosome-linked IAP is a direct inhibitor of caspases - pro-apoptotic executioner proteases - whereas cellular IAP proteins block the assembly of pro-apoptotic protein signalling complexes and mediate the expression of anti-apoptotic mols.  Furthermore, mutations, amplifications and chromosomal translocations of IAP genes are assocd. with various malignancies.  Among the therapeutic strategies that have been designed to target IAP proteins, the most widely used approach is based on mimicking the IAP-binding motif of second mitochondria-derived activator of caspase (SMAC), which functions as an endogenous IAP antagonist.  Alternative strategies include transcriptional repression and the use of antisense oligonucleotides.  This Review provides an update on IAP protein biol. as well as current and future perspectives on targeting IAP proteins for therapeutic intervention in human malignancies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-R51O_sZcdLVg90H21EOLACvtfcHk0lgE9pvBC1shVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GgsLo%253D&md5=219506817f8526ba0bbd27117ed4f290</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fnrd3627&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3627%26sid%3Dliteratum%253Aachs%26aulast%3DFulda%26aufirst%3DS.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DTargeting%2520IAP%2520proteins%2520for%2520therapeutic%2520intervention%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2012%26volume%3D11%26spage%3D109%26epage%3D124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyin, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span> </span><span class="NLM_article-title">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">406</span><span class="NLM_x">, </span> <span class="NLM_fpage">855</span><span class="NLM_x">–</span> <span class="NLM_lpage">862</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2F35022514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=10972280" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=406&publication_year=2000&pages=855-862&author=J.+Chaiauthor=C.+Duauthor=J.-W.+Wuauthor=S.+Kyinauthor=X.+Wangauthor=Y.+Shi&title=Structural+and+biochemical+basis+of+apoptotic+activation+by+Smac%2FDIABLO"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and biochemical basis of apoptotic activation by Smac/DIABLO</span></div><div class="casAuthors">Chai, Jijie; Du, Chunying; Wu, Jia-Wei; Kyin, Saw; Wang, Xiaodong; Shi, Yigong</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">406</span>
        (<span class="NLM_cas:issue">6798</span>),
    <span class="NLM_cas:pages">855-862</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Apoptosis (programmed cell death), an essential process in the development and homeostasis of metazoans, is carried out by caspases.  The mitochondrial protein Smac/DIABLO performs a crit. function in apoptosis by eliminating the inhibitory effect of IAPs (inhibitor of apoptosis proteins) on caspases.  Here we show that Smac/DIABLO promotes not only the proteolytic activation of procaspase-3 but also the enzymic activity of mature caspase-3, both of which depend upon its ability to interact phys. with IAPs.  The crystal structure of Smac/DIABLO at 2.2Å resoln. reveals that it homodimerizes through an extensive hydrophobic interface.  Missense mutations inactivating this dimeric interface significantly compromise the function of Smac/DIABLO.  As in the Drosophila proteins Reaper, Grim and Hid, the amino-terminal amino acids of Smac/DIABLO are indispensable for its function, and a seven-residue peptide derived from the amino terminus promotes procaspase-3 activation in vitro.  These results establish an evolutionarily conserved structural and biochem. basis for the activation of apoptosis by Smac/DIABLO.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQ4zPSamJORbVg90H21EOLACvtfcHk0ljEqsbwWSSS-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsVCrsLk%253D&md5=e3e65405a679b11556fa875b7c5dc9fa</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1038%2F35022514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35022514%26sid%3Dliteratum%253Aachs%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DJ.-W.%26aulast%3DKyin%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DShi%26aufirst%3DY.%26atitle%3DStructural%2520and%2520biochemical%2520basis%2520of%2520apoptotic%2520activation%2520by%2520Smac%252FDIABLO%26jtitle%3DNature%26date%3D2000%26volume%3D406%26spage%3D855%26epage%3D862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Brabander, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P. G.</span><span> </span><span class="NLM_article-title">A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">305</span><span class="NLM_x">, </span> <span class="NLM_fpage">1471</span><span class="NLM_x">–</span> <span class="NLM_lpage">1474</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2004&pages=1471-1474&author=L.+Liauthor=R.+M.+Thomasauthor=H.+Suzukiauthor=J.+K.+De+Brabanderauthor=X.+Wangauthor=P.+G.+Harran&title=A+small+molecule+Smac+mimic+potentiates+TRAIL-+and+TNF%CE%B1-mediated+cell+death"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%26aulast%3DThomas%26aufirst%3DR.%2BM.%26aulast%3DSuzuki%26aufirst%3DH.%26aulast%3DDe%2BBrabander%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DHarran%26aufirst%3DP.%2BG.%26atitle%3DA%2520small%2520molecule%2520Smac%2520mimic%2520potentiates%2520TRAIL-%2520and%2520TNF%25CE%25B1-mediated%2520cell%2520death%26jtitle%3DScience%26date%3D2004%26volume%3D305%26spage%3D1471%26epage%3D1474" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomita, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krajewski, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Design, synthesis, and characterization of a potent, nonpeptide, cell-permeable, bivalent Smac mimetic that concurrently targets both the BIR2 and BIR3 domains in XIAP</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">129</span><span class="NLM_x">, </span> <span class="NLM_fpage">15279</span><span class="NLM_x">–</span> <span class="NLM_lpage">15294</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja074725f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2007&pages=15279-15294&author=H.+Sunauthor=Z.+Nikolovska-Coleskaauthor=J.+Luauthor=J.+L.+Meagherauthor=C.-Y.+Yangauthor=S.+Qiuauthor=Y.+Tomitaauthor=Y.+Uedaauthor=S.+Jiangauthor=K.+Krajewskiauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Design%2C+synthesis%2C+and+characterization+of+a+potent%2C+nonpeptide%2C+cell-permeable%2C+bivalent+Smac+mimetic+that+concurrently+targets+both+the+BIR2+and+BIR3+domains+in+XIAP"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja074725f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja074725f%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DTomita%26aufirst%3DY.%26aulast%3DUeda%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DKrajewski%26aufirst%3DK.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520characterization%2520of%2520a%2520potent%252C%2520nonpeptide%252C%2520cell-permeable%252C%2520bivalent%2520Smac%2520mimetic%2520that%2520concurrently%2520targets%2520both%2520the%2520BIR2%2520and%2520BIR3%2520domains%2520in%2520XIAP%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2007%26volume%3D129%26spage%3D15279%26epage%3D15294" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Cossu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mastrangelo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vachette, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Servida, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canevari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delia, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drago, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzo, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manzoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seneci, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scolastico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognesi, M.</span><span> </span><span class="NLM_article-title">Structural basis for bivalent Smac-mimetics recognition in the IAP protein family</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">392</span><span class="NLM_x">, </span> <span class="NLM_fpage">630</span><span class="NLM_x">–</span> <span class="NLM_lpage">644</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=392&publication_year=2009&pages=630-644&author=F.+Cossuauthor=M.+Milaniauthor=E.+Mastrangeloauthor=P.+Vachetteauthor=F.+Servidaauthor=D.+Lecisauthor=G.+Canevariauthor=D.+Deliaauthor=C.+Dragoauthor=V.+Rizzoauthor=L.+Manzoniauthor=P.+Seneciauthor=C.+Scolasticoauthor=M.+Bolognesi&title=Structural+basis+for+bivalent+Smac-mimetics+recognition+in+the+IAP+protein+family"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCossu%26aufirst%3DF.%26aulast%3DMilani%26aufirst%3DM.%26aulast%3DMastrangelo%26aufirst%3DE.%26aulast%3DVachette%26aufirst%3DP.%26aulast%3DServida%26aufirst%3DF.%26aulast%3DLecis%26aufirst%3DD.%26aulast%3DCanevari%26aufirst%3DG.%26aulast%3DDelia%26aufirst%3DD.%26aulast%3DDrago%26aufirst%3DC.%26aulast%3DRizzo%26aufirst%3DV.%26aulast%3DManzoni%26aufirst%3DL.%26aulast%3DSeneci%26aufirst%3DP.%26aulast%3DScolastico%26aufirst%3DC.%26aulast%3DBolognesi%26aufirst%3DM.%26atitle%3DStructural%2520basis%2520for%2520bivalent%2520Smac-mimetics%2520recognition%2520in%2520the%2520IAP%2520protein%2520family%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D392%26spage%3D630%26epage%3D644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Oost, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armstrong, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Al-Assaad, A.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betz, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deckwerth, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meadows, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olejniczak, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oleksijew, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oltersdorf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoemaker, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomaselli, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zou, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S. W.</span><span> </span><span class="NLM_article-title">Discovery of potent antagonists of the antiapoptotic protein XIAP for the treatment of cancer</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4417</span><span class="NLM_x">–</span> <span class="NLM_lpage">4426</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm040037k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4417-4426&author=T.+K.+Oostauthor=C.+Sunauthor=R.+C.+Armstrongauthor=A.-S.+Al-Assaadauthor=S.+F.+Betzauthor=T.+L.+Deckwerthauthor=H.+Dingauthor=S.+W.+Elmoreauthor=R.+P.+Meadowsauthor=E.+T.+Olejniczakauthor=A.+Oleksijewauthor=T.+Oltersdorfauthor=S.+H.+Rosenbergauthor=A.+R.+Shoemakerauthor=K.+J.+Tomaselliauthor=H.+Zouauthor=S.+W.+Fesik&title=Discovery+of+potent+antagonists+of+the+antiapoptotic+protein+XIAP+for+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent Antagonists of the Antiapoptotic Protein XIAP for the Treatment of Cancer</span></div><div class="casAuthors">Oost, Thorsten K.; Sun, Chaohong; Armstrong, Robert C.; Al-Assaad, Ali-Samer; Betz, Stephen F.; Deckwerth, Thomas L.; Ding, Hong; Elmore, Steven W.; Meadows, Robert P.; Olejniczak, Edward T.; Oleksijew, Andrew; Oltersdorf, Tilman; Rosenberg, Saul H.; Shoemaker, Alexander R.; Tomaselli, Kevin J.; Zou, Hua; Fesik, Stephen W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4417-4426</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Inhibitor of apoptosis (IAP) proteins are overexpressed in many cancers and have been implicated in tumor growth, pathogenesis, and resistance to chemo- or radiotherapy.  On the basis of the NMR structure of a SMAC peptide complexed with the BIR3 domain of X-linked IAP (XIAP), a novel series of XIAP antagonists was discovered.  The most potent compds. in this series bind to the baculovirus IAP repeat 3 (BIR3) domain of XIAP with single-digit nanomolar affinity and promote cell death in several human cancer cell lines.  In a MDA-MB-231 breast cancer mouse xenograft model, these XIAP antagonists inhibited the growth of tumors.  Close structural analogs that showed only weak binding to the XIAP-BIR3 domain were inactive in the cellular assays and showed only marginal in vivo activity.  Our results are consistent with a mechanism in which ligands for the BIR3 domain of XIAP induce apoptosis by freeing up caspases.  The present study validates the BIR3 domain of XIAP as a target and supports the use of small mol. XIAP antagonists as a potential therapy for cancers that overexpress XIAP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzSXHFufBtZbVg90H21EOLACvtfcHk0ljEqsbwWSSS-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtFOltbo%253D&md5=ccd77135a42ab84cd36f221abdb4fee7</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm040037k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040037k%26sid%3Dliteratum%253Aachs%26aulast%3DOost%26aufirst%3DT.%2BK.%26aulast%3DSun%26aufirst%3DC.%26aulast%3DArmstrong%26aufirst%3DR.%2BC.%26aulast%3DAl-Assaad%26aufirst%3DA.-S.%26aulast%3DBetz%26aufirst%3DS.%2BF.%26aulast%3DDeckwerth%26aufirst%3DT.%2BL.%26aulast%3DDing%26aufirst%3DH.%26aulast%3DElmore%26aufirst%3DS.%2BW.%26aulast%3DMeadows%26aufirst%3DR.%2BP.%26aulast%3DOlejniczak%26aufirst%3DE.%2BT.%26aulast%3DOleksijew%26aufirst%3DA.%26aulast%3DOltersdorf%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DShoemaker%26aufirst%3DA.%2BR.%26aulast%3DTomaselli%26aufirst%3DK.%2BJ.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DFesik%26aufirst%3DS.%2BW.%26atitle%3DDiscovery%2520of%2520potent%2520antagonists%2520of%2520the%2520antiapoptotic%2520protein%2520XIAP%2520for%2520the%2520treatment%2520of%2520cancer%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4417%26epage%3D4426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Laurent, A.</span><span> </span><span class="NLM_article-title">IAP BIR domain binding compounds</span>. Patent US20070093428,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=A.+Laurent&title=IAP+BIR+domain+binding+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLaurent%26aufirst%3DA.%26atitle%3DIAP%2520BIR%2520domain%2520binding%2520compounds%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yalcin-Chin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harran, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Autocrine TNFα signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">445</span><span class="NLM_x">–</span> <span class="NLM_lpage">456</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=445-456&author=S.+L.+Petersenauthor=L.+Wangauthor=A.+Yalcin-Chinauthor=L.+Liauthor=M.+Peytonauthor=J.+Minnaauthor=P.+Harranauthor=X.+Wang&title=Autocrine+TNF%CE%B1+signaling+renders+human+cancer+cells+susceptible+to+Smac-mimetic-induced+apoptosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DYalcin-Chin%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%26aulast%3DHarran%26aufirst%3DP.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DAutocrine%2520TNF%25CE%25B1%2520signaling%2520renders%2520human%2520cancer%2520cells%2520susceptible%2520to%2520Smac-mimetic-induced%2520apoptosis%26jtitle%3DCancer%2520Cell%26date%3D2007%26volume%3D12%26spage%3D445%26epage%3D456" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Ndubaku, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varfolomeev, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zobel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lau, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federova, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dynek, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hymowitz, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsui, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshayes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairbrother, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flygare, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vucic, D.</span><span> </span><span class="NLM_article-title">Antagonism of c-IAP and XIAP proteins is required for efficient induction of cell death by small-molecule IAP antagonists</span> <span class="citation_source-journal">ACS Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">557</span><span class="NLM_x">–</span> <span class="NLM_lpage">566</span></span><div class="citationLinks">[<a href="/doi/10.1021/cb900083m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=557-566&author=C.+Ndubakuauthor=E.+Varfolomeevauthor=L.+Wangauthor=K.+Zobelauthor=K.+Lauauthor=L.+O.+Elliottauthor=B.+Maurerauthor=A.+V.+Federovaauthor=J.+N.+Dynekauthor=M.+Kohlerauthor=S.+G.+Hymowitzauthor=V.+Tsuiauthor=K.+Deshayesauthor=W.+J.+Fairbrotherauthor=J.+A.+Flygareauthor=D.+Vucic&title=Antagonism+of+c-IAP+and+XIAP+proteins+is+required+for+efficient+induction+of+cell+death+by+small-molecule+IAP+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antagonism of c-IAP and XIAP Proteins Is Required for Efficient Induction of Cell Death by Small-Molecule IAP Antagonists</span></div><div class="casAuthors">Ndubaku, Chudi; Varfolomeev, Eugene; Wang, Lan; Zobel, Kerry; Lau, Kevin; Elliott, Linda O.; Maurer, Brigitte; Fedorova, Anna V.; Dynek, Jasmin N.; Koehler, Michael; Hymowitz, Sarah G.; Tsui, Vickie; Deshayes, Kurt; Fairbrother, Wayne J.; Flygare, John A.; Vucic, Domagoj</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">557-566</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis (IAP) proteins are crit. regulators of cancer cell survival, which makes them attractive targets for therapeutic intervention in cancers.  Herein, the structure-based design of IAP antagonists with high affinities and selectivity (>2000-fold) for c-IAP1 over XIAP and their functional characterization as activators of apoptosis in tumor cells are described.  Although capable of inducing cell death and preventing clonogenic survival, c-IAP-selective antagonists are significantly less potent in promoting apoptosis when compared to pan-selective compds.  However, both pan-IAP- and c-IAP-selective antagonists stimulate c-IAP1 and c-IAP2 degrdn. and activation of NF-κB pathways with comparable potencies.  Therefore, although compds. that specifically target c-IAP1 and c-IAP2 are capable of inducing apoptosis, antagonism of the c-IAP proteins and XIAP is required for efficient induction of cancer cell death by IAP antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7xO3yZNCyz7Vg90H21EOLACvtfcHk0lgh7FO48UjaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Sjur4%253D&md5=f1c82b7c5632453ba36e039441f039c9</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fcb900083m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb900083m%26sid%3Dliteratum%253Aachs%26aulast%3DNdubaku%26aufirst%3DC.%26aulast%3DVarfolomeev%26aufirst%3DE.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZobel%26aufirst%3DK.%26aulast%3DLau%26aufirst%3DK.%26aulast%3DElliott%26aufirst%3DL.%2BO.%26aulast%3DMaurer%26aufirst%3DB.%26aulast%3DFederova%26aufirst%3DA.%2BV.%26aulast%3DDynek%26aufirst%3DJ.%2BN.%26aulast%3DKohler%26aufirst%3DM.%26aulast%3DHymowitz%26aufirst%3DS.%2BG.%26aulast%3DTsui%26aufirst%3DV.%26aulast%3DDeshayes%26aufirst%3DK.%26aulast%3DFairbrother%26aufirst%3DW.%2BJ.%26aulast%3DFlygare%26aufirst%3DJ.%2BA.%26aulast%3DVucic%26aufirst%3DD.%26atitle%3DAntagonism%2520of%2520c-IAP%2520and%2520XIAP%2520proteins%2520is%2520required%2520for%2520efficient%2520induction%2520of%2520cell%2520death%2520by%2520small-molecule%2520IAP%2520antagonists%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2009%26volume%3D4%26spage%3D557%26epage%3D566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hennessy, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saeh, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquila, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferguson, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laing, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span> </span><span class="NLM_article-title">Discovery of aminopiperidine-based Smac mimetics as IAP antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1690</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2Fj.bmcl.2011.12.109" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=22264476" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC38XitVajtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1690-1694&author=E.+J.+Hennessyauthor=J.+C.+Saehauthor=L.+Shaauthor=T.+MacIntyreauthor=H.+Wangauthor=N.+A.+Larsenauthor=B.+M.+Aquilaauthor=A.+D.+Fergusonauthor=N.+M.+Laingauthor=C.+A.+Omer&title=Discovery+of+aminopiperidine-based+Smac+mimetics+as+IAP+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of aminopiperidine-based Smac mimetics as IAP antagonists</span></div><div class="casAuthors">Hennessy, Edward J.; Saeh, Jamal C.; Sha, Li; MacIntyre, Terry; Wang, Haiyun; Larsen, Nicholas A.; Aquila, Brian M.; Ferguson, Andrew D.; Laing, Naomi M.; Omer, Charles A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1690-1694</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of structurally unique Smac mimetics that act as antagonists of inhibitor of apoptosis proteins (IAPs) has been discovered.  While most previously described Smac mimetics contain the proline ring (or a similar cyclic motif) found in Smac, a key feature of the compds. described herein is that this ring has been removed.  Despite this, compds. in this series potently bind to cIAP1 and elicit the expected phenotype of cIAP1 inhibition in cancer cells.  Marked selectivity for cIAP1 over XIAP is obsd. for these compds., which is attributed to a slight difference in the binding groove between the two proteins and the resulting steric interactions with the inhibitors.  XIAP binding can be improved by constraining the inhibitor so that these unfavorable steric interactions are minimized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMxW_JEoe3-bVg90H21EOLACvtfcHk0lgh7FO48UjaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XitVajtL0%253D&md5=91ee3b34d5a9dbebd3ac7702444aa9ac</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.109%26sid%3Dliteratum%253Aachs%26aulast%3DHennessy%26aufirst%3DE.%2BJ.%26aulast%3DSaeh%26aufirst%3DJ.%2BC.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DN.%2BA.%26aulast%3DAquila%26aufirst%3DB.%2BM.%26aulast%3DFerguson%26aufirst%3DA.%2BD.%26aulast%3DLaing%26aufirst%3DN.%2BM.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26atitle%3DDiscovery%2520of%2520aminopiperidine-based%2520Smac%2520mimetics%2520as%2520IAP%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1690%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Potent bivalent Smac mimetics: Effect of the linker on binding to inhibitor of apoptosis proteins (IAPs) and anticancer activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">3306</span><span class="NLM_x">–</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101651b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=3306-3318&author=H.+Sunauthor=L.+Liuauthor=J.+Luauthor=L.+Baiauthor=X.+Liauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=C.-Y.+Yangauthor=S.+Qiuauthor=H.+Yiauthor=D.+Sunauthor=S.+Wang&title=Potent+bivalent+Smac+mimetics%3A+Effect+of+the+linker+on+binding+to+inhibitor+of+apoptosis+proteins+%28IAPs%29+and+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm101651b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101651b%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DPotent%2520bivalent%2520Smac%2520mimetics%253A%2520Effect%2520of%2520the%2520linker%2520on%2520binding%2520to%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520and%2520anticancer%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D3306%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bettjeman, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Budhidarmo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mace, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chunduru, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinlay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaux, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, C. L.</span><span> </span><span class="NLM_article-title">Smac mimetics activate the E3 ligase activity of cIAP1 protein by promoting RING domain dimerization</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">286</span><span class="NLM_x">, </span> <span class="NLM_fpage">17015</span><span class="NLM_x">–</span> <span class="NLM_lpage">17028</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2011&pages=17015-17028&author=R.+Felthamauthor=B.+Bettjemanauthor=R.+Budhidarmoauthor=P.+D.+Maceauthor=S.+Shirleyauthor=S.+M.+Condonauthor=S.+K.+Chunduruauthor=M.+A.+McKinlayauthor=D.+L.+Vauxauthor=J.+Silkeauthor=C.+L.+Day&title=Smac+mimetics+activate+the+E3+ligase+activity+of+cIAP1+protein+by+promoting+RING+domain+dimerization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DBettjeman%26aufirst%3DB.%26aulast%3DBudhidarmo%26aufirst%3DR.%26aulast%3DMace%26aufirst%3DP.%2BD.%26aulast%3DShirley%26aufirst%3DS.%26aulast%3DCondon%26aufirst%3DS.%2BM.%26aulast%3DChunduru%26aufirst%3DS.%2BK.%26aulast%3DMcKinlay%26aufirst%3DM.%2BA.%26aulast%3DVaux%26aufirst%3DD.%2BL.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DDay%26aufirst%3DC.%2BL.%26atitle%3DSmac%2520mimetics%2520activate%2520the%2520E3%2520ligase%2520activity%2520of%2520cIAP1%2520protein%2520by%2520promoting%2520RING%2520domain%2520dimerization%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2011%26volume%3D286%26spage%3D17015%26epage%3D17028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0liYt3qa5CsxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Kipp, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wist, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cresson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albiniak, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semmelhack, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLendon, G. L.</span><span> </span><span class="NLM_article-title">Molecular targeting of inhibitor of apoptosis proteins based on small molecule mimics of natural binding partners</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">7344</span><span class="NLM_x">–</span> <span class="NLM_lpage">7349</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi0121454" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2002&pages=7344-7349&author=R.+A.+Kippauthor=M.+A.+Caseauthor=A.+D.+Wistauthor=C.+M.+Cressonauthor=M.+Carrellauthor=E.+Grinerauthor=A.+Wiitaauthor=P.+A.+Albiniakauthor=J.+Chaiauthor=Y.+Shiauthor=M.+F.+Semmelhackauthor=G.+L.+McLendon&title=Molecular+targeting+of+inhibitor+of+apoptosis+proteins+based+on+small+molecule+mimics+of+natural+binding+partners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Targeting of Inhibitor of Apoptosis Proteins Based on Small Molecule Mimics of Natural Binding Partners</span></div><div class="casAuthors">Kipp, Rachael A.; Case, Martin A.; Wist, Aislyn D.; Cresson, Catherine M.; Carrell, Maria; Griner, Erin; Wiita, Arun; Albiniak, Philip A.; Chai, Jijie; Shi, Yigong; Semmelhack, Martin F.; McLendon, George L.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7344-7349</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An assay based on a solvent-sensitive fluorogenic dye mol., badan, is used to test the binding affinity of a library of tetrapeptide mols. for the BIR3 (baculovirus IAP repeat) domain of XIAP (X-linked inhibitor of apoptosis protein).  The fluorophore is attached to a tetrapeptide, Ala-Val-Pro-Cys-NH2, through a thiol linkage and, upon binding to XIAP, undergoes a solvatochromic shift in fluorescence emission.  When a mol. (e.g., a natural protein known to bind to XIAP or a tetrapeptide mimic) displaces the dye, the emission shifts back to the spectrum obsd. in water.  As emission intensity is related to the binding of the tetrapeptide, the intensity can be used to det. the equil. const., K, for the displacement of the dye by the tetrapeptide.  The results permit residue-specific anal. of the interaction.  Furthermore, we show that hydrophobic effects in the fourth position are general and can effectively increase overall affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2jRD1J251H7Vg90H21EOLACvtfcHk0liYt3qa5CsxOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xjs1egsL4%253D&md5=ce6f8ed9b3a195523b98dc4943142312</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi0121454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0121454%26sid%3Dliteratum%253Aachs%26aulast%3DKipp%26aufirst%3DR.%2BA.%26aulast%3DCase%26aufirst%3DM.%2BA.%26aulast%3DWist%26aufirst%3DA.%2BD.%26aulast%3DCresson%26aufirst%3DC.%2BM.%26aulast%3DCarrell%26aufirst%3DM.%26aulast%3DGriner%26aufirst%3DE.%26aulast%3DWiita%26aufirst%3DA.%26aulast%3DAlbiniak%26aufirst%3DP.%2BA.%26aulast%3DChai%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DY.%26aulast%3DSemmelhack%26aufirst%3DM.%2BF.%26aulast%3DMcLendon%26aufirst%3DG.%2BL.%26atitle%3DMolecular%2520targeting%2520of%2520inhibitor%2520of%2520apoptosis%2520proteins%2520based%2520on%2520small%2520molecule%2520mimics%2520of%2520natural%2520binding%2520partners%26jtitle%3DBiochemistry%26date%3D2002%26volume%3D41%26spage%3D7344%26epage%3D7349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Condon, S. M.; LaPorte, M. G.; Deng, Y.; Rippin, S. R.</span><span> </span><span class="NLM_article-title">Dimeric IAP inhibitors</span>. Patent WO2006091972,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=S.+M.+Condon&author=M.+G.+LaPorte&author=Y.+Deng&author=S.+R.+Rippin&title=Dimeric+IAP+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCondon%26aufirst%3DS.%2BM.%26atitle%3DDimeric%2520IAP%2520inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meagher, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roller, P. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuckey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">Interaction of a cyclic, bivalent Smac mimetic with the X-linked inhibitor of apoptosis protein</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">9811</span><span class="NLM_x">–</span> <span class="NLM_lpage">9824</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi800785y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2008&pages=9811-9824&author=Z.+Nikolovska-Coleskaauthor=J.+L.+Meagherauthor=S.+Jiangauthor=C.-Y.+Yangauthor=S.+Qiuauthor=P.+P.+Rollerauthor=J.+A.+Stuckeyauthor=S.+Wang&title=Interaction+of+a+cyclic%2C+bivalent+Smac+mimetic+with+the+X-linked+inhibitor+of+apoptosis+protein"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Interaction of a Cyclic, Bivalent Smac Mimetic with the X-Linked Inhibitor of Apoptosis Protein</span></div><div class="casAuthors">Nikolovska-Coleska, Zaneta; Meagher, Jennifer L.; Jiang, Sheng; Yang, Chao-Yie; Qiu, Su; Roller, Peter P.; Stuckey, Jeanne A.; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">9811-9824</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have designed and synthesized a cyclic, bivalent Smac mimetic (compd. 3) and characterized its interaction with the X-linked inhibitor of apoptosis protein (XIAP).  Compd. 3 binds to XIAP contg. both BIR2 and BIR3 domains with a biphasic dose-response curve representing two binding sites with IC50 values of 0.5 and 406 nM, resp.  Compd. 3 binds to XIAPs contg. the BIR3-only and BIR2-only domain with Ki values of 4 nM and 4.4 μM, resp.  Gel filtration expts. using wild-type and mutated XIAPs showed that 3 forms a 1:2 stoichiometric complex with XIAP contg. the BIR3-only domain.  However, it forms a 1:1 stoichiometric complex with XIAP contg. both BIR2 and BIR3 domains, and both BIR domains are involved in the binding.  Compd. 3 efficiently antagonizes inhibition of XIAP in a cell-free functional assay and is >200 times more potent than its corresponding monovalent compd. 2.  Detn. of the crystal structure of 3 in complex with the XIAP BIR3 domain confirms that 3 induces homodimerization of the XIAP BIR3 domain and provides a structural basis for the cooperative binding of one mol. of compd. 3 to two XIAP BIR3 mols.  On the basis of this crystal structure, a binding model of XIAP contg. both BIR2 and BIR3 domains and 3 was constructed, which sheds light on the ability of 3 to relieve the inhibition of XIAP with not only caspase-9 but also caspase-3/-7.  Compd. 3 is cell-permeable, effectively activates caspases in whole cells, and potently inhibits cancer cell growth.  Compd. 3 is a useful biochem. and pharmacol. tool for further elucidating the role of XIAP in regulation of apoptosis and represents a promising lead compd. for the design of potent, cell-permeable Smac mimetics for cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpSEyxJPGLGNLVg90H21EOLACvtfcHk0lhVQskUI_jySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWmu7vK&md5=e4bc922befd427c343f908017286d6f7</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fbi800785y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi800785y%26sid%3Dliteratum%253Aachs%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMeagher%26aufirst%3DJ.%2BL.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DRoller%26aufirst%3DP.%2BP.%26aulast%3DStuckey%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DInteraction%2520of%2520a%2520cyclic%252C%2520bivalent%2520Smac%2520mimetic%2520with%2520the%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%26jtitle%3DBiochemistry%26date%3D2008%26volume%3D47%26spage%3D9811%26epage%3D9824" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Burton, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conradi, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgers, A. R.</span><span> </span><span class="NLM_article-title">Transcellular mechanism of peptide and protein absorption: Passive aspects</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">386</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1991&pages=365-386&author=P.+S.+Burtonauthor=R.+A.+Conradiauthor=A.+R.+Hilgers&title=Transcellular+mechanism+of+peptide+and+protein+absorption%3A+Passive+aspects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurton%26aufirst%3DP.%2BS.%26aulast%3DConradi%26aufirst%3DR.%2BA.%26aulast%3DHilgers%26aufirst%3DA.%2BR.%26atitle%3DTranscellular%2520mechanism%2520of%2520peptide%2520and%2520protein%2520absorption%253A%2520Passive%2520aspects%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D1991%26volume%3D7%26spage%3D365%26epage%3D386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="note"><p class="first last">Because of technical difficulties in obtaining accurate experimental Log D measurements for these compounds, values calculated using the ACD LogD software (v.12.01, © 1997–2009 Advanced Chemistry Development, Inc.) are presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> instead.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Stenberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthman, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Artursson, P.</span><span> </span><span class="NLM_article-title">Prediction of membrane permeability to peptides from calculated dynamic molecular surface dynamics</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">205</span><span class="NLM_x">–</span> <span class="NLM_lpage">212</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=1999&pages=205-212&author=P.+Stenbergauthor=K.+Luthmanauthor=P.+Artursson&title=Prediction+of+membrane+permeability+to+peptides+from+calculated+dynamic+molecular+surface+dynamics"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStenberg%26aufirst%3DP.%26aulast%3DLuthman%26aufirst%3DK.%26aulast%3DArtursson%26aufirst%3DP.%26atitle%3DPrediction%2520of%2520membrane%2520permeability%2520to%2520peptides%2520from%2520calculated%2520dynamic%2520molecular%2520surface%2520dynamics%26jtitle%3DPharm.%2520Res.%26date%3D1999%26volume%3D16%26spage%3D205%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rich, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, H.</span><span> </span><span class="NLM_article-title">Requirement of both the second and third BIR domains for the relief of X-linked inhibitor of apoptosis protein (XIAP)-mediated caspase inhibition by Smac</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49517</span><span class="NLM_x">–</span> <span class="NLM_lpage">49522</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1074%2Fjbc.M310061200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=14512414" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49517-49522&author=Y.+Huangauthor=R.+L.+Richauthor=D.+G.+Myszkaauthor=H.+Wu&title=Requirement+of+both+the+second+and+third+BIR+domains+for+the+relief+of+X-linked+inhibitor+of+apoptosis+protein+%28XIAP%29-mediated+caspase+inhibition+by+Smac"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Requirement of Both the Second and Third BIR Domains for the Relief of X-linked Inhibitor of Apoptosis Protein (XIAP)-mediated Caspase Inhibition by Smac</span></div><div class="casAuthors">Huang, Yihua; Rich, Rebecca L.; Myszka, David G.; Wu, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49517-49522</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The inhibitor of apoptosis proteins (IAP) are endogenous caspase inhibitors in the metazoan and characterized by the presence of baculoviral IAP repeats (BIR).  X-linked IAP (XIAP) contains three BIR domains and directly inhibits effector caspases such as caspase-7 via a linker BIR2 fragment and initiator caspases such as caspase-9 via the BIR3 domain.  A mitochondrial protein Smac/DIABLO, which is released during apoptosis, antagonizes XIAP-mediated caspase inhibition by interacting directly with XIAP.  Here, using glutathione S-transferase pulldown and caspase activity assay, we show that Smac is ineffective in relieving either caspase-7 or caspase-9 inhibition by XIAP domain fragments.  In addn., Smac forms a ternary complex with caspase-7 and linker BIR2, suggesting that Smac/linker BIR2 interaction does not sterically exclude linker BIR2/caspase-7 interaction.  However, Smac is effective in removing caspase-7 and caspase-9 inhibition by XIAP fragments contg. both the BIR2 and BIR3 domains.  Surface plasmon resonance measurements show that Smac interacts with the BIR2 or BIR3 domain in micromolar dissocn. consts.  On the other hand, Smac interacts with an XIAP construct contg. both BIR2 and BIR3 domains in a subnanomolar dissocn. const. by the simultaneous interaction of the Smac dimer with the BIR2 and BIR3 domains of a single XIAP mol.  This 2:1 Smac/XIAP interaction not only possesses enhanced affinity but also sterically excludes XIAP/caspase-7 interaction, demonstrating the requirement of both BIR2 and BIR3 domains for Smac to relieve XIAP-mediated caspase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlkdgJwimDMLVg90H21EOLACvtfcHk0lhVQskUI_jySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrtL8%253D&md5=10937a5499d990c1237753ed28cb9509</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M310061200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M310061200%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DRich%26aufirst%3DR.%2BL.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DWu%26aufirst%3DH.%26atitle%3DRequirement%2520of%2520both%2520the%2520second%2520and%2520third%2520BIR%2520domains%2520for%2520the%2520relief%2520of%2520X-linked%2520inhibitor%2520of%2520apoptosis%2520protein%2520%2528XIAP%2529-mediated%2520caspase%2520inhibition%2520by%2520Smac%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49517%26epage%3D49522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Copeland, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pompliano, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meek, T. D.</span><span> </span><span class="NLM_article-title">Drug-target residence time and its implications for lead optimization</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">730</span><span class="NLM_x">–</span> <span class="NLM_lpage">739</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fnrd2082" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=16888652" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=730-739&author=R.+A.+Copelandauthor=D.+L.+Pomplianoauthor=T.+D.+Meek&title=Drug-target+residence+time+and+its+implications+for+lead+optimization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-target residence time and its implications for lead optimization</span></div><div class="casAuthors">Copeland, Robert A.; Pompliano, David L.; Meek, Thomas D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">730-739</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Much of drug discovery today is predicated on the concept of selective targeting of particular bioactive macromols. by low-mol.-mass drugs.  The binding of drugs to their macromol. targets is therefore seen as paramount for pharmacol. activity.  In vitro assessment of drug-target interactions is classically quantified in terms of binding parameters such as IC50 or Kd.  This article presents an alternative perspective on drug optimization in terms of drug-target binary complex residence time, as quantified by the dissociative half-life of the drug-target binary complex.  We describe the potential advantages of long residence time in terms of duration of pharmacol. effect and target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGry6SJrMlrrTbVg90H21EOLACvtfcHk0lhVQskUI_jySg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptVCltro%253D&md5=60ede2301584b10ac4e8fa18e1e6d107</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1038%2Fnrd2082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2082%26sid%3Dliteratum%253Aachs%26aulast%3DCopeland%26aufirst%3DR.%2BA.%26aulast%3DPompliano%26aufirst%3DD.%2BL.%26aulast%3DMeek%26aufirst%3DT.%2BD.%26atitle%3DDrug-target%2520residence%2520time%2520and%2520its%2520implications%2520for%2520lead%2520optimization%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D730%26epage%3D739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Cai, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nikolovska-Coleska, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qiu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leopold, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2714</span><span class="NLM_x">–</span> <span class="NLM_lpage">2726</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm101505d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2714-2726&author=Q.+Caiauthor=H.+Sunauthor=Y.+Pengauthor=J.+Luauthor=Z.+Nikolovska-Coleskaauthor=D.+McEachernauthor=L.+Liuauthor=S.+Qiuauthor=C.-Y.+Yangauthor=R.+Millerauthor=H.+Yiauthor=T.+Zhangauthor=D.+Sunauthor=S.+Kangauthor=M.+Guoauthor=L.+Leopoldauthor=D.+Yangauthor=S.+Wang&title=A+potent+and+orally+active+antagonist+%28SM-406%2FAT-406%29+of+multiple+inhibitor+of+apoptosis+proteins+%28IAPs%29+in+clinical+development+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">A Potent and Orally Active Antagonist (SM-406/AT-406) of Multiple Inhibitor of Apoptosis Proteins (IAPs) in Clinical Development for Cancer Treatment</span></div><div class="casAuthors">Cai, Qian; Sun, Haiying; Peng, Yuefeng; Lu, Jianfeng; Nikolovska-Coleska, Zaneta; McEachern, Donna; Liu, Liu; Qiu, Su; Yang, Chao-Yie; Miller, Rebecca; Yi, Han; Zhang, Tao; Sun, Duxin; Kang, Sanmao; Guo, Ming; Leopold, Lance; Yang, Dajun; Wang, Shaomeng</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2714-2726</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery and characterization of SM-406 (compd. 2), a potent and orally bioavailable Smac mimetic and an antagonist of the inhibitor of apoptosis proteins (IAPs).  This compd. binds to XIAP, cIAP1, and cIAP2 proteins with Ki of 66.4, 1.9, and 5.1 nM, resp.  Compd. 2 effectively antagonizes XIAP BIR3 protein in a cell-free functional assay, induces rapid degrdn. of cellular cIAP1 protein, and inhibits cancer cell growth in various human cancer cell lines.  It has good oral bioavailability in mice, rats, non-human primates, and dogs, is highly effective in induction of apoptosis in xenograft tumors, and is capable of complete inhibition of tumor growth.  Compd. 2 is currently in phase I clin. trials for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgYOZBCwfnLrVg90H21EOLACvtfcHk0li4v02QOT_FsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvV2hurg%253D&md5=5b73a2ea1a5a2a6b3e3f4c978b49706f</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fjm101505d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm101505d%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DQ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DNikolovska-Coleska%26aufirst%3DZ.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DQiu%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DMiller%26aufirst%3DR.%26aulast%3DYi%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DKang%26aufirst%3DS.%26aulast%3DGuo%26aufirst%3DM.%26aulast%3DLeopold%26aufirst%3DL.%26aulast%3DYang%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DA%2520potent%2520and%2520orally%2520active%2520antagonist%2520%2528SM-406%252FAT-406%2529%2520of%2520multiple%2520inhibitor%2520of%2520apoptosis%2520proteins%2520%2528IAPs%2529%2520in%2520clinical%2520development%2520for%2520cancer%2520treatment%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2714%26epage%3D2726" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Petersen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyton, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minna, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X.</span><span> </span><span class="NLM_article-title">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x">, </span> <span class="NLM_fpage">11936</span><span class="NLM_x">–</span> <span class="NLM_lpage">11941</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1073%2Fpnas.1005667107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=20547836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2010&pages=11936-11941&author=S.+L.+Petersenauthor=M.+Peytonauthor=J.+D.+Minnaauthor=X.+Wang&title=Overcoming+cancer+cell+resistance+to+Smac+mimetic+induced+apoptosis+by+modulating+cIAP-2+expression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression</span></div><div class="casAuthors">Petersen, Sean L.; Peyton, Michael; Minna, John D.; Wang, Xiaodong</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">11936-11941, S11936/1-S11936/3</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Smac mimetics target cancer cells in a TNFα-dependent manner, partly via proteasome degrdn. of cellular inhibitor of apoptosis 1 (cIAP1) and cIAP2.  Degrdn. of cIAPs triggers the release of receptor interacting protein kinase (RIPK1) from TNF receptor 1 (TNFR1) to form a caspase-8 activating complex together with the adaptor protein Fas-assocd. death domain (FADD).  We report here a means through which cancer cells mediate resistance to Smac mimetic/TNFα-induced apoptosis and corresponding strategies to overcome such resistance.  These human cancer cell lines evades Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds and is refractory to subsequent degrdn. clAP2 is induced by TNFa via NF-κB and modulation of the NF-κB signal renders otherwise resistant cells sensitive to Smac mimetics.  In addn., other signaling pathways, including phosphatidyl inositol-3 kinase (PI3K), have the potential to concurrently regulate cIAP2.  Using the P13K inhibitor, LY294002, dAP2 up-regulation was suppressed and resistance to Smac mimetics-induced apoptosis was also overcome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpp5NQOxkS-wLVg90H21EOLACvtfcHk0li4v02QOT_FsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXovVartLg%253D&md5=278c84b651abd7af0357a7023977d54b</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1005667107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1005667107%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DS.%2BL.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DWang%26aufirst%3DX.%26atitle%3DOvercoming%2520cancer%2520cell%2520resistance%2520to%2520Smac%2520mimetic%2520induced%2520apoptosis%2520by%2520modulating%2520cIAP-2%2520expression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2010%26volume%3D107%26spage%3D11936%26epage%3D11941" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Darding, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feltham, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenev, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benetatos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meier, P.</span><span> </span><span class="NLM_article-title">Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1376</span><span class="NLM_x">–</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1038%2Fcdd.2011.10" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Fjm401075x&amp;key=21331077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm401075x&amp;key=1%3ACAS%3A528%3ADC%252BC3MXos1Gku7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1376-1386&author=M.+Dardingauthor=R.+Felthamauthor=T.+Tenevauthor=K.+Bianchiauthor=C.+Benetatosauthor=J.+Silkeauthor=P.+Meier&title=Molecular+determinants+of+Smac+mimetic+induced+degradation+of+cIAP1+and+cIAP2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2</span></div><div class="casAuthors">Darding, M.; Feltham, R.; Tenev, T.; Bianchi, K.; Benetatos, C.; Silke, J.; Meier, P.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death and Differentiation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1376-1386</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The inhibitors of apoptosis (IAP) proteins cIAP1 and cIAP2 have recently emerged as key ubiquitin-E3 ligases regulating innate immunity and cell survival.  Much of our knowledge of these IAPs stems from studies using pharmacol. inhibitors of IAPs, dubbed Smac mimetics (SMs).  Although SMs stimulate auto-ubiquitylation and degrdn. of cIAPs, little is known about the mol. determinants through which SMs activate the E3 activities of cIAPs.  In this study, we find that SM-induced rapid degrdn. of cIAPs requires binding to tumor necrosis factor (TNF) receptor-assocd. factor 2 (TRAF2).  Moreover, our data reveal an unexpected difference between cIAP1 and cIAP2.  Although SM-induced degrdn. of cIAP1 does not require cIAP2, degrdn. of cIAP2 critically depends on the presence of cIAP1.  In addn., degrdn. of cIAP2 also requires the ability of the cIAP2 RING finger to dimerize and to bind to E2s.  This has important implications because SM-mediated degrdn. of cIAP1 causes non-canonical activation of NF-κB, which results in the induction of cIAP2 gene expression.  In the absence of cIAP1, de novo synthesized cIAP2 is resistant to the SM and suppresses TNFα killing.  Furthermore, the cIAP2-MALT1 oncogene, which lacks cIAP2's RING, is resistant to SM treatment.  The identification of mechanisms through which cancer cells resist SM treatment will help to improve combination therapies aimed at enhancing treatment response.  Cell Death and Differentiation (2011) 18, 1376-1386; doi:10.1038/cdd.2011.10; published online 18 Feb. 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4NOSBSh10pbVg90H21EOLACvtfcHk0li4v02QOT_FsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXos1Gku7Y%253D&md5=9b2f69d64a67edb7c9def4b6b6e3602a</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2011.10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2011.10%26sid%3Dliteratum%253Aachs%26aulast%3DDarding%26aufirst%3DM.%26aulast%3DFeltham%26aufirst%3DR.%26aulast%3DTenev%26aufirst%3DT.%26aulast%3DBianchi%26aufirst%3DK.%26aulast%3DBenetatos%26aufirst%3DC.%26aulast%3DSilke%26aufirst%3DJ.%26aulast%3DMeier%26aufirst%3DP.%26atitle%3DMolecular%2520determinants%2520of%2520Smac%2520mimetic%2520induced%2520degradation%2520of%2520cIAP1%2520and%2520cIAP2%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2011%26volume%3D18%26spage%3D1376%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Bai, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McEachern, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span> </span><span class="NLM_article-title">LRIG1 modulates cancer cell sensitivity to Smac mimetics by regulating TNFα expression and receptor tyrosine kinase signaling</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1238</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=1229-1238&author=L.+Baiauthor=D.+McEachernauthor=C.-Y.+Yangauthor=J.+Luauthor=H.+Sunauthor=S.+Wang&title=LRIG1+modulates+cancer+cell+sensitivity+to+Smac+mimetics+by+regulating+TNF%CE%B1+expression+and+receptor+tyrosine+kinase+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBai%26aufirst%3DL.%26aulast%3DMcEachern%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DC.-Y.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DLRIG1%2520modulates%2520cancer%2520cell%2520sensitivity%2520to%2520Smac%2520mimetics%2520by%2520regulating%2520TNF%25CE%25B1%2520expression%2520and%2520receptor%2520tyrosine%2520kinase%2520signaling%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D1229%26epage%3D1238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Bellucci, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergamini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cozzi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagliavini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umani-Ronchi, A.</span><span> </span><span class="NLM_article-title">Catalytic asymmetric synthesis of secondary alcohols using chiral <i>cis</i>-1-amino-2-hydroxy-1,2,3,4-tetrahydronapthalene as chiral ligand</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=895-902&author=C.+M.+Bellucciauthor=A.+Bergaminiauthor=P.+G.+Cozziauthor=A.+Papaauthor=E.+Tagliaviniauthor=A.+Umani-Ronchi&title=Catalytic+asymmetric+synthesis+of+secondary+alcohols+using+chiral+cis-1-amino-2-hydroxy-1%2C2%2C3%2C4-tetrahydronapthalene+as+chiral+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBellucci%26aufirst%3DC.%2BM.%26aulast%3DBergamini%26aufirst%3DA.%26aulast%3DCozzi%26aufirst%3DP.%2BG.%26aulast%3DPapa%26aufirst%3DA.%26aulast%3DTagliavini%26aufirst%3DE.%26aulast%3DUmani-Ronchi%26aufirst%3DA.%26atitle%3DCatalytic%2520asymmetric%2520synthesis%2520of%2520secondary%2520alcohols%2520using%2520chiral%2520cis-1-amino-2-hydroxy-1%252C2%252C3%252C4-tetrahydronapthalene%2520as%2520chiral%2520ligand%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D895%26epage%3D902" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Winstein, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boschan, R.</span><span> </span><span class="NLM_article-title">The role of neighboring groups in replacement reactions. XVII. Complex neighboring groups. The benzamido group</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1950</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">4669</span><span class="NLM_x">–</span> <span class="NLM_lpage">4677</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja01166a090" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=1950&pages=4669-4677&author=S.+Winsteinauthor=R.+Boschan&title=The+role+of+neighboring+groups+in+replacement+reactions.+XVII.+Complex+neighboring+groups.+The+benzamido+group"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fja01166a090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja01166a090%26sid%3Dliteratum%253Aachs%26aulast%3DWinstein%26aufirst%3DS.%26aulast%3DBoschan%26aufirst%3DR.%26atitle%3DThe%2520role%2520of%2520neighboring%2520groups%2520in%2520replacement%2520reactions.%2520XVII.%2520Complex%2520neighboring%2520groups.%2520The%2520benzamido%2520group%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1950%26volume%3D72%26spage%3D4669%26epage%3D4677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Higashijima, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, S.</span><span> </span><span class="NLM_article-title"><i>cis</i>-1-Amino-1,2,3,4-tetrahydro-2-napthalenol: Resolution and application to the catalytic enantioselective reduction of ketones</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">3107</span><span class="NLM_x">–</span> <span class="NLM_lpage">3110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1997&pages=3107-3110&author=S.+Higashijimaauthor=H.+Itohauthor=Y.+Sendaauthor=S.+Nakano&title=cis-1-Amino-1%2C2%2C3%2C4-tetrahydro-2-napthalenol%3A+Resolution+and+application+to+the+catalytic+enantioselective+reduction+of+ketones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHigashijima%26aufirst%3DS.%26aulast%3DItoh%26aufirst%3DH.%26aulast%3DSenda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DS.%26atitle%3Dcis-1-Amino-1%252C2%252C3%252C4-tetrahydro-2-napthalenol%253A%2520Resolution%2520and%2520application%2520to%2520the%2520catalytic%2520enantioselective%2520reduction%2520of%2520ketones%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D1997%26volume%3D8%26spage%3D3107%26epage%3D3110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Lakshman, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zajc, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resnick, S. M.</span><span> </span><span class="NLM_article-title">A general chemoenzymatic synthesis of enantiopure cis β-amino alcohols from microbially derived cis-glycols</span> <span class="citation_source-journal">Synthesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1352</span><span class="NLM_x">–</span> <span class="NLM_lpage">1356</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm401075x&amp;key=10.1055%2Fs-1998-6082" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1998&pages=1352-1356&author=M.+K.+Lakshmanauthor=S.+Chaturvediauthor=B.+Zajcauthor=D.+T.+Gibsonauthor=S.+M.+Resnick&title=A+general+chemoenzymatic+synthesis+of+enantiopure+cis+%CE%B2-amino+alcohols+from+microbially+derived+cis-glycols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1055%2Fs-1998-6082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-1998-6082%26sid%3Dliteratum%253Aachs%26aulast%3DLakshman%26aufirst%3DM.%2BK.%26aulast%3DChaturvedi%26aufirst%3DS.%26aulast%3DZajc%26aufirst%3DB.%26aulast%3DGibson%26aufirst%3DD.%2BT.%26aulast%3DResnick%26aufirst%3DS.%2BM.%26atitle%3DA%2520general%2520chemoenzymatic%2520synthesis%2520of%2520enantiopure%2520cis%2520%25CE%25B2-amino%2520alcohols%2520from%2520microbially%2520derived%2520cis-glycols%26jtitle%3DSynthesis%26date%3D1998%26volume%3D30%26spage%3D1352%26epage%3D1356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Orsini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sello, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bestetti, G.</span><span> </span><span class="NLM_article-title">Enantiopure vic-amino alcohols and vic-diamines from (1<i>R</i>,2<i>S</i>)-1,2-dihydroxy-1,2-dihydronapthalene</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2961</span><span class="NLM_x">–</span> <span class="NLM_lpage">2969</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2001&pages=2961-2969&author=F.+Orsiniauthor=G.+Selloauthor=G.+Bestetti&title=Enantiopure+vic-amino+alcohols+and+vic-diamines+from+%281R%2C2S%29-1%2C2-dihydroxy-1%2C2-dihydronapthalene"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOrsini%26aufirst%3DF.%26aulast%3DSello%26aufirst%3DG.%26aulast%3DBestetti%26aufirst%3DG.%26atitle%3DEnantiopure%2520vic-amino%2520alcohols%2520and%2520vic-diamines%2520from%2520%25281R%252C2S%2529-1%252C2-dihydroxy-1%252C2-dihydronapthalene%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2001%26volume%3D12%26spage%3D2961%26epage%3D2969" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Shieh, W.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKenna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prasad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Repic, O.</span><span> </span><span class="NLM_article-title">Synthesis of sterically-hindered peptidomimetics using 4-(4,6-dimethoxy-1,3,5-triazine-2-yl)-4-methyl-morpolinium chloride</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5359</span><span class="NLM_x">–</span> <span class="NLM_lpage">5362</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=5359-5362&author=W.-C.+Shiehauthor=Z.+Chenauthor=S.+Xueauthor=J.+McKennaauthor=R.-M.+Wangauthor=K.+Prasadauthor=O.+Repic&title=Synthesis+of+sterically-hindered+peptidomimetics+using+4-%284%2C6-dimethoxy-1%2C3%2C5-triazine-2-yl%29-4-methyl-morpolinium+chloride"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShieh%26aufirst%3DW.-C.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DS.%26aulast%3DMcKenna%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DR.-M.%26aulast%3DPrasad%26aufirst%3DK.%26aulast%3DRepic%26aufirst%3DO.%26atitle%3DSynthesis%2520of%2520sterically-hindered%2520peptidomimetics%2520using%25204-%25284%252C6-dimethoxy-1%252C3%252C5-triazine-2-yl%2529-4-methyl-morpolinium%2520chloride%26jtitle%3DTetrahedron%2520Lett.%26date%3D2008%26volume%3D49%26spage%3D5359%26epage%3D5362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Vu, T. C.; Brzozowksi, D. B.; Fox, R.; Godfrey, J. D.; Hanson, R. L.; Kolotuchin, S. V.; Mazzullo, J. A.; Patel, R. N.; Wang, J.; Wong, K.; Yu, J.; Zhu, J.; Magnin, D. R.; Augeri, D. J.; Hamann, L. G.</span><span> </span><span class="NLM_article-title">Methods and compounds producing dipeptidyl peptidase IV inhibitors and intermediates thereof</span>. Patent WO2004052850,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=T.+C.+Vu&author=D.+B.+Brzozowksi&author=R.+Fox&author=J.+D.+Godfrey&author=R.+L.+Hanson&author=S.+V.+Kolotuchin&author=J.+A.+Mazzullo&author=R.+N.+Patel&author=J.+Wang&author=K.+Wong&author=J.+Yu&author=J.+Zhu&author=D.+R.+Magnin&author=D.+J.+Augeri&author=L.+G.+Hamann&title=Methods+and+compounds+producing+dipeptidyl+peptidase+IV+inhibitors+and+intermediates+thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DT.%2BC.%26atitle%3DMethods%2520and%2520compounds%2520producing%2520dipeptidyl%2520peptidase%2520IV%2520inhibitors%2520and%2520intermediates%2520thereof%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Nötzel, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labahn, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Es-Sayed, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Meijere, A.</span><span> </span><span class="NLM_article-title">A new and efficient access to thiazoline-4-carboxylates and cysteine derivatives incorporating cyclopropyl groups</span> <span class="citation_source-journal">Eur. J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_fpage">3025</span><span class="NLM_x">–</span> <span class="NLM_lpage">3030</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=3025-3030&author=M.+W.+N%C3%B6tzelauthor=T.+Labahnauthor=M.+Es-Sayedauthor=A.+de+Meijere&title=A+new+and+efficient+access+to+thiazoline-4-carboxylates+and+cysteine+derivatives+incorporating+cyclopropyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DN%25C3%25B6tzel%26aufirst%3DM.%2BW.%26aulast%3DLabahn%26aufirst%3DT.%26aulast%3DEs-Sayed%26aufirst%3DM.%26aulast%3Dde%2BMeijere%26aufirst%3DA.%26atitle%3DA%2520new%2520and%2520efficient%2520access%2520to%2520thiazoline-4-carboxylates%2520and%2520cysteine%2520derivatives%2520incorporating%2520cyclopropyl%2520groups%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2001%26spage%3D3025%26epage%3D3030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Walker, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wrobel, P. J.</span><span> </span><span class="NLM_article-title">Stereospecific cis radical addition. Convincing evidence for a 1,3-radical transfer reaction</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_fpage">462</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1980&pages=462-463&author=B.+J.+Walkerauthor=P.+J.+Wrobel&title=Stereospecific+cis+radical+addition.+Convincing+evidence+for+a+1%2C3-radical+transfer+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWalker%26aufirst%3DB.%2BJ.%26aulast%3DWrobel%26aufirst%3DP.%2BJ.%26atitle%3DStereospecific%2520cis%2520radical%2520addition.%2520Convincing%2520evidence%2520for%2520a%25201%252C3-radical%2520transfer%2520reaction%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1980%26spage%3D462%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i87"><a href="/doi/suppl/10.1021/jm401075x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_62220"></div></div></div></div></div><hr /></hr><p class="last">Procedures for cIAP1, cIAP2, and XIAP binding assays, MDA-MB-231 cell assays, in vivo experiments, and pharmacokinetic experiments; representative fluorescence polarization titration curves for compound <b>14</b>; western blots of MDA-MB-231 cells treated with different concentrations of <b>14</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm401075x/suppl_file/jm401075x_si_001.pdf">jm401075x_si_001.pdf (664.94 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm401075x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-24%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm401075x%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm401075x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799c1951a6c192e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
